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By simply hydrogenating enones in the presence of aldehydes at ambient 
temperature and pressure, aldol adducts are generated under neutral conditions in the 
absence of any stoichiometric byproducts. Using cationic rhodium complexes modified 
by tri(2-furyl)phosphine, highly syn-diastereoselective reductive aldol additions of vinyl 
ketones are achieved. Finally, using novel monodentate TADDOL-like phosphonite 
ligands, the first highly diastereo- and enantioselective reductive aldol couplings of vinyl 
ketones were devised. These studies, along with other works from our laboratory, 
demonstrate that organometallics arising transiently in the course of catalytic 
hydrogenation offer byproduct-free alternatives to preformed organometallic reagents 
employed in classical carbonyl addition processes. Existing methods for enantioselective 
 vi
carbonyl allylation, crotylation and tert-prenylation require stoichiometric generation of 
pre-metallated nucleophiles, and often employ stoichiometric chiral modifiers. Under the 
conditions of transfer hydrogenation employing an ortho-cyclometallated iridium C,O-
benzoate catalyst, enantioselective carbonyl allylations, crotylations and tert-prenylations 
are achieved in the absence of stoichiometric metallic reagents or stoichiometric chiral 
modifiers. Moreover, under transfer hydrogenation conditions, primary alcohols function 
dually as hydrogen donors and aldehyde precursors, enabling enantioselective carbonyl 
addition directly from the alcohol oxidation level. 
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Chapter 1 Total Synthesis of Antifungal Macrolide Antibiotic Roxaticin  
1.1 INTRODUCTION 
The polyene macrolide antibiotics consist of more than 200 members.1 Some of 
these natural products such as nystatin, amphotericin B and pimaricin, have been used as 
medicine for a long time. For example, amphotericin B is used in the treatment of fungal 
infections; it forms ion channels in the cell to exhibit antifungal activity.2 Many of the 
oxo polyene macrolide antibiotics are produced from antinomyces soil bacteria that  
 
 
Figure 1.1 Representative examples of oxo polyene macrolides. 
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belongs to the genera Strepotomyces. Some of the oxo polyene macrolides are shown in 
Figure 1.1. 
Among the oxo polyene macrolides, mycoticin was isolated and its structure was 
first determined.3 Since then, many natural products of this family were isolated and 
their structures were revealed. Even though the structures of the members in this family 
are very challenging to make, many organic chemists have been attracted to their unique 
structures and efficacy as a medicine.4 Amphotericin B was first synthesized among the 
class by Nicolaou in 1988.5 The total synthesis of mycoticin A,6 roxaticin,7 filipin III,8 
roflamycoin,9  RK-39710  and dermostatin11  then followed. Roxticin is the smallest 
member in the family, and was isolated in 1992.12 Like the other members within its 
class, it also shows antifungal activity. The structure was determined by X-ray analysis of 
the heptaacetate derivative (Figure 1.2).12 Similar to the family, it consists of alternating 
polyene chain and both syn-, anti-1,3-diol units; this interesting structure has been 
synthesized by Rychnovsky7a, Mory7b-d and Evans groups.7e This review focuses on the 
total synthesis of roxaticin and methodologies employed for this construction.  
 
 
Figure 1.2 Roxaticin heptaacetate X-ray structure (acetates omitted for clarity). 
 
 3
1.2 SYNTHESIS OF (-)-ROXATICIN BY RYCHONOVSKY GROUP. 
1.2.1 Synthetic plan 
(-)-Roxaticin was first synthesized Rynchnovsky’s group in 1994.7a The synthesis 
mainly used alkylation and reductive decyanation of cyanohydrin acetonides.13 Due to 
the instability of the polyene fragment, it was introduced at the late stage of the synthesis. 
As shown in Scheme 1.1, the Horner-Emmons Witting reaction was exploited for 
macrocyclic ring formation. The polyene piece was synthesized through two sequential 
Grignard additions, leading to fragment 1.I. C23-C24 and C19-C18 was connected by  
 
 
Scheme 1.1 Rychnovsky’s retrosynthetic analysis of (-)-roxaticin. 
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alkylation reaction, resulting in three fragments 1.II, 1.III and 1.IV. Fragment 1.II was 
generated from isobutyronitrile via Blaise reaction, enantioselective reduction and Wittig 
coupling reaction. The dibromide 1.III was synthesized from pentanedione.14  The 
cyanohydrins acetonide 1.IV was obtained from tert-butyl acetoacetate using Noyori’s 
reduction15 and Frater-Seebach alkylation.16 
1.2.2 Synthesis of cyanohydrin aectonide fragment 1.II 
Rynchnovsky’s group used Kishi’s modified Blaise reaction17 to construct 2,4-
dimethyl-3-oxopentanonate 1.2, which was proved to be very effective. [((R)-
BINAP)RuCl2]2•Et3N18 was used for the enantioselective reduction of 1.2 (Scheme 1.2). 
Interestingly, 7:1 mixture of syn:anti products 1.3 were produced at 80 oC rather than 
previously reported 1:1 mixture of the products.15 Because the reduction is slower than 
the epimerization of 1.2, the reduction became more selective. The alcohol 1.3 was 
obtained in 94% yield and the enantioselectivity of the syn isomer was proved to 58% ee 
after Mosher’s ester analysis.19 Reduction of the ester and recrystallization afforded diol 
1.4, which was obtained in >98% ee. Even though the selectivity of asymmetric 
hydrogenation was moderate, this route was more practical than the route previously 
reported by Helqust20 due to the facile recrystallization. Protection of both alcohols and 
selective deprotection produced monoprotected TBS ether 1.5. The optically pure 
unsaturated ester 1.6 was obtained through Swern oxidation and Wittig reaction in 98% 
yield. DIBAL-H reduction of 1.6 and sequential Leys’s catalytic oxidation21 generated 
the corresponding aldehyde 1.7 in high yield. Brown’s Ipc2BCH2CH=CH2 reagent was  
 5
 
Scheme 1.2 Synthesis of cyanohydrin aectonide fragment 1.II. 
 
successfully applied for allylation of aldehyde 1.7 to set the last stereogenic center of 
1.II. Having the alcohol protected with TES group, dihydroxylation with OsO4 was 
conducted to produce triol 1.9. Direct oxidation from unprotected alcohol gave only 11% 
yield of product with other competitive oxidation side products (Scheme 1.3). 
Presumably bulky TES protecting group prevented the oxidation of the internal olefin.  
 
 
Scheme 1.3 Direct oxidation reaction. 
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Oxidative cleavage with NaIO4, followed by cyanide exchange and acetonide protection 
produced fragment 1.II in 78% yield from 1.9. 
1.2.3 Synthesis of dibromide fragment 1.III 
The copper(II) complex 1.11 was isolated when 2,4-pentanedione 1.10 was 
treated with AlCl3, ClCH2C(O)Cl and Cu(OAc)2 (Scheme 1.4). 22  This crystalline 
complex 1.11 was asymmetrically hydrogenated using Noyori’s catalyst23 to produce diol 
1.12 which was then treated with KOH to give diepoxide 1.13 in 89% yield. Dibromide 
1.III was prepared from diepoxide 1.13 in two step sequences. First the epoxide was 




















Key: (a) AlCl3, ClCH2C(O)Cl, 60 oC, Cu(OAc)2; (b) H3O+, [((S)-BINAP)RuCl2]2Et3N, H2 1200 psi, 120 oC, MeOH, recrystallize; (c) KOH, Et2O; (d)
Li2NiBr4, 25 oC, THF; (e) 2,2-DMP, CSA, Acetone
2
1.10 1.11 1.12 1.13 1.III
 
Scheme 1.4 Synthesis of dibromide fragment 1.III. 
 
1.2.4 Synthesis of cyanohydrins acetonide fragment 1.IV 
β-keto ester 1.15 was synthesized by the alkylation reaction with NaH, n-BuLi 
and chlromethyl benzyl ether in 50% yield (Scheme 1.5). The ester 1.15 was then 
subjected to asymmetric hydrogenation with [((R)-BINAP)RuCl2]2•Et3N18 prepared in 
situ. This reaction was improved when acidified with HCl at 45 oC.25 The selectivity of 
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the reaction was 96% ee. The ester 1.16 was alkylated according to Frater-Seebach 
protocol,16 which gave a 10:1 mixture of anti and syn isomers in 75% yield. Reduction of 
1.17 and acetonide protection produced protected ether 1.18. The benzyl group of 1.18 
was cleaved using Pearlman’s catalytic hydrogenation condition. The resulting alcohol 
1.19 was oxidized and then subjected to Brown’s allylation reaction, resulting in a single 
homoallylic alcohol product, which was isolated as TMS ether 1.21 after protection. 
Oxidation with OsO4, cyanation with TMSCN and KCN/18-crown-6, followed by 
acetonide protection produced fragment IV. 
 
Scheme 1.5 Synthesis of cyanohydrin aectonide fragment 1.IV. 
1.2.5 Endgame of (-)-roxaticin 
The three fragments 1.II, 1.III and 1.IV were combined by alkylation and  
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Scheme 1.6 Endgame of (-)-roxaticin. 
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reductive decyanation protocols (Scheme 1.6). Dibromide 1.III was alkylated with 
cyanohydrin acetonide 1.IV. In this reaction, excess of the dibromide was used to avoid 
overalkylation. Similar reaction condition was used for the second alkylation of 1.23, but 
1.II was used in 2-fold excess. Reductive elimination of the cyano group was performed 
with 10 equiv. of lithium di-tert-butylbiphenylide (LiDBB). Under these reaction 
conditions, the three fragments were successfully combined to afford tetraacetonide 1.24. 
TES enol ether from 1.24 was obtained when the tetraacetonide 1.24 was treated with 
TESOTf and i-Pr2NEt in DCM at 110 oC. The resulting enol ether was directly 
hydrolyzed with OsO4 to give alcohol 1.25. After protection of alcohol 1.25 with 1,3-
benzodithiolyl tetrafluoroborate, deprotection of silyl groups and introduction of 
phosphonoacetate gave alcohol 1.27. Dess-Martin oxidation produced the corresponding 
aldehyde 1.28, which was then subjected to the modified Wollenberg polyene synthesis 
reaction.26 The Grignard reagent generated from the corresponding tributyl tin was added 
to aldehyde 1.28 and the elimination was conducted with MsCl and Et3N. The same 
sequence of the reaction was repeated to generate tetraenal 1.30. For the cyclization 
reaction, Roush-Masamune cyclization protocol was used,27 which gave cyclized product 
1.31 in moderate yield. Grobal deprotection with Dowex H+ gave (-)-roxaticin. 
1.2.6 Summary 
The unnatural (-)-roxaticin was first synthesized by Rychnovsk group. The 
synthesis was completed in 31 steps from isobutyronitrile (longest linear sequence), with 
a total number of 51 steps. Most of the stereogenic centers were constructed using Noyori 
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asymmetric hydrogenation, Rychnovsk’s reductive decyanation, and Brown’s 
enantioselective allylation reaction. Tthe first highly convergent synthesis of polyene 





















1.3 SYNTHESIS OF (+)-ROXATICIN BY MORY GROUP. 
1.3.1 Synthetic plan 
Mory’s group synthesized the (+)-roxaticin in 1994.7b,c,d Their synthetic plan was 
shown in Scheme 1.7. The macrocyclic ring was formed using the Yamaguchi method.28 
Due to the light sensitive nature of the oxo pentaene moiety was introduced at the last 
stage using Horner-Wadsworth-Emmons protocol.29 Internal olefin was generated via 
Julia olefination reaction.30 These reactions led to fragments 1.V, 1.VI and 1.VII. 
Fragment 1.VII was formed from fragments 1.VIII, 1.VIIII and 1.X through three 
sequential alkylation reactions. These three fragments were generated from (S), (R)-
glycidols and (S)-diethyl malate. 
 
Scheme 1.7 Mory’s retrosynthetic analysis of (+)-roxaticin. 
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1.3.2 Synthesis of sulfone fragment 1.V 
The sulfone fragment 1.V was synthesized from 1.32 using Evan’s auxiliary 
(Scheme 1.8).31 Isobutryaldehyde was successfully coupled with 1.33 to give the aldol 
product 1.34 in 93% yield. Aldol compound 1.34 was protected with THP, and the 
auxiliary was cleaved with LiAlH4 to produce primary alcohol 1.35. Direct cleavage of 
the auxiliary from 1.34 failed and a decarbonylated byproduct was formed. After 
deprotection of the THP group, the primary alcohol was selectively tosylated (1.36). The 
tosyl group was replaced by a phenylthio group and the remaining secondary alcohol was 
protected with PMB (1.37). Final oxidation of the sulfide 1.37 with m-CPBA afforded 
sulfone fragment 1.V.  
 
 
Scheme 1.8 Synthesis of sulfone fragment 1.V. 
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1.3.3 Synthesis of tetraene phosphonate fragment 1.VI 
Originally, Mory group attempted to use Hanessian’s protocol for the synthesis of 
tetraene phosphonate 1.VI (Scheme 1.9).32 Due to the difficulty of C-C bond cleavage, 
they developed their own sequence of synthesizing fragment 1.VI. Diol 1.38 was 
monoprotected with TBDPSCl in 48% yield. After oxidation of alcohol 1.39 with MnO2, 
Wittig reaction with Vedejs reagent33 was conducted to produce unstable tetraene ester 
1.41 as a mixture of E and Z isomers. Silyl deprotection with Bu4NF and photochemical 
isomerization generated all-trans tetraene alcohol 1.42 in 63% yield. Finally, bromination 
with PBr3 and treatment with triethyl phosphate produced desired tetrahene phosphonate 
fragment 1.VI in 73% yield (Scheme 1.10). 
 
Scheme 1.9 Wittig reaction with Vedejs reagent. 
 
Scheme 1.10 Synthesis of tetraene phophonate fragment 1.VI. 
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1.3.4 Synthesis of chiral building blocks 1.VIII, 1.VIIII and 1.X. 
Fragments 1.VIII and 1.VIIII were synthesized from (S) and (R)-glycidol (1.43 
and 1.45). The glycidols were protected with TESCl and the epoxides were opened with 
2-lithio-1,3-dithiane, which gave the corresponding alcohols (1.44 and 1.46). 
Deprotection of the TES group and subsequent protection with benzophenone dimethyl 
ketal produced desired chiral building blocks 1.VIII and 1.VIIII (Scheme 1.11). 
 
 
Scheme 1.11 Synthesis of chiral building blocks 1.VIII and VIIII. 
 
Chiral epoxide 1.X was synthesized from (S)-diethyl malate 1.47 (Scheme 1.12). 
Methylation of 1.47 under the condition of Frater-Seebach methylation16 followed by 
reduction with LiAlH4 produced triol 1.48.34 Benzaldehyde dimethyl acetal protection 
generated the more favored six membered benzylidene product 1.49. Regioselective 
reductive cleavage was conducted in the presence of DIBAL-H and desired ether 1.50 
was successfully made in 70% yield. Finally, tosylation of the secondary alcohol and 
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treatment of the resulting product with t-BuOK generated chiral epoxide 1.X in 65% 
yield. 
 
Scheme 1.12 Synthesis of the chiral building block 1.X. 
1.3.5 Synthesis of fragment 1.VII. 
Chiral epoxide 1.X and dithiane 1.VIIII were coupled with n-BuLi to generate 
alkylated dithiane 1.51 in 74% yield (Scheme 1.13). Treatment of the dithiane 1.51 with 
Hg(ClO4)2 in aqueous THF produced β-hydroxy ketone 1.52, which was subjected to a 
diastereoselective reduction. Syn-diol 1.53 was generated in 97% yield with very high 
selectivity (syn:anti=99.7:0.3) when ketone 1.52 was treated with NaBH4 in the presence 
of Et2BOMe. Acetonide protection of the diol and protecting group swap produced 
diphenylmethylene ketal 1.52. It was necessary to change the protecting group from 
benzyl to TBS group because diphenylmethylene ketal group could be reductively 
cleaved in the later stage. The reductive cleavage was successfully conducted with Li and 
NH3 to generate diol 1.55. Chiral epoxide 1.56 was generated with the same condition of 
making chiral expoxide 1.X. Similiar sequence of the reactions was conducted to 
generate chiral epoxide 1.60. Alkylation followed by hydrolysis gave β-hydroxy ketone 
1.57. Anti-selective reduction was successfully conducted with Me4NBH(OAc)3 to 
produce the corresponding anti-diol in 95% yield with 97:3 diastereoselecivity. 
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Scheme 1.13 Synthesis of fragment 1.VII. 
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Acetonide protection (1.58), diphenylmethylene group deprotection (1.59) and 
epoxidation gave chiral epoxide 1.60. Again, alkylation with 1.VIII, anit-selective 
reduction and deprotection gave diol 1.63. Monoprotected product 1.64 was generated 
with the sequential protection group manipulation. The final oxidation of the primary 
alcohol produced fragment 1.VII. 
1.3.6 Endgame of (+)-roxaticin 
Coupling reaction of fragments 1.VII and 1.V was conducted under Julia  
 
Scheme 1.14 Endgame of (+)-roxaticin. 
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olefination condition30 to generate trans-disubstituted olefin 1.66 in 51% yield with 9:1 
mixture of E and Z isomers (Scheme 1.14). TBS deprotection and subsequent oxidation 
gave a PMB protected aldehyde. The PMB group was successfully cleaved with DDQ to 
produce aldehyde 1.67, which was then subjected to olefination reaction with 1.VI. 
Aldehyde 1.67 was treated with the phosphonate anion generated in situ gave seco-ester 
1.68 in 94% yield. Finally, the Yamaguchi method28 modified by Yonemitsu35 was 
conducted to generate macrolactone 1.69. Global deprotection produced (+)-roxaticin. 
1.3.7 Summary 
The synthesis was completed in 45 steps from (S)-diethyl malate (longest linear 
sequence), with a total number of 71 steps. Most of the stereogenic centers were 
constructed with diastereoselective reductions and Evans aldol reaction. The synthesis 
mainly depended on 1,3-polyol synthesis in an iterative fashion with four-carbon units. 
Interestingly, macrolactonization was conducted at the last stage of the synthesis using 









1.4 SYNTHESIS OF (+)-ROXATICIN BY EVANS GROUP. 
1.4.1. Synthetic plan 
Evan synthesis7e also used the late stage introduction of oxo pentanes like Mory 
group synthesis,7b,c,d which led to two fragments 1.XI and 1.XII. The internal double 
bond was formed by Julia olefination.30 C21-C22 and C19-C20 bonds were generated 
through aldol reaction, which gave four fragments, 1.XIII, 1.XIV, 1.XV and 1.XVI. 
Sulfone fragment 1.XIII was constructed from isobutyaldehyde using asymmetric aldol 
reaction. Fragment 1.XIV was formed under the addition of Chan’s diene analogue to 
(benzyloxy)acetaldehyde. Ketone fragment 1.XVI was generated by aldol and sequential 
homolgation reactions.  
 
Scheme 1.15 Synthetic plan of (+)-roxaticin by Evans’ group. 
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1.4.2 Synthesis of tetraene phosphonate fragment 1.XI 
Evans group synthesized the polyene fragment 1.XI in a single stereocontrolled 
step because most of other cases used repetitive and stepwise methods. This synthesis 
started with one-pot electrocyclic ring closure and Hg(II) mediated transacetylation  
reaction to produce compound 1.71 in 88% yield. Treatment of the compound 1.71 with 
LiAlH4 and O2 produced dialdehyde 1.72 through 2-electron oxidative ring fragmentation 
and olefin isomerization. Immediate treatment of 1.72 with sodium hydride and 
triethylphosphonacetate generated monoester-monoaldehyde, which was reduced with 
NaBH4 to produce compound 1.73. Allylic bromide was produced with SOBr2, and a 

























Key: (a) Hg(OAc)2, AcOH; (b) LiAlH4, THF, 0 oC to rt, then O2; (c) triethylphosphonoacetate, NaH, -78 oC to rt, THF; (d) NaBH4, EtOH; (e) SOBr2,
2,6-di-ter t-butylpyridine, -20 oC, THF; (f) (EtO)3P, toluene, 110 o C
1.XI
1.70 1.71 1.72 1.73
 
Scheme 1.16 Synthesis of tetraene phosphonate fragment 1.XI. 
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1.4.3 Synthesis of sulfone fragment 1.XIII 
Sulfone fragment 1.V was synthesized from 1.74 with the Evan’s auxiliary 
(Scheme 1.17).31 Compound 1.77 was successfully coupled with isobutyraldehyde using 
boron-mediated aldol reaction to produce aldol product 1.78. Cleavage of the auxiliary 
with LiBH4 and protection provided p-anisaldehyde dimethylacetal 1.79. Selective 
cleavage gave primary alcohol 1.80 with DIBAL-H, Mesylation, displacement of lithium 
thiophenylate, and with m-CPBA generated the sulfone fragment 1.XIII. These three 
sequential steps were conducted without purification in 96% yield. 
 
 
Scheme 1.17 Synthesis of sulfone fragment 1.XIII. 
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1.4.4 Synthesis of fragment 1.XIV 
Fragment 1.XIV began with the coupling of Chan’s diene analogue 1.83 and 
(benyloxy)acetaldehyde using [Cu((S,S)-Ph-pybox)](SbF6)2 as catalyst (Scheme 1.18). 
The corresponding product 1.84 was reduced with Et2BOMe and NaBH4 to generate syn- 
diol, which was bis-protected with TBS groups. Under the hydrogenation condition with 




Scheme 1.18 Synthesis of fragment 1.XIV. 
 
1.4.5 Synthesis of ketone fragment 1.XVI 
The synthesis of ketone fragment 1.XVI began with Evans auxiliary chemistry. 
Asymmetric aldol reaction using titanium enolate generated from propionyl 
oxazolidinone 1.86 afforded 1.87, which was then subjected to auxiliary cleavage with 
LiBH4, followed by oxidation to give chiral aldehyde 1.88 (Scheme 1.19). This sequence 
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of reactions provided large quantities of enantiomerically pure aldehyde 1.88 in 85% 
yield over three steps. Keck’s allylation method36 was adopted for constructing 
homoallylic alcohol 1.89. This chelation-cotrolled allylation provided 35:1 anti-
diastereoseletivity in 90% yield. TES protection followed by ozonolysis provided 
aldehyde intermediate that was subjected to homologation with N-methoxy-N-methyl-2-
(triphenylphosphoranylidene) acetamide to generate amide 1.90 in 86% yield. 
Intramolecular hemiacetal conjugate addition of amide 1.90 produced syn-protected 
actetal 1.91 with benzaldehyde in the presence of catalytic amount of KHMDS. The 
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Key: (a) TiCl4, NEt3, BnOCH2Cl, 0 oC, CH2Cl2; (b) LiBH4, 0 oC, THF; (c) SO3.pyr, DMSO, -10 oC, CH2Cl2; (d) allyltributyltin, SnCl4, -78 oC, CH2Cl2;
(e) TESCl, imidazole, CH2Cl2; (f) O3, Ph3P, N-MeO-N-Me(triphenylphosphoranylidene)-acetamide, TsOH, CH2Cl2; (g) cat. KHMDS, PhCHO, 0 oC,
















Scheme 1.19 Synthesis of ketone fragment 1.XVI. 
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incompatibility of reductive reaction at the later stage. Final treatment with MeLi 
provided desired ketone fragment 1.XVI in 92% yield.37 
1.4.6 Endgame of (+)-roxaticin 
The synthesis of roxaticin began with the coupling reaction of fragments 1.XIII 
and 1.XIV (Scheme 1.20). Deprotonation of the sulfone 1.XIII with n-BuLi and 
subsequent addition of BF3•OEt2 and aldehyde 1.XIV afforded β-hydroxy sulfones.30 
Treatment with Na/Hg amalgam in buffered methanol generated E-olefin 1.94. TBS ether 
protection groups were exchanged with cyclopentylidene ketal group (1.95) for better 
selectivity at the later stage of the synthesis. Upon oxidation state manipulation, aldehyde 
1.96 was generated and was subjected to aldol reaction. Diastereoselecivity of the 
reaction was 5-7:1 With BF3•OEt2 and the mixture was protected with TBS group to give 
thioester 1.97. Reduction with DIBAL-H and aldol reaction with fragment 1.XVI gave 
aldol product 1.99 in 79% yield as a single isomer. Subsequent reduction was performed 
with Me4NHB(OAc), at -35 °C to produce the corresponding anti-diol as a single isomer. 
After protection with cyclopentylidene ketal (1.100), the benzyl group was reductively 
cleaved with LiDBB to generate the primary alcohol, which was oxidized under Dess-
Martin oxidation condition (1.101). The PMB group was successfully cleaved with DDQ 
to produce substrate 1.102 for the olefination reaction with 1.XI. Treatment of aldehyde 
1.102 with the phosphonate anion generated in situ by LiHMDS gave the seco-ester 
1.103 in 83% yield. Yamaguchi latonization28 provided the macrolactone 1.104 in 66% 


















































































































































Key: (a) n-BuLi, BF3OEt2, -78 oC, THF; (b) Na/Hg, Na2HPO4, -40 oC to 23 oC, MeOH; (c) HFpyr, THF; (d) cyclopentylidene dimethyl ketal, PPTS,
CH2Cl2; (e) LiAlH4, THF; (f) Dess-Martin, CH2Cl2; (g) BF3OEt2, -90 oC, toluene; (h) TBSOTf, 2,6-lutidine, -78 oC, CH2Cl2; (i) DIBAl-H, -78 oC,
toluene; (j) BuBOTf, NEt3, -78 oC to 100 oC, Et2O; (k) Me4NBH(OAc)3, -25 oC, CH3CN, AcOH; (l) cyclopentylidene dimethyl ketal, PPTS, CH2Cl2;
(m) LiDBB, -78 oC, THF; (n) Dess-Martin, CH2Cl2; (o) DDQ, H2O, CH2Cl2; (p) 3, LiHMDS, -78 oC, THF; (q) LiOH, THF, H2O, MeOH; (r) 2,4,6-
trichlorobenzoyl chloride, NEt3, DMAP, 23 oC, toluene; (s) PPTS, MeOH









Scheme 1.20 Endgame of (+)-roxaticin. 
 26
1.103’ needed more harsh condition than cyclopentylidene ketals 1.103 to affore the 
corresponding cyclized compound 1.104’ (Scheme 1.21). More significantly, 
deproteciton of the acetonide gave only less than 10% yield of the natural product. 
 
Scheme 1.21 Synthesis of (+)-roxaticin from acetonide protected acid 1.103’. 
 
1.4.7 Summary 
The synthesis was completed in 29 steps from (L)-phenyl alanine (longest linear 
sequence), with a total number of 52 steps. Most of the stereogenic centers were 
constructed by asymmetric aldol reactions using chiral auxiliaries. In this synthesis, new 
approach of generating the polyene fragment was illustrated. Among the previous 







Chapter 2 Rhodium-Catalyzed Aldol Coupling Reaction under 
Hydrogenation Condition 
2.1 REDUCTIVE ALDOL COUPLING OF DIVINYL KETONES VIA RHODIUM-CATALYZED 
HYDROGENATION 
2.1.1 Background 
Following seminal studies by Revis (1987),1a the catalytic reductive coupling of 
α,β-unsaturated carbonyl compounds and aldehydes to form aldol products, termed the 
“reductive aldol reaction”, has been the subject of intensive investigation. To date, 
catalysts for reductive aldol coupling based on rhodium,1, 2  cobalt, 3  iridium, 4 a 
palladium,4b copper,4c-g and indium4h have been described. Further, highly diastereo-
1c,2e,3b-d,4e,h,i and enantioselective1d,g,h,4a,f,g variants have been achieved. The majority of 
catalytic systems for reductive aldol coupling employ acrylate pronucleophiles in 
combination with hydrosilanes as the terminal reductant. Krische and coworkers have 
developed conditions for hydrogen-mediated reductive aldol coupling that are applicable 
to commercially available methyl and ethyl vinyl ketones (MVK and EVK).2a,e 
Furthermore, upon the use of cationic rhodium catalysts ligated by tri-2-furylphosphine, 
exceptionally high levels of syn-diastereo-selection are observed.2e,5 Remarkably, under 
the conditions of hydrogen-mediated aldol coupling, functional groups borne by the 
aldehyde that are generally considered “hydrogen labile” (alkynes, alkenes, benzylic 
ethers, and nitroarenes) remain intact.2e These results support the feasibility of couplings 
involving vinyl ketones that incorporate unsaturated functional groups.  
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2.1.2 Reaction optimization 
 
Our initial studies focused on the reductive coupling of crotyl vinyl ketone 2.1a to 
p-nitrobenzaldehyde under our previously developed conditions for syn-selective aldol 
coupling.2e To our delight, crotyl vinyl ketone 2.1a (200 mol%) was subjected to 
hydrogenation at ambient temperature and pressure in the presence of p-
nitrobenzaldehyde 2.2a (100 mol%) to furnish hydroxyenone 2.3a in 72% isolated yield 
with an 8:1 syn/anti ratio (Scheme 2.1).  
 
 
Scheme 2.1 reductive coupling of croty vinyl ketone to aldehyde. 
 
In the hope of improving chemical yield and diastereoselectivity, solvent, reaction 
temperature and concentration were screened. Unfortunately the better reactivity and 
selectivity were not obtained. Finally, alternate rhodium precatalysts such as 
Rh(cod)2BARF (BARF=[3,5-(CF3)2C6H3]4B-), Rh(cod)2BF4 and Rh(cod)2SbF6 were 
screened. Upon use of Rh(cod)2BARF, a substantial increase in diastereoselectivity is 
observed, but the isolated yield of hydroxyenone 2.3a is diminished considerably (Table 
2.1, entry 2). Similarly, upon use of Rh(cod)2BF4, a 61% isolated yield of coupling 
product 2.3a is obtained with a 9:1 diastereomeric ratio (Table 2.1, entry 3). Gratifyingly, 
upon use of Rh(cod)2SbF6 as the precatalyst, hydroxyenone 2.3a is produced in 82% 
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isolated yield with a 13:1 diastereomeric ratio, representing an improvement in both yield 
and stereoselectivity in comparison to the reaction employing Rh(cod)2OTf as the 
precatalyst (Table 2.1, entry 4). 
 
 
Table 2.1 Counterion effects in the hydrogen-mediated reductive aldol coupling of 
divinyl ketone 2.1a to p-nitrobenzaldehyde 2.2a employing cationic rhodium precatalyts. 
 
Under optimized conditions using Rh(cod)2SbF6 as the precatalyst and (2-Fur)3P 
as the ligand, the hydrogen-mediated aldol coupling of crotyl vinyl ketone 2.1a to diverse 
aldehydes 2.2a-e was conducted at ambient temperature and pressure (Table 2.2). High 
levels of syn-diastereoselection were observed using aromatic aldehydes (2.3a, 82% 
yield, 13:1 dr), α-heteroatom substituted aldehydes (2.3b, 80% yield, 9:1 dr; 2.3c, 85% 
yield, 13:1 dr), heterocyclic aromatic aldehydes (2.3d, 94% yield, 11:1 dr), and α,β-
unsaturated aldehydes (2.3e, 75% yield, 12:1 dr). Notably, the unsaturated products 2.3a-
e are not subject to overreduction under the conditions of hydrogen-mediated coupling 
due to a diminished rate of conjugate reduction in response to substitution of the enone 
moiety. Generally, reactions are complete within 7 h, as determined by consumption of 
the aldehyde. If the couplings are allowed to continue beyond this point, product 
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overreduction becomes evident. As a control experiment, hex-4-en-3-one and p-
nitrobenzaldehyde were exposed to standard coupling conditions, and aldol addition 
product 2.3a was not formed. Finally, upon reexposure of aldol addition product 2.3a to 
standard coupling conditions, 2.3a was recovered in high yield without any noticeable 
erosion in diastereoselectivity. This latter experiment suggests that hydrogen-mediated 



















































































Table 2.2 Hydrogen-mediated aldol coupling of crotyl vinyl enone 2.1a to aldehydes 
2.2a-e. 
 
As one would anticipate, crotyl vinyl ketone 2.1a is somewhat unstable with 
respect to polymerization and must be used immediately upon isolation. Accordingly, 
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crystalline divinyl ketones of enhanced stability were sought, which led to the preparation 
of para-substituted styryl vinyl enones 2.1b-e. With the exception of 2.1c, these 
compounds are crystalline materials that may be stored for prolonged periods of time in 
the dark. To evaluate their reactivity in the reductive aldol coupling, styryl vinyl enones 
2.1b-e (150 mol %) were hydrogenated in the presence of p-nitrobenzaldehyde (100 
mol %) at ambient temperature and pressure using Rh(cod)2SbF6 as the precatalyst (Table 
2.3). As reflected by the isolated yield of aldol coupling products 2.4b-e, it was found 
that the reaction responds remarkably to the effect of remote electron-withdrawing or -
releasing groups. For example, whereas para-nitrostyryl vinyl enone 2.1b provides only a 
44% isolated yield of aldol coupling product 2.4b (Table 2.3, entry 1), the corresponding 
para-(dimethylamino)styryl vinyl enone 2.1e furnishes aldol coupling product 2.4e in 
93% yield under identical coupling conditions (Table 2.3, entry 4). These effects may be 
attributed to modulation of the HOMO energies of the intermediate rhodium enolates, 
with more reactive rhodium enolates being derived from precursors possessing electron-
releasing p-styryl substituents. It is also interesting to note that diastereoselectivity 
decreases with increasing enolate reactivity, presumably due to intervention of boatlike 
transition structures, or increased isomerization of enolate geometry in advance of aldol 
coupling. As previously hypothesized,2e it is believed that Z-(O)-enolate formation occurs 
with high levels of kinetic stereospecificity by way of internal hydride delivery to the 
enone s-cis conformer through a six-centered transition structure.6 Addition of the Z-(O)-
enolate to the aldehyde through a Zimmerman-Traxler-type transition structure would 





























































Table 2.3. Reductive aldol coupling of styryl vinyl ketones. 
 
Under standard conditions using Rh(cod)2SbF6 as the catalyst precursor and Fur3P 
as the ligand, the hydrogen- mediated aldol coupling of para-(dimethylamino)styryl vinyl 
ketone 2.1e to aldehydes 2.2a-e was conducted at ambient temperature and pressure 
(Table 2.4). Again, highly syn-diastereoselective coupling is observed for aromatic 
aldehydes (2.5a, 93% yield, 10:1 dr), α-heteroatom-substituted aldehydes (2.5b, 90% 
yield, 10:1 dr; 2. 5c, 81% yield, 17:1 dr), heterocyclic aromatic aldehydes (2.5d, 87% 
yield, 11:1 dr), and α,β-unsaturated aldehydes (2.5e, 71% yield, 13:1 dr). Unlike adducts 
2.3a-e, the para-(dimethylamino)styryl containing adducts 2.5a-e are far less susceptible 
to overreduction under the conditions of hydrogen-mediated C-C coupling. Additionally, 
























































































To illustrate the relevance of this methodology with respect to the synthesis of 
polypropionate-derived substructures, aldol coupling product 2.3b was subjected to 
several different transformations (Scheme 2.2). Exposure of 2.3b to conditions for syn-
diastereoselective hydroxy-directed reduction affords the syn-1,3-diol containing 
stereotriad 2.6a with a diastereomeric ratio of 13:1.8 Access to the corresponding anti-
1,3-diol 2.6b is achieved upon treatment of 2.3b with NaHB(OAc)3. 9  Here, a 
diastereomeric ratio of 10:1 is observed. As illustrated by the conversion of 2.6a to 2.6c, 
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the crotyl residue may serve as a masked aldehyde, enabling entry into higher polyols. 








Rhodium-catalyzed hydrogenation of divinyl ketones 2.1a and 2.1e in the 
presence of aldehydes 2.2a-e results in highly syn-diastereoselective reductive aldol 
coupling to afford the α,β-unsaturated coupling products 2.3a-e and 2.5a-e, respectively, 
without overreduction. As revealed by a survey of counterions (Rh(cod)2X, where X = 
OTf, BF4, SbF6, BARF), Rh(cod)2SbF6 is identified as the optimum precatalyst for 
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reductive aldol couplings of this type. Finally, for para-substituted styryl vinyl ketones 
2.1b-e, a progressive increase in isolated yield in response to the presence of electron-
releasing para-substituents is observed. These studies offer further insight into the 
structural and interactional features of the catalytic system required for efficient 
hydrogen-mediated aldol coupling and provide new methods for the construction of 














2.2 DIASTEREO- AND ENANTIOSELECTIVE HYDROGENATIVE ALDOL COUPLING OF 
VINYL KETONES 
2.2.1 Background 
The reductive coupling of α,β-unsaturated carbonyl compounds to aldehydes and 
ketones, termed the “reductive aldol reaction”, has become the topic of intensive 
investigation.11 Enantioselective reductive aldol couplings of vinyl ketones, such as 
methyl vinyl ketone (MVK), would enable access to branched aldol adducts, providing a 
regiochemical complement to direct organocatalytic and metal catalyzed aldol couplings 
of nonsymmetric ketones, such as 2-butanone, which furnish linear aldol adducts (eqn. 
1).12 In 2002, catalytic hydrogenation of vinyl ketones in the presence of aldehydes 
results in reductive aldol coupling to furnish branched aldol adducts as diastereomeric 
mixtures.13a Later (2006), it was found that high levels of syn-diastereoselectivity in 
hydrogen-mediated reductive aldol couplings of vinyl ketones are obtained through the 
use of tri-2-furylphosphine (Fur3P) ligated rhodium catalysts (eqn. 2).13b-d However, to 


































Major Product Not formed
(Minor Product)
Not formed 62-92% Yield
8:1 - 50:1 dr (rac)
(co-solvent)
(150 mol%)
Direct Catalytic Asymmetric Aldol Addition






2.2.2 Reaction optimization 
The initial screen for the asymmetric reductive aldol reaction began with 
attempting to couple methyl vinyl ketone and aldehyde 2.7b under hydrogenation 
condition with various chiral ligands (Table 2.5). As indicated in Table 2.5, most of the 
ligands showed low to moderate selectivity. Efforts toward enantioselective variants of 
such hydrogenative aldol couplings were especially challenging due to the fact that (a) 
only trace quantities of product are obtained using chelating phosphine ligands (Table 
2.5, entry 1), (b) π-acidic ligands such as Fur3P are required to enforce high levels of 
diastereoselection, yet (c) commercially available π-acidic chiral monodentate ligands, for  
 




example, BINOL-derived phosphites and phosphoramidites, are presumably too π-acidic 
and provide only trace quantities of product.(Table 2.5, entry 4, 5 and 6) 
To address the issue, the design, preparation and assay of novel chiral 
monodentate P-based ligands were undertaken. Over a period of years numerous ligands 
were assayed, yet those displaying promising levels of asymmetric induction were not 
amenable to facile and systematic structural variation. Hence, a versatile template 
enabling well-defined structure-selectivity trends was sought. TADDOL-like 
phosphonites14 present three structural elements that may be independently optimized: 
(a) the P-aryl moiety (R1), (b) the ketal substructure (R3), and (c) the groups appended to 
the tertiary carbinol center (R2). (Figure 2.1) 
 
 
Figure 2.1 TADDOL-like phosphonite ligand. 
 
Initially different P-aryl moieties (R1) were screened while R2 and R3 were fixed 
as a methyl group (Table 2.6). Furyl substitution gave excellent reactivity (90% yield) 
and moderate selectivity (59% ee) (Table 2.6, entry 1). 2-methyl furyl gave only 52% 
product with poor selectivity (50% ee) (Table 2.6, entry 2). When the furyl group was 
changed to benzofuryl, product 2.8a was produced with moderate reactivity (64% yield) 
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a conducted by Dr. Cisco Bee  
Table 2.6 Screen for R1 group of TADDOL-like phosphonites ligands. 
 
position gave very high selectivity (80% ee) but poor reactivity (20% yield) (Table 2.6, 
entry 4).  
Having set the benzofuryl group as R1, R2 group was investigated. Changing R2 
group from methyl to ethyl and even phenyl group resulted in poor reactivity with 32% 
and 15% yield, respectively. Methyl was used since evne though ethyl gives good 
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a conducted by Dr. Cisco Bee  
 
Table 2.7 R2 group screen in synthesis of TADDOL-like phosphonite ligands. 
 
Finally, the ketal substructure (R3) groups were tested. When the size of the group 
is increased from methyl to ethyl, the selectivity (75% ee) and reactivitiy (75% yield) 
were increased (Table 2.8, entry 2). However, further increasing to n-propyl group did 
not help to increase the reactivity and selectivity (Table 2.8, entry 3). Cyclic ketals such 
as cyclohexyl group improved the yield of product (90%) but only moderate selectivity 
(56% ee) was observed (Table 2.8, entry 4). Adamantyl group also displayed only 
moderate reactivity and selectivity (Table 2.8, entry 5). Based on the results, ethyl group 




Table 2.8 Screen for R3 group of TADDOL-like phosphonite ligands. 
 
Gratifyingly further screens of R1 group revealed a benzothiophene group gave 
better results than benzofuran (Table 2.9, entry 2). Lowering the reaction temperature 
also helped to increase the reactivity and selectivity (Table 2.9, entry 3). Optimal 
efficiencies and selectivities were observed using the preformed Rh complex I derived 
from Rh(cod)2OTf and benzothiphene substituted ligand AP-I as a precatalyst. Under 
these reaction conditions, aldehyde 2.7a is transformed to the syn-aldol 2.8a with 




Table 2.9 Optimization of asymmetric hydrogenative aldol reaction. 
 
The scope of the preformed AP-I ligated Rh complex I was examined in 
reductive aldol couplings of MVK to diverse aldehydes. Beyond aldehyde 2.7a, benzyl 
protected aldehyde 2.7b (Table 2.10, entry 2), β-heteroatom substituted aldehyde 2.7c 
(Table 2.10, entry 3) and α-(hetero)aryl aldehydes 2.7d, 2.7e, and 2.7f (Table 2.10, entry 
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a conducted by Dr. Cisco Bee, b conducted by Abbas Hassan  
 
Table 2.10 Diastereo- and enantioselective aldol coupling of methyl vinyl ketone to 
aldehdes 2.7a-f. 
 
An identical set of aldehydes were tested with ethyl vinyl ketone under the 
hydrogenation condition. Generally, slightly better reactivity but similar selectivity were 
observed (Table 2.11)  
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a conducted by Dr. Cisco Bee, b conducted by Abbas Hassan
Li2CO3 (10 mol%)
DCM (1 M), 0 oC
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Table 2.11 Diastereo- and enantioselective aldol coupling of ethyl vinyl ketone to 
aldehdes 2.7a-f. 
 
Single crystal X-ray diffraction analysis of [Rh(cod)(L)2]OTf (L = the acetonide 
of AP-I) reveals a C2-symmetric arrangement around Rh (Figure 2.2). Based upon the 
hypothesis that a similar metal-ligand arrangement is evident in the stereo-determining 
event, ligands AP-II and AP-IV were also designed. For ligands AP-II and AP-IV the 






























Top View  
aThe figure graphics are depictions of crystallographic data imported into ChemDraw Ultra 9.0. For clarity, the following 
substructures were omitted. Top: The methyl groups and triflate ion. Front: The methyl groups, triflate ion and 1,5-cyclooctadiene. 
Side: The methyl groups, triflate ion, dioxolane rings and phosphonite oxygen atoms 
Figure 2.2 Structure of [Rh(cod)(L)2]OTf (L = the acetonide analogue of AP-I) 
determined by X-ray diffraction reveals C2-symmetric arrangement. 
 
thus potentially conferring heightened levels of enantioselection. The veracity of this 
analysis is supported by the fact that AP-II and AP-IV are both found to induce higher 
levels of optical enrichment, whereas AP-III, which projects the methyl residue into an 




Table 2.12 Enantioselective aldol coupling of MVK to BnO(CH2)2CHO using ligands 





In summary, we report the first enantioselective reductive aldol coupling of vinyl 
ketones, which were achieved through the design of an effective new class of TADDOL-
like phosphonite ligands. This study further demonstrates that organometallics arising 
transiently in the course of catalytic hydrogenation offer a byproduct free alternative to 
preformed organometallic reagents, for example enol(ate) derivatives, employed 



















To a solution of hexa-1,4-dien-3-ol (1.0 g, 10.2 mmol, 100 mol%) in CH2Cl2 (50 
mL) at 0 oC was added MnO2 (8.86 g, 101.9 mmol, 999 mol%). The reaction mixture was 
allowed to stir for 12 hours at ambient temperature, at which point the reaction mixture 
was filtered through a pad of celite with the aid of Et2O. The resulting solution was 
evaporated and the residue was purified by flash chromatography (SiO2: Et2O/pentane) to 
afford the title compound (380 mg, 3.95 mmol) as a viscous yellow solid (39 % yield). 
TLC: Rf 0.3 (Et2O/pentane, 1/10). 1H NMR (300 MHz, CDCl3): δ 6.96 (dq, J = 15.6, 6.9 
Hz, 1H), 6.60 (dd, J = 17.4, 10.5 Hz, 1H), 6.40 (dq, J = 15.6, 1.8 Hz, 1H), 6.28 (dd, J = 
17.4, 1.5 Hz, 1H), 5.82 (dd, J = 10.5, 1.5 Hz, 1H), 1.95 (dd, J = 6.9, 1.8 Hz, 3H). 13C 
NMR (75 MHz, CDCl3): δ 189.6, 144.1, 134.8, 129.7, 128.3, 18.5. HRMS Calcd. for 
C6H8O (M+1): 97.0653, Found: 97.0653. FTIR (NaCl film): 1666, 1635, 1611, 1443, 


























To a solution of vinylmagnesium bromide (1.0 M in THF, 25.6 mL, 25.6 mmol, 
113 mol%) was added a solution of 3-(4-nitro-phenyl)-propenal (4.0 g, 22.6 mmol, 100 
mol%) in THF (25 mL) at -78 oC. The reaction mixture was allowed to stir for 2 hours at 
ambient temperature, at which point the reaction mixture was cooled to 0 oC and 
saturated NH4Cl (aq.) was added. The reaction mixture was extracted with Et2O (3 times). 
The combined organic phases were dried (MgSO4), filtered, and evaporated. The residue 
was purified by flash chromatography (SiO2: EtOAc/hexane) to afford the title compound 
(3.33 g, 16.2 mmol) as a yellow solid (72 % yield). 
TLC: Rf 0.4 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 8.20-8.17 (m, 2H), 
7.53-7.50 (m, 2H), 6.71 (d, J = 15.9 Hz, 1H), 6.42 (dd, J = 15.9, 5.7 Hz, 1H), 5.97 (ddd, J 
= 17.1, 10.5, 6.0 Hz, 1H), 5.38 (d, J = 17.1 Hz, 1H), 5.25 (d, J = 10.5 Hz, 1H). 4.88 (ddd, 
J = 6.0, 5.7, 3.6 Hz, 1H), 1.86 (d, J = 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 147.3, 
143.4, 138.8, 135.4, 128.5, 127.3, 124.3, 116.6, 73.7. HRMS Calcd. for C11H11NO3 
(M+1): 206.0817, Found: 206.0816. FTIR (NaCl film): 3384, 1595, 1513, 1343, 1109, 





1H NMR  
 
 









To a solution of 1-(4-nitro-phenyl)-penta-1,4-diene-3-ol (1.89 g, 9.21 mmol, 100 
mol%) in CH2Cl2 (50 mL) at 0 oC was added MnO2 (8.00 g, 92.1 mmol, 1000 mol%). The 
reaction mixture was allowed to stir for 12 hours at ambient temperature, at which point 
the reaction mixture was filtered through a pad of celite with the aid of Et2O. The 
resulting solution was evaporated and the residue was purified by flash chromatography 
(SiO2: EtOAc/hexane) to afford the title compound (590 mg, 2.90 mmol) as a yellow 
solid (32 % yield). 
TLC: Rf 0.3 (EtOAc/hexane, 1/7). 1H NMR (300 MHz, CDCl3): δ 8.28-8.26 (m, 2H), 
7.75-7.73 (m, 2H), 7.69 (d, J = 12.0 Hz, 1H), 7.13 (d, J = 12.0 Hz, 1H), 6.71 (dd, J = 
12.9, 8.1 Hz, 1H), 6.43 (dd, J = 12.9, 0.9 Hz, 1H), 5.98 (dd, J = 8.1, 0.9 Hz, 1H). 13C 
NMR (75 MHz, CDCl3): δ 188.8, 140.8, 140.7, 135.4, 129.7, 128.9, 127.3, 124.2. HRMS 
Calcd. for C12H14O2 (M+1): 204.0661, Found: 204. 0663. FTIR (NaCl film): 2360, 1655, 






1H NMR  
 








To a solution of 1-(4-methoxy-phenyl)-penta-1,4-dien-3-ol (2.32 g, 12.19 mmol, 
100 mol%) in CH2Cl2 (50 mL) at 0 oC was added MnO2 (10.60 g, 121.95 mmol, 1000 
mol%). The reaction mixture was allowed to stir for 12 hours at ambient temperature, at 
which point the reaction mixture was filtered through a pad of celite with the aid of Et2O. 
The resulting solution was evaporated and the residue was purified by flash 
chromatography (SiO2: EtOAc/hexane) to afford the title compound (1.56 g, 8.29 mmol) 
as a yellow solid (68 % yield). 
TLC: Rf 0.3 (EtOAc/hexane, 1/4). 1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 15.9 Hz, 
1H), 7.56-7.53 (m, 2H), 6.94-6.91 (m, 2H), 6.80 (d, J = 15.9 Hz, 1H), 6.71 (dd, J = 17.4, 
10.5 Hz, 1H), 6.36 (dd, J = 17.4, 1.5 Hz, 1H), 5.85 (dd, J = 10.5, 1.5 Hz, 1H), 3.85 (s, 
3H). 13C NMR (75 MHz, CDCl3): δ 189.5, 161.7, 143.8, 135.5, 130.1, 128.1, 127.3, 
122.0, 114.4, 55.4. HRMS Calcd. for C12H12O2 (M+1): 189.0916, Found: 189.0912. FTIR 
(NaCl film): 2966, 1652, 1619, 1600, 1571, 1511, 1462, 1423, 1403, 1306, 1255, 1221, 





1H NMR  
 








To a solution of vinylmagnesium bromide (1.0 M in THF, 37.1 mL, 37.1 mmol, 
130 mol%) was added a solution of 3-(4-dimethylamino-phenyl)-propenal (5.0 g, 28.5 
mmol, 100 mol%) in THF (25 mL) at -78 oC. The reaction mixture was allowed to stir for 
2 hours at ambient temperature, at which point the reaction mixture was cooled to 0 oC 
and saturated NH4Cl (aq.) was added. The reaction mixture was extracted with Et2O (3 
times). The combined organic phases were dried (MgSO4), filtered, and evaporated. The 
residue was purified by flash chromatography (SiO2: EtOAc/hexane) to afford the title 
compound (4.29 g, 21.1 mmol) as a viscous yellow oil (74 % yield). 
TLC: Rf 0.3 (EtOAc/hexane, 1/4). 1H NMR (300 MHz, CDCl3): δ 7.29-7.26 (m, 2H), 
6.68-6.66 (m, 2H), 6.52 (d, J = 15.9 Hz, 1H), 6.03 (dd, J = 15.9, 7.2 Hz, 1H), 5.99 (ddd, J 
= 17.4, 10.5, 5.7 Hz, 1H), 5.32 (d, J = 17.4 Hz, 1H), 5.17 (d, J = 10.5 Hz, 1H). 4.77 (dd, J 
= 7.2, 5.7 Hz, 1H), 2.96 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 150.2, 139.7, 131.3, 
127.5, 125.9, 124.8, 114.9, 112.3, 74.3, 40.4. HRMS Calcd. for C13H17NO (M): 
203.1310, Found: 203.1312. FTIR (NaCl film): 3362, 2885, 2360, 1609, 1521, 1444, 





1H NMR  
 









To a solution of 1-(4-dimethylamino-phenyl)-penta-1,4-dien-3-ol (2.12 g, 10.43 
mmol, 100 mol%) in CH2Cl2 (50 mL) at 0 oC was added MnO2 (9.06 g, 104.30 mmol, 
1000 mol%). The reaction mixture was allowed to stir for 12 hours at ambient 
temperature, at which point the reaction mixture was filtered through a pad of celite with 
the aid of Et2O. The resulting solution was evaporated and the residue was purified by 
flash chromatography (SiO2: EtOAc/hexane) to afford the title compound (1.47 g, 7.30 
mmol) as a red solid (70 % yield).  
TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 7.64 (d, J = 15.9 Hz, 
1H), 7.48-7.45 (m, 2H), 6.79 (d, J = 15.9 Hz, 1H), 6.68 (dd, J = 17.4, 10.5 Hz, 1H), 6.67-
6.64 (m, 2H), 6.33 (dd, J = 17.4, 1.5 Hz, 1H), 5.77 (dd, J = 10.5, 1.5 Hz, 1H), 3.01 (s, 
6H). 13C NMR (75 MHz, CDCl3): δ 189.3, 152.0, 144.8, 135.6, 130.2, 127.1, 119.4, 
111.7, 40.0. HRMS Calcd. for C13H15NO (M+1): 202.1232, Found: 202.1231. FTIR 






1H NMR  
 






Generarl Procedure for Reductive Aldol coupling of Divinyl ketones via Rhodium-
Catalyzed Hydrogenation 
To a 13 mm × 100 mm test-tube were added Li2CO3 (3.9 mg, 0.05 mmol, 10 
mol%), (2-Fur)3P (13.9 mg, 0.06 mmol, 12 mol%), Rh(cod)2SbF6 (13.9 mg, 0.025 mmol, 
5 mol%), aldehyde (0.5 mmol, 100 mol%) and CH2Cl2 (0.5 mL, 1.0 M). The test-tube 
was sealed and the reaction system was purged with Ar(g) and H2(g) for 20 seconds each. 
The reaction system was placed under one atmosphere of hydrogen using a balloon and 
divinyl ketone (1.0 mmol, 200 mol%) was added to the reaction mixture. The reaction 
mixture was allowed to stir at ambient temperature for 7 hours, at which point the 
reaction mixture was directly deposited onto a column of silica and purified 





TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 8.22-8.19 (m, 2H), 
7.55-7.52 (m, 2H), 6.99 (dq, J = 15.6, 6.9 Hz, 1H), 6.19 (dq, J = 15.6, 1.8 Hz, 1H), 5.24 
(d, J = 2.7 Hz, 1H), 3.93 (br, 1H), 3.03 (dq, J = 7.2, 2.7 Hz, 1H), 1.95 (dd, J = 6.9, 1.8 
Hz, 3H), 1.03 (d, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 204.2, 149.3, 147.0, 
145.3, 130.0, 126.7, 123.3, 71.9, 48.8, 18.3, 10.1. HRMS Calcd. for C13H15NO4 (M): 
 60
250.1079; Found: 250.1082. FTIR (NaCl film): 3461, 2975, 2937, 2369, 1683, 1651, 
1624, 1605, 1519, 1441, 1375, 1347, 1201, 1108, 1056, 970, 854, 749, 707, 668 cm-1. 
 
1H NMR  
 








TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 7.37-7.26 (m, 5H), 6.91 
(dq, J = 15.6, 6.9 Hz, 1H), 6.16 (dq, J = 15.6, 1.5 Hz, 1H), 4.52 (s, 2H), 4.04-4.14 (m, 
1H), 3.53-3.41 (m, 2H), 3.01 (dq, J = 7.2, 5.4 Hz, 1H), 2.91 (d, J = 3.3Hz, 1H), 1.90 (dd, 
J = 6.9, 1.5 Hz, 3H), 1.16 (d, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 203.6, 
143.9, 137.8, 130.8, 128.4, 127.7, 73.3, 71.5, 70.6, 45.0, 18.3, 11.8. HRMS Calcd. for 
C12H20O3 (M+1): 249.1491, Found: 249.1497. FTIR (NaCl film): 3447, 2912, 2360, 1654, 
1626, 1453, 1374, 1101, 970, 738, 698, 668 cm-1. 











TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 7.87-7.84 (m, 2H), 
7.74-7.33 (m, 2H), 6.92 (dq, J = 15.6, 6.9 Hz, 1H), 6.19 (d, J = 15.6 Hz, 1H), 4.32-4.22 
(m, 1H), 3.87 (dd, J = 14.1, 4.5 Hz, 1H), 3.73 (dd, J = 14.1, 7.8 Hz, 1H), 3.26 (br, 1H), 
2.88 (m, 1H), 1.91 (d, J = 6.9 Hz, 3H), 1.29 (d, J = 7.2 Hz, 3H). 13C NMR (75 MHz, 
CDCl3): δ 203.2, 168.5, 144.3, 134.0, 131.9, 130.1, 123.3, 69.5, 45.8, 41.3, 18.3, 11.0. 
HRMS Calcd. for C16H17NO4 (M+1): 288.1236, Found: 288.1234. FTIR (NaCl film): 
 63
3472, 2937, 2360, 1772, 1712, 1625, 1431, 1395, 1190, 1034, 969, 714 cm-1. M.P.: 110-
112 oC. 
 
1H NMR  
 








TLC: Rf 0.5 (EtOAc/hexane, 1/2). 1H NMR (300 MHz, CDCl3): δ 7.59-7.48 (m, 2H), 
7.38-7.35 (m, 2H), 6.99 (dq, J = 15.6, 6.9 Hz, 1H), 6.20 (dq, J = 15.6, 1.5 Hz, 1H), 5.12 
(dd, J = 3.3, 3.3 Hz, 1H), 4.04 (d, J = 3.3 Hz, 1H), 3.43 ( dq, J = 6.9, 3.3 Hz, 1H), 1.93 
(dd, J = 6.9, 1.5 Hz, 3H), 1.93 (dd, J = 6.9, 1.5 Hz, 3H), 1.00 (d, J = 6.9 Hz, 3H). 13C 
NMR (75 MHz, CDCl3): δ 204.5, 162.5, 144.8, 140.9, 138.8, 130.1, 126.3, 119.9, 72.8, 
47.3, 18.3, 10.3. HRMS Calcd. for C12H14BrNO2 (M+1): 284.0286, Found: 284.0283. 
FTIR (NaCl film): 3443, 2973, 2935, 2360, 1684, 1653, 1626, 1582, 1555, 1437, 1406, 
1375, 1290, 1199, 1157, 1127, 1044, 986, 969, 933, 788, 747, 697 cm-1. 










TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 7.94-7.91 (m, 1H), 
7.57-7.56 (m, 2H), 7.42-7.26 (m, 1H), 7.10 (d, J = 15.9 Hz, 1H), 6.98 (dq, J = 14.7, 6.9 
Hz, 1H), 6.22 (d, J = 14.7 Hz, 1H), 6.16 (dd, J = 15.9, 5.7 Hz, 1H), 4.70 (dd, J = 5.7, 3.3 
Hz, 1H), 3.24 (br, 1H), 3.01( dq, J = 7.5, 3.3 Hz, 1H), 1.95 (d, J = 6.9 Hz, 3H), 1.23 (d, J 
= 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 204.0, 147.7, 144.6, 134.8, 133.0, 132.6, 
130.4, 128.8, 128.0, 126.3, 124.4, 71.8, 47.7, 18.3, 11.1. HRMS Calcd. for C15H17NO4 
(M+1): 276.1236, Found: 276.1238. FTIR (NaCl film): 3447, 2973, 2933, 2359, 2341, 
 66
1685, 1654, 1624, 1570, 1522, 1441, 1345, 1302, 1199, 1042, 967, 860, 785, 742, 668 
cm-1. 
 
1H NMR  
 









TLC: Rf 0.3 (EtOAc/hexane, 1/2). 1H NMR (300 MHz, CDCl3): δ 8.29-8.26 (m, 5H), 
7.74-7.71 (m, 2H), 7.59-7.56 (m, 2H), 6.91 (d, J = 15.9 Hz, 1H), 3.61 (d, J = 2.4 Hz, 1H), 
3.14 (dq, J = 7.5, 2.7 Hz, 1H), 1.15 (d, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 
203.5, 149.2, 149.1, 147.5, 141.5, 140.4, 129.4, 127.7, 127.1, 124.5, 124.0, 123.8, 72.2, 
51.0, 10.3. HRMS Calcd. for C18H16NO6 (M+1): 357.1087, Found: 357.1083. FTIR (NaCl 
film): 3495, 3107, 2360, 1684, 1596, 1516, 1344, 1108, 848 cm-1. M.P.: 140-142 oC. 
 










TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 8.24-8.21 (m, 
2H), 7.67 (d, J = 15.9 Hz, 1H), 7.59-7.56 (m, 4H), 7.45-7.41 (m, 3H), 6.80 (d, J = 15.9 
Hz, 1H), 5.36-5.30 (m, 1H), 3.94 (br, 1H), 3.15 (dq, J = 7.5, 2.7 Hz, 1H), 1.12 (d, J = 7.5 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 204.3, 149.2, 144.6, 133.9, 131.1, 129.0, 128.5, 
126.8, 124.0, 123.4, 72.0, 49.8, 10.1. HRMS Calcd. for C18H17NO4 (M+1): 312.1236, 
Found: 312.1241. FTIR (NaCl film): 3445, 2941, 1678, 1603, 1575, 1517, 1449, 1345, 
1184, 1107, 1051, 982, 852, 764, 707 cm-1. 
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TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 8.23-8.20 (m, 
2H), 7.63 (d, J = 15.9 Hz, 1H), 7.59-7.52 (m, 4H), 6.95-6.92 (m, 2H), 6.67 (d, J = 15.9 
Hz, 1H), 5.34-5.30 (m, 1H), 4.08 (br, 1H), 3.86 (s, 3H), 3.12 (dq, J = 7.5, 2.7 Hz, 1H), 
1.10 (d, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 204.3, 162.1, 149.3, 147.0, 
144.5, 130.4, 126.8, 126.5, 123.4, 121.7, 114.5, 72.1, 55.4, 49.5, 10.2. HRMS Calcd. for 
C19H19NO5 (M+1): 342.1341, Found: 342.1344. FTIR (NaCl film): 3448, 2935, 1596, 
1571, 1511, 1458, 1422, 1345, 1255, 1172, 1108, 1028, 984, 853, 828, 705 cm-1. M.P.: 
98-90 oC. 
1H NMR  
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TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 8.24-8.21 (m, 2H), 
7.63 (d, J = 15.9 Hz, 1H), 7.59-7.56 (m, 2H), 7.49-7.46 (m, 2H), 6.58 (d, J = 15.9 Hz, 
1H), 5.24-5.26 (m, 1H), 4.34 (br, 1H), 3.12 (dd, J = 7.5, 2.7 Hz 1H), 3.06 (s, 6H), 1.08 (d, 
J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 204.3, 152.3, 149.5, 146.6, 130.6, 126.8, 
123.3, 121.3, 118.6, 111.7, 72.2, 48.9, 39.9, 10.4. HRMS Calcd. for C20H22N2O4 (M): 
 72
354.1580, Found: 354.1581. FTIR (NaCl film): 3421, 2916, 1574, 1523, 1434, 1369, 
1344, 1182, 1052, 853, 815 cm-1. M.P.: 114-116 oC. 
 
1H NMR  
 
 








TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 7.57 (d, J = 15.9 Hz, 
1H), 7.46-7.43 (m, 2H), 7.33-7.26 (m, 5H), 6.68-6.65 (m, 2H), 6.58 (d, J = 15.9 Hz, 1H), 
4.53 (s, 2H), 4.19-4.10 (m, 1H), 3.58-3.46 (m, 2H), 3.14-2.98 (m, 8H), 1.23 (d, J = 6.9 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 203.7, 152.0, 144.5, 137.9, 130.3, 128.3, 127.7, 
127.6, 121.8, 120.0, 111.7, 73.3, 71.7, 70.9, 45.3, 40.0, 12.2. HRMS Calcd. for 
C22H27NO3 (M+1): 354.2069, Found: 354.2067. FTIR (NaCl film): 3454, 2921, 1579, 
1525, 1433, 1365, 1227, 1182, 1063, 984, 945, 815, 737, 698 cm-1. 
 
1H NMR  
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TLC: Rf 0.5 (EtOAc/hexane, 1/1). 1H NMR (300 MHz, CDCl3): δ 7.86-7.83 (m, 2H), 
7.72-7.69 (m, 2H), 7.56 (d, J = 15.6 Hz, 1H), 7.45-7.42 (m, 2H), 6.69-6.64 (m, 2H), 6.58 
(d, J = 15.6 Hz, 1H), 4.36-4.31 (m, 1H), 3.91 (dd, J = 14.1, 8.1 Hz, 1H), 3.55 (dd, J = 
14.1, 4.5 Hz, 1H), 3.53(br, 1H), 3.03 (s, 6H), 3.03-2.90 (m, 1H), 1.36 (d, J = 7.2 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 203.3, 168.4, 152.0, 144.8, 133.9, 131.8, 130.3, 123.2, 
121.6, 119.1, 111.6, 69.5, 46.0, 41.3, 39.9, 11.2. HRMS Calcd. for C23H24N2O4 (M+1): 
 75
393.1814, Found: 393.1810. FTIR (NaCl film): 3463, 2922, 2368, 1710, 1577, 1524, 
1432, 1394, 1366, 1183, 1033, 816, 714 cm-1. M.P.: 154-156 oC. 
 













TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 7.62 (d, J = 15.9 Hz, 
1H), 7.56-7.34 (m, 5H), 6.69-6.66 (m, 2H), 6.60 (d, J = 15.9 Hz, 1H), 5.19 (d, J = 3.0 Hz, 
1H), 4.33 (br, 1H), 3.52 (dq, J = 7.2, 3.0 Hz, 1H), 3.04 (s, 6H), 1.05 (d, J = 7.2 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 204.7, 162.8, 152.1, 145.2, 140.9, 138.7, 130.4, 126.2, 
121.6, 119.2, 111.6, 73.2, 47.5, 39.9, 10.7. HRMS Calcd. for C19H21BrN2O2 (M+1): 
389.0865, Found: 389.0865. FTIR (NaCl film): 3425, 2917, 2360, 1597, 1524, 1434, 
1366, 1182, 1052, 985, 945, 813 cm-1. M.P.: 125-127 oC. 
1H NMR  
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TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 7.91-7.89 (m, 1H), 7.62 
(d, J = 15.6 Hz, 1H), 7.59-7.33 (m, 6H), 7.13 (d, J = 15.9 Hz, 1H), 6.68-6.64 (m, 2H), 
6.62 (d, J = 15.6 Hz, 1H), 6.21(dd, J = 15.9, 5.7 Hz, 1H), 4.75 (dd, J = 5.7, 3.3 Hz, 1H), 
3.10 (dq, J = 15.6, 3.3 Hz, 1H), 3.03 (s, 6H), 3.03-3.00 (br, 1H), 1.29 (d, J = 7.2 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 204.2, 152.1, 147.7, 145.1, 135.1, 133.0, 132.7, 130.5, 
128.8, 127.9, 126.1, 124.3, 121.6, 119.3, 111.7, 72.1, 47.9, 40.0, 11.4. HRMS Calcd. for 
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C22H24N2O4 (M+1): 381.1814 ; Found: 381.1812 FTIR (NaCl film): 3424, 2926, 2359, 
1577, 1523, 1434, 1344, 1182, 1168, 1053, 970, 946, 860, 815, 742 cm-1. 
1H NMR  
 







A solution of Et3B (1.0M in hexane, 0.46 mL, 0.46 mmol, 119 mol%) was added 
to a mixture of dry THF (1.5 mL) and MeOH (0.6 mL) at ambient temperature under 
nitrogen. After 1hour, the mixture was cooled to -78 oC followed by the enone 2.3b (96 
mg, 0.39 mmol, 100 mol%) in THF (0.5 mL). The resulting solution was stirred for 
1hour. Then NaBH4 (18 mg, 0.46 mmol, 120 mol%) was added, and the mixture was 
stirred for 5 hours. The reaction mixture was diluted with ether (15 mL), and treated with 
saturated NH4Cl (aq.) (15 mL). The layers were separated and the aqueous layer was 
extracted with ether (3x25 mL). The combined organic extracts were dried (MgSO4) and 
concentrated. The residue was azeotroped a few times with MeOH until boroncontaining 
compounds were removed. Flash chromatography (SiO2: EtOAc/hexane) afforded the 
title compound (96 mg, 0.38 mmol) as colorless oil (98 % yield). 
TLC: Rf 0.4 (EtOAc/hexane, 1/2). 1H NMR (300 MHz, CDCl3): δ 7.38-7.26 (m, 5H), 5.74 
(ddq, J = 15.3, 6.3, 1.2 Hz, 1H), 5.51 (ddq, J = 15.3, 6.0, 1.5 Hz, 1H), 4.55 (d, J = 1.2, 
2H), 4.34-4.26 (m, 1H), 4.10-4.02 (m, 1H), 3.54-3.44 (m, 2H), 2.85 (br, 1H), 2.62 (br, 
1H) 1.70 (dd, J = 6.3, 1.5 Hz, 3H), 1.69-1.63 (m, 1H), 0.92 (d, J = 7.2 Hz, 3H). 13C NMR 
(75 MHz, CDCl3): δ 137.8, 132.2, 128.4, 127.7, 126.6, 76.1, 73.7, 73.4, 72.7, 39.9, 17.7, 
6.4. HRMS Calcd. for C15H22O3 (M+1): 251.1647, Found: 251.1648. FTIR (NaCl film): 
3395, 3029, 2968, 2914, 2858, 1670, 1496, 1453, 1377, 1253, 1094, 966, 736, 698 cm-1. 
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1H NMR  
 
 







A solution of Me4NBH(OAc)3 (530 mg, 2.02 mmol, 1010 mol%) in AcOH (2.5 
mL) and MeCN (2.5 mL) was prepared under Ar and stirred at ambient temperature for 
20 min.The mixture was cooled to -30 oC. A solution of the enone 2.3b (50 mg, 0.20 
mmol, 100 mol%) in MeCN (2.5 mL) at 0 oC was added dropwise via cannular over 10 
min. The resulting mixture was allowed to warm to -20 oC and stirred for 24 hours. 
CH2Cl2 was added to the reaction mixture, and then a saturated aqueous NaHCO3 
solution was slowly added. After 45 min at ambient temperature, the aqueous phase was 
extracted with CH2Cl2 (3 times), The organic phases were dried (MgSO4), filtered, and 
evaporated, and the residue was purified by flash chromatography (SiO2: EtOAc/hexane) 
to afford the title compound (47 mg, 19 mmol) as a colorless oil (94 % yield). 
TLC: Rf 0.4 (EtOAc/hexane, 1/2). 1H NMR (300 MHz, CDCl3): δ 7.38-7.27 (m, 5H), 5.68 
(ddq, J = 15.3, 6.3, 1.3 Hz, 1H), 5.45 (ddq, J = 15.3, 7.8, 1.5 Hz, 1H), 4.57 (d, J = 5.4, 
2H), 4.10-4.04 (m, 1H), 3.63 (dd, J = 9.6, 2.7 Hz, 1H), 3.46 (dd, J = 9.3, 7.2 Hz, 1H), 
3.28 (br, 2H), 1.74-1.68 (m, 1H), 1.71 (dd, J = 6.3, 1.5 Hz, 3H), 0.77 (d, J = 6.9 Hz, 3H). 
13C NMR (75 MHz, CDCl3): δ 137.8, 132.3, 128.6, 128.5, 127.8, 127.7, 75.0, 73.4, 72.7, 
41.0, 29.7, 17.7, 12.8. HRMS Calcd. for C15H22O3 (M+1): 251.1647, Found: 251.1648. 
FTIR (NaCl film): 3385, 3029, 2918, 1720, 1496, 1453, 1376, 1326, 1101, 1005, 968, 
927, 738, 698 cm-1. 
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1H NMR  
 
 







To a solution of 1-benzyloxy-3-methyl-hept-5-ene-2,4-diol 2.6a (54 mg, 0.22 
mmol, 100 mol%) in 2,2-dimethoxypropane (5 mL) at 0 oC was added p-TsOH•H2O (2 
mg, 0.01 mmol, 5 mol%). After 3 hours at ambient temperature, the reaction mixture was 
quenched with saturated NaHCO3 (aq.), extracted with EtOAc (3 times), The organic 
phases were dried (MgSO4), filtered, and evaporated, and the residue was purified by 
flash chromatography (SiO2: EtOAc/hexane) to afford the title compound (58 mg, 0.20 
mmol) as a colorless oil (91 % yield). 
TLC: Rf 0.6 (EtOAc/hexane, 1/10). 1H NMR (300 MHz, CDCl3): δ 7.35-7.26 (m, 5H), 
5.70 (ddq, J = 15.3, 6.6, 1.2 Hz, 1H), 5.47 (ddq, J = 15.3, 6.3, 1.5 Hz, 1H), 4.62 (d, J = 
12, 1H), 4.48 (d, J = 12, 1H), 4.42 (ddd, J = 6.3, 5.7, 1.2, 1H), 4.21(ddd, J = 6.6, 6.3, 2.4, 
1H), 3.50 (dd, J = 9.9, 6.6, 1H), 3.41 (2.85 (dd, J = 9.9, 6.3, 1H), 1.71 (dd, J = 6.6, 1.5 
Hz, 3H), 1.59-1.48 (m, 1H), 1.48 (s, 3H), 1.43(s, 3H), 0.92 (d, J = 7.2 Hz, 3H). 13C NMR 
(75 MHz, CDCl3): δ 138.1, 129.9, 128.3, 127.7, 127.6, 127.3, 99.0, 74.0, 73.4, 71.8, 70.9, 
34.3, 29.9, 19.6, 17.8, 5.4. HRMS Calcd. for C18H26O3 (M+1): 291.1960, Found: 
291.1962. FTIR (NaCl film): 2989, 2936, 1453, 1379, 1254, 1199, 1176, 1103, 1075, 


















A solution of 4-benzyloxymethyl-2,2,5-trimethyl-6-propenyl-[1,3]dioxane (47 
mg, 0.16 mmol, 100 mol%) in CH2Cl2 (30 mL) at -78 oC was bubbled with O3 until blue 
color persisted. N2 was bubbled for 10 min and PPh3 (47 mg, 0.18 mmol, 113 mol%) was 
added to the reaction mixture, and stirred the reaction mixture overnight at ambient 
temperature. The reaction mixture was evaporated, and the residue was purified by flash 
chromatography (SiO2: EtOAc/hexane) to afford the title compound (33 mg, 0.12 mmol) 
as a colorless oil (74 % yield).  
TLC: Rf 0.2 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 9.59 (s, 1H), 7.38-7.29 
(m, 5H), 4.63 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 12.0 Hz, 1H), 4.38 (d, J = 3.0 Hz, 1H), 
4.25 (ddd, J = 6.6, 6.3, 2.4 Hz, 1H), 3.53 (dd, J = 9.6, 6.3 Hz, 1H), 3.44 (dd, J = 9.6, 6.6 
Hz, 1H), 2.14 (ddq, J = 6.6, 3.0, 2.4 Hz, 1H), 1.54 (s, 3H), 1.50 (s, 3H), 0.89 (d, J = 6.6 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 202.2, 137.9, 128.4, 127.7, 99.7, 78.2, 73.5, 71.3, 
70.1, 31.2, 29.5, 19.1, 6.3. HRMS Calcd. for C16H22O4 (M+1): 279.1596, Found: 
279.1598. FTIR (NaCl film): 3454, 2933, 2869, 2359, 1720, 1626, 1453, 1374, 1274, 


















A 25 mL Schlenk tube was charged with PdCl2 (7 mg, 0.04 mmol, 10 mol%), 
CuCl (4 mg, 0.04 mmol, 10 mol%), and Na2HPO4 (7 mg, 0.04 mmol, 10 mol%) and 
evacuated and backfilled with oxygen (3 times, balloon). A solution of the enone 2.3b 
(100 mg, 0.40 mmol, 100 mol%) in DME (3 mL) was added via cannula. The resulting 
mixture was heated to 50 oC and allowed to stir at this temperature for 12 hours. The 
reaction mixture was allowed to cool to ambient temperature, diluted with Et2O and 
filtered through a pad of silica, and concentrated in vacuo to give a crude residue that was 
further purified by flash column chromatography (SiO2: EtOAc/hexane) to afford the title 
compound (70 mg, 0.28 mmol) as a colorless oil (71 % yield). 
TLC: Rf 0.3 (EtOAc/hexane, 1/3). 1H NMR (300 MHz, CDCl3): δ 7.37-7.30 (m, 5H), 
5.26 (s, 1H), 4.66-4.53 (m, 3H), 3.61 (dd, J = 10.5, 4.5 Hz, 1H), 3.79 (dd, J = 10.5, 7.2 
Hz, 1H), 2.41 (dq, J = 7.2, 3.6 Hz, 1H), 2.02 (s, 3H), 1.03 (d, J = 7.2 Hz, 3H). 13C NMR 
(75 MHz, CDCl3): δ 196.6, 173.3, 137.5, 128.5, 127.9, 127.7, 103.7, 80.2, 73.5, 68.7, 
40.8, 20.8, 10.0. HRMS Calcd. for C15H18O8 (M+1): 247.1344, Found: 247.1346. FTIR 





1H NMR  
 
 





General Procedure for Asymmetric Aldol Coupling of Enones and Aldehydes 
To a 13 mm × 100 mm test-tube were added Li2CO3 (10 mol%), [Rh(cod)(AP-I)2]OTf 
(5 mol%), aldehyde (100 mol%) and DCM (1.0 M). The test-tube was sealed, cooled to 0 
oC and the reaction system was sparged with Ar (g) followed by H2 (g) for 20 seconds 
each. The reaction system was placed under one atmosphere of hydrogen using a balloon 
and enone (300 mol%) was added to the reaction mixture. The reaction mixture was 
allowed to stir for 24 h at 0 oC. The reaction mixture was evaporated and the aldol 
products were separated by flash chromatography (SiO2: EtOAc/Hexane).  
 
General Procedure for the determination of Enantiomeric Excess  
Enantioselectivities were determined by chiral stationary phase HPLC analyses 
made in comparison to racemic diastereomeric mixtures prepared by (i) hydrogenation of 
the corresponding Morita-Baylis-Hillman adducts, or in the case of the ethyl vinyl ketone 
adducts (ii) the aldol reaction between the lithium enolate of 3-pentanone and the 
corresponding aldehyde, followed by treatment with magnesium bromide etherate. The 
enantiomeric excess reported for all products is based on the average of two reactions, 
with a minimum of two HPLC analyses per reaction (averaged). In all cases the 





General Procedure for the Synthesis of Racemic Diastereomeric Mixtures of Aldol 
Products  
Aldehyde (1.0 mmol, 100 mol%), enone (3 mmol, 300 mol%), and DABCO (12 
mg, 0.10 mmol, 10 mol%) were dissolved in THF (0.1 M) and stirred at 25 oC for 12 h. 
The solvent was removed under reduced pressure and the crude product was purified by 
flash chromatography (SiO2: EtOAc/Hexane). The MBH adduct (0.50 mmol, 100 mol%) 
was dissolved in EtOAc (0.1 M) and 10% Pd-C (10 wgt%) was added. The reaction 
vessel was flushed with H2 (g) and the mixture was stirred for 8 h at 25 oC. The solvent 
was removed under reduced pressure and the crude product was purified by flash 
chromatography (SiO2: EtOAc/Hexane) to give the racemic aldol adducts as 
diastereomeric mixtures in variable yields (20-70% over 2 steps).  
 
Representative procedure for the synthesis of Chiral Ligands 
 
To a solution of (4R,5R)-diethyl- 2,2-dimethyl-1,3-dioxolane-4,5-dipropan-2-ol 
(4.0 g, 16.2 mmol, 100 mol%) and triethylamine (6.8 mL, 48.6 mmol, 300 mol%) in THF 
(0.1 M) at -78 oC, PCl3 (2.2 mL, 20.0 mmol, 120 mol%) was added quickly with stirring, 
and the reaction was allowed to come to 25 oC over 1 hour, and then was stirred for 10 
hours at 25 oC. The reaction was then filtered through a plug of celite under an argon 
atmosphere with the exclusion of moisture, and the solvent was removed via distillation 
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at reduced pressure. The crude solid was then dissolved in 50 mL of ether, and the solids 
were removed by filtration through a plug of celite under an argon atmosphere with the 
exclusion of moisture. The solvent was again removed under reduced pressure. The 
resulting oil (3aR,8aR)-6-chloro-2,2-diethyl-tetrahydro-4,4,8,8-tetramethyl-
[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine (4.9 g, 15.8 mmol) was of sufficient purity to 
be used directly in the next step.  
To benzothiophene (1.65 g, 12.3 mmol, 100 mol%) dissolved in THF (0.1 M) and 
cooled to -78 oC, tert-butyllithium (1.2 M, 10.2 mL, 12.2 mmol, 100 mol%) was added 
dropwise and the mixture was stirred for 1 hour at -78 oC. This solution was then 
transferred via cannula quickly to a solution of (3aR,8aR)-6-chloro-2,2-diethyl-
tetrahydro-4,4,8,8-tetramethyl-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine (4.9 g, ~15.8 
mmol, 100 mol%) in THF (0.1 M) at -78 oC. The reaction was allowed to warm to 25 oC 
over 1 hour, and then stirred for 10 hours at 25 oC. The solvent was then removed under 
reduced pressure and the crude product was purified by flash chromatography (SiO2: 






1H NMR (400 MHz, CDCl3): δ 7.63 (d, J = 1.4 Hz, 1H), 6.84-6.81 (m, 1H), 6.42–6.40 
(m, 1H), 4.46 (dd, J = 9.2, 3.7 Hz, 1H), 3.99 (d, J = 9.2 Hz, 1H), 1.53 (s, 6H), 1.44 (s, 
3H), 1.41 (s, 6H), 1.35 (S, 3H). 13C NMR (100 MHz, CDCl3): δ 155.6 (d, J = 11.2 Hz), 
146.7 (d, J = 4.5 Hz), 118.2 (d, J = 26.9 Hz), 110.1 (d, J = 5.2 Hz), 109.7, 82.5 (d, J = 3.7 
HZ), 81.8 (d, J = 22.4 Hz), 76.5 (d, J = 4.5 Hz), 76.4 (d, J = 6.7 Hz), 29.9 (d, J = 3.0 Hz), 
29.0 (d, J = 3.0 Hz), 27.3, 27.1, 23.2, 19.8 (d, J = 9.7 Hz). 31P NMR (162 MHz, CDCl3): 
δ 134.6. HRMS calcd for C15H24O5P (M+1): 315.1361, Found: 315.1366. FTIR (neat): 
2980, 2936, 2884, 1456, 1370, 1243, 1560, 1071, 1041, 1010, 972, 926, 906, 883, 829, 
750, 743 cm-1. MP: 55-58 oC. [α]D25 +12o, c = 0.83 in DCM  






















1H NMR (400 MHz, CDCl3): δ 6.71-6.75 (m, 1H), 6.01-6.00 (m, 1H), 4.45 (d, J = 9.2, 
3.7 Hz, 1H), 3.98 (d, J = 9.2 Hz, 1H), 2.35 (s, 3H), 1.55 (s, 3H), 1.53 (s, 3H), 1.45 (s, 
3H), 1.41 (s, 6H), 1.35 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 157.2 (d, J = 4.5 Hz), 
153.7 (d, J = 10.5 Hz), 120.1 (d, J = 29.9 Hz), 109.6, 106.6 (6.7 HZ), 82.4 (d, J = 4.5 
Hz), 81.8 (d, J = 22.4), 76.4 (d, J = 4.5 Hz), 76.2 (d, J = 6.0 Hz), 29.9 (d, J = 3.0 Hz), 
29.0 (d, J = 3.0 Hz), 27.3, 27.1, 23.2, 19.8 (d, J = 10.5 Hz), 13.9. 31P NMR (121.5 MHz, 
CDCl3): δ 132.1. HRMS calcd for C16H26O5P (M+1): 329.1518, Found: 329.1520. FTIR 
(neat): 2986, 2935, 1508, 1374, 1242, 1169, 1145, 1078, 1015, 935, 878, 627 cm-1. MP: 










1H NMR  
 
 










1H NMR (400 MHz, CDCl3): δ 7.59 (dm, J = 7.8, 1H), 7.55 (dm, J = 8.2 Hz, 1H), 7.32 
(ddd, J = 8.4, 7.2, 1.4 Hz, 1H), 7.24-7.18 (m, 2H), 4.49 (dd, J = 9.4, 3.7 Hz, 1H), 4.02 (d, 
J = 9.2 Hz, 1H), 1.58 (s, 6H), 1.48 (s, 3H), 1.43 (s, 3H), 1.42 (s, 3H), 1.38 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ 158.2 (d, J = 13.5 Hz), 157.3 (d, J = 3.7 Hz), 127.2 (d, J = 
6.0 Hz), 125.6, 122.9, 121.8, 114.2 (d, J = 23.9 Hz), 112.0, 109.9, 82.5 (d, J = 4.5 Hz), 
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82.0 (J = 22.4 Hz), 30.0 (J = 3.0 Hz), 29.1 (d, J = 3.0 Hz), 27.4, 27.2, 23.2 (2C), 19.9, 
19.8. 31P NMR (121.5 MHz, CDCl3): δ 136.8. HRMS calcd for C19H26O5P (M+1): 
365.1518, Found: 365.1519. FTIR (neat): 2984, 2974, 1540, 1374, 1236, 1171, 1089, 
979, 794, 753, 641 cm-1. MP: 72–75 oC. [α]D25 +12o, c = 0.50 in DCM  
1H NMR  
 









1H NMR (400 MHz, CDCl3): δ 7.65-7.60 (m, 2H), 7.40-7.37 (m, 3H), 4.54 (dd, J = 9.4, 
3.9 Hz, 1H), 3.95 (d, J = 9.2 Hz, 1H), 1.56 (s, 6H), 1.45 (s, 3H), 1.42 (s, 3H), 1.41 (s, 
3H), 1.34 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 140.9 (d, J = 6.0 Hz), 130.4, 129.7 (d, 
J = 23.9 Hz), 128.2 (d, J = 7.5 Hz), 109.6, 82.6 (d, J = 3.7 Hz), 82.0 (d, J = 22.4 Hz), 
76.4 (d, J = 4.7 Hz), 76.2 (d, J = 5.2 Hz), 30.2 (d, J = 3.0 Hz), 29.1 (d, J = 3.0 Hz), 27.3, 
27.2, 23.3 (2C), 20.1, 20.0. 31P NMR (121.5 MHz, CDCl3): δ 131.6. HRMS calcd for 
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C17H26O4P (M+1): 325.1569, Found: 325.1568. FTIR (neat): 2982, 2974, 1520, 11282, 
1231, 1171, 1042, 997, 792, 638 cm-1. MP: 62–64 oC. [α]D25 +18o, c = 0.4 in DCM  
 
1H NMR  
 
 










1H NMR (400 MHz, CDCl3): δ 8.03 (m, 2H), 7.89 (s, 1H), 4.52 (dd, J = 9.2 Hz, 1H), 3.96 
(d, J = 9.2 Hz, 1H), 1.59 (s, 6H), 1.48 (s, 3H), 1.43 (s, 3H), 1.42 (s, 3H), 1.37 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ 144.4 (d, J = 14.2 Hz), 131.4 (qd, J = 33.7, 6.0 Hz, 2C), 
130.0 (dm, J = 23.2 Hz, 2C), 124.0 (m), 123.3 (q, J = 273.0 Hz, 2C), 110.0, 82.6, 82.0 (d, 
J = 21.6 Hz), 77.3 (d, J = 3.7 Hz), 77.2 (d, J = 5.2 Hz), 30.0 (d, J = 3.0 Hz), 29.2 (d, J = 
3.0 Hz), 27.3, 27.1, 23.2, 20.0 (d, J = 9.7 Hz). 31P NMR (161 MHz, CDCl3): δ 147.0. 
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HRMS calcd for C19H24O4F6P (M+1): 461.1316, Found: 461.1287. FTIR (neat): 2988, 
2940, 2896, 1456, 1372, 1280, 1136, 1078, 1016, 973, 936, 905, 835, 812, 742, 703, 682, 
608 cm-1. MP: 101-105 oC (dec). [α]D25 +23o, c = 0.83 in DCM  
 
1H NMR  
 
 









1H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 7.2 Hz, 1H), 7.54 (dd, J = 8.0 Hz, 0.8 Hz, 
1H), 7.31 (td, J = 8.0 Hz, 1.2 Hz, 1H), 7.22 (td, J = 8.0 Hz, 0.8 Hz, 1H), 7.14 (s, 1H), 
4.61 (dd, J = 9.2 Hz, 2.8 Hz, 1H), 4.29 (d, J = 9.2 Hz, 1H), 2.32-2.24 (m, 1H), 2.03-1.82 
(m, 5H), 1.75-1.55 (m, 2H), 1.39 (s,6H), 1.03-0.94 (m, 12H). 13C NMR (75.5 MHz, 
CDCl3): δ 159.5 (d, J = 15.4 Hz), 157.3 (d, J = 4.4 Hz), 127.3 (d, J = 4.4 Hz), 125.2, 
122.7, 121.7, 112.9 (d, J = 19.8 Hz), 111.9, 109.2, 81.1 (d, J = 17.7 Hz), 80.1 (d, J = 2.7 
 103
Hz), 79.8 (d, J = 2.7 Hz), 79.5 (d, J = 4.4 Hz), 31.6 (d, J = 5.0 Hz), 30.0 (d, J = 3.9 Hz), 
27.3, 27.0, 25.6, 23.5 (d, J = 9.9 Hz), 8.0 (d, J = 1.7 Hz), 7.6, 7.2, 7.1 (d, J = 2.2 Hz). 31P 
NMR (121.5 MHz, CDCl3): δ 136.8. HRMS calcd for C23H34O5P(M+1): 421.2144, 
Found: 421.2144. FTIR (neat): 2971, 2938, 2881, 1461, 1378, 1355, 1275, 1175, 1134, 
1081, 1020, 974, 935, 840, 745, 724 cm-1. MP: 54-56 oC. [α]D25 +34.4, c = 1.13 in DCM  
1H NMR  
 









1H NMR (400 MHz, CDCl3): δ 7.59 (ddd, J = 7.8, 1.3, 0.7 Hz, 1H), 7.55, (ddd, J = 8.4, 
1.8, 0.9 Hz, 1H), 7.32 (ddd, J = 8.4, 7.2, 1.3 Hz,1H), 7.22 (ddd, J = 7.9, 7.9, 1.0 Hz, 1H), 
7.18 (dd, J = 1.3, 1.3 Hz, 1H), 4.44 (dd, J = 9.4, 3.4 Hz, 1H), 3.98 (d, J = 9.4 Hz, 1H), 
1.67 (q, J = 7.5 Hz, 2H), 1.66 (q, J = 7.5 Hz, 2H) 1.60 (s, 6H), 1.49 (s, 3H), 1.40 (s, 3H), 
0.93 (t, J = 7.5 Hz, 3H), 0.92 (t, J = 7.5 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 158.3 
(d, J = 13.4 Hz), 157.3 (d, J = 3.7 Hz), 127.2 (d, J = 5.2 Hz), 125.5, 122.9, 121.8, 114.2 
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(d, J = 24.7 Hz), 113.2, 112.0, 82.6 (d, J = 4.5 Hz), 82.1 (d, J = 22.4 Hz), 77.2 (d, J = 6.7 
Hz, 2C), 30.2 (d, J = 10.4 Hz, 2C), 30.1 (d, J = 2.9 Hz), 29.3 (d, J = 2.9 Hz), 23.5, 20.2 
(d, J = 10.5 Hz), 8.1 (d, J = 2.2 Hz, 2C). 31P NMR (121 MHz, CDCl3): δ 136.6. HRMS 
calcd for C21H30O5P (M+1): 393.1830, Found: 393.1831. FTIR (neat): 2976, 2939, 2881, 
1535, 1463, 1449, 1383, 1368, 1253, 1157, 1078, 1008, 970, 938 cm-1. [α]D25 +196, c = 
1.0 in DCM  
1H NMR  
 









1H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 7.2 Hz, 1H), 7.54 (dd, J = 8.0 Hz, 0.8 Hz, 
1H), 7.31 (td, J = 8.0 Hz, 1.2 Hz, 1H), 7.22 (td, J = 8.0 Hz, 0.8 Hz, 1H), 7.14 (s, 1H), 
4.48 (dd, J = 11.5 Hz, 5 Hz, 1H), 4.00 (d, J = 11.5 Hz, 1H), 1.62 – 1.55 (m, 16H), 1.37 (s, 
6H). 13C NMR (100.5 MHz, CDCl3): δ 158.2 (d, J = 13.8 Hz), 157.3 (d, J = 3.8 Hz), 
127.2 (d, J = 5.3 Hz), 125.5, 122.8, 121.7, 114.1 (d, J = 23.8 Hz), 111.9, 110.2, 82.0 (d, J 
= 3.8 Hz), 80.6, 81.4, 77.0 (d, J = 6.1 Hz), 76.9 (d, J = 6.1 Hz), 36.7 (d, J = 9.2 Hz), 30.0 
(d, J = 3.1 Hz), 29.7, 29.1 (d, J = 2.3 Hz), 25.0, 23.8, 23.2, 19.9 (d, J = 9.9 Hz). 31P NMR 
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(121.5 MHz, CDCl3): δ 135.6. HRMS calcd for C22H30O5P(M+1): 405.1831, Found: 
405.1833. FTIR (neat): 2933, 2856, 1445, 1384, 1368, 1278, 1253, 1159, 1144, 1122, 
1090, 1059, 1009, 970, 945, 927, 826, 793, 743 cm-1. MP: 90-92 oC. [α]D25 -52.7, c = 0.97 
in DCM.  
1H NMR  
 









1H NMR (400 MHz, CDCl3): δ 7.86-7.84 (m, 1H), 7.81-7.79 (m, 1H), 7.67 (dd, J = 7.6, 
0.7 Hz, 1H), 7.35-7.32 (m, 2H), 4.44 (dd, J = 9.4, 3.4 Hz, 1H), 3.95 (d, J = 9.4 Hz, 1H), 
1.68-1.64 (m, 4H), 1.58 (s, 6H), 1.48 (s, 3H), 1.38, (s, 3H), 0.95-0.90 (m, 6H). 13C NMR 
(100 MHz, CDCl3): 144.4 (d, J = 26.2 Hz), 142.8, 139.6 (d, J = 10.47 Hz), 130.4 (d, J = 
35.9), 125.3, 124.4, 124.3 (d, J = 23.2 Hz), 122.5, 113.1, 82.6 (d, J = 3.7 Hz), 82.0, 77.2, 
77.1, 30.2 (d, J = 4.4 Hz, 2C) 29.3 (d, J = 2.2 Hz), 23.5, 20.4, 20.3, 8.1 (2C). 31P NMR 
(162 MHz, CDCl3): δ 143.2. HRMS calcd for C21H30O4PS (M+1): 409.1602, Found: 
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409.1602. FTIR (neat) 3400, 2973, 2939, 1503, 1461, 1373, 1227, 1177, 1157, 1075, 
















1H NMR (400 MHz, CDCl3): δ 7.69 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.27 (d, 
J = 7.2 Hz, 1H), 7.15-7.12 (m, 1H), 4.45 (dd, J = 9.6, 3.2 Hz, 1H), 3.96 (d, J = 9.6 Hz, 
1H), 2.56 (s, 3H), 1.70-1.63 (m, 4H), 1.58 (s, 6H), 1.49 (s, 3H), 1.39, (s, 3H), 0.95-0.90 
(m, 6H). 13C NMR (100 MHz, CDCl3): 143.6 (d, J = 26.0 Hz), 143.0, 139.4 (d, J = 10.4 
Hz), 132.1, 131.2 (d, J = 36.5 Hz), 125.4, 124.6, 122.0, 113.0, 82.6 (d, J = 3.7 Hz), 82.2, 
82.0, 77.0 (d, J = 6.0 Hz), 30.3 (d, J = 3.0 Hz), 30.2 (d, J = 2.9 Hz), 29.3 (d, J = 2.9 Hz), 
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23.5, 22.6, 20.3 (d, J = 10.4 Hz), 20.3, 8.1 (2C). 31P NMR (121.5 MHz, CDCl3): δ 142.0. 
HRMS calcd for C22H31O4PS (M+1): 423.159, Found: 423.1755. FTIR (neat) 2975, 2938, 














1H NMR (400 MHz, CDCl3): δ 7.72 (d, J = 8.4 Hz, 1H), 7.60-7.58 (m, 2H), 7.17 (dd, J = 
8.4 Hz, 1.6 Hz, 1H), 4.44 (dd, J = 9.2, 3.2 Hz, 1H), 3.96 (d, J = 9.6 Hz, 1H), 2.45 (s, 3H), 
1.70-1.64 (m, 4H), 1.57 (s, 6H), 1.47 (s, 3H), 1.37, (s, 3H), 0.95-0.90 (m, 6H). 13C NMR 
(100 MHz, CDCl3): 144.3 (d, J = 26.0 Hz), 140.0 (d, J = 16.3 Hz), 130.0 (d, J = 5.2 Hz), 
133.8, 130.1 (d, J = 36.5 Hz), 127.2, 124.1, 122.1, 113.0, 82.6 (d, J = 3.8 Hz), 82.2, 82.0, 
77.0 (d, J = 5.2 Hz), 30.2, 30.1, 29.3 (d, J = 3.0 Hz), 23.5, 21.3, 20.4, 20.3, 8.1 (2C). 31P 
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NMR (121.5 MHz, CDCl3): δ 142.1. HRMS calcd for C22H32O4PS (M+1): 423.1759, 
Found: 423.1764. FTIR (neat) 2975, 2937, 1463, 1383, 1368, 1157, 1079, 993, 970, 940 














1H NMR (400 MHz, CDCl3): δ 7.61 (ddd, J = 7.6, 2.0, 0.8 Hz, 2H), 7.41-7.34 (m, 3H), 
7.30 (ddd, J = 7.2, 1.2, 1.2 Hz, 1H), 7.27 (dd, J = 3.5, 1.6 Hz, 1H), 4.43 (dd, J = 9.4, 
3.3Hz, 1H), 3.94 (d, J = 9.4Hz, 1H), 1.66 (q, J = 2.9Hz, 2H), 1.66 (q, J = 3.5Hz, 2H), 
1.56 (s, 6H), 1.47 (s, 3H), 1.37 (s, 3H), 0.93 (t, J = 7.4Hz, 3H), 0.92 (t, J = 7.4Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 150.8 (d, J = 2.2Hz), 142.8, 142.6, 134.7, 134.4, 134.3, 
129.1, 128.2, 126.5, 123.6 (d, J = 9.7Hz), 113.2, 82.9 (d, J = 3.7Hz), 82.3 (d, J = 
21.7Hz), 77.1 (d, 2.2Hz), 77.1, 30.5 (2C), 30.5 (d, J = 5.2Hz), 29.6 (d, J = 3.0Hz), 23.8, 
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20.6 (d, J = 10.5Hz), 8.4 (2C). 31P NMR (121.5) MHz, CDCl3): δ 140.8. HRMS calcd for 
C23H32O4PS (M+1): 435.1756, Found: 435.1759. FTIR (neat): 3062, 2976, 2940, 2881, 
1772, 1715, 1601, 1528, 1490, 1463, 1437, 1383, 1368, 1205, 1174, 1157 cm-1. MP: 93-











Procedure for the Formation of [Rh(cod)(AP-I)2]OTf complex 
(3aR,8aR)-6-(Benzo[b]thiophen-2-yl)-2,2-diethyl-tetrahydro-4,4,8,8-tetramethyl-
[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine (AP-I) (700 mg, 1.7 mmol, 210 mol%) and 
Rh(cod)2OTf (375 mg, 0.8 mmol, 100 mol%) were dissolved in DCM (0.1 M) and stirred 
for 6 h at 25 oC. The solvent was removed under reduced pressure and the residue was 
triturated with dry degassed hexanes for 10 h with vigorous stirring. The resulting 
mixture was filtered, and the solid was dried under vacuum to give the product as a 
yellow powder (775 mg, 82% yield).  
1H NMR (400 MHz, CDCl3): δ 7.85 (d, J = 7.9 Hz, 2H), 7.65 (d, J = 7.9 Hz, 2H), 7.46-
7.36 (m, 6H), 5.55 (bs, 2H), 5.47 (bs, 2H), 3.86 (d, J = 9.2 Hz, 2H), 3.74 (d, J = 9.2 Hz, 
2H), 2.70-2.50 (m, 8H), 1.51 (m, 14H), 1.25 (m, 12H), 1.06 (s, 6H), 0.79 (q, J = 8.2 Hz, 
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1H NMR (400 MHz, CDCl3): δ 7.61-7.59 (m, 4H), 7.44-7.36 (m, 10H), 5.55 (bs, 2H), 
5.42 (bs, 2H), 3.89 (d, J = 9.4Hz, 2H), 3.78 (d, J = 9.4Hz, 2H), 2.69-2.52 (m, 8H), 1.62 
(m, 8H), 1.52 (s, 6H), 1.39 (s, 6H), 1.31 (s, 6H), 1.14 (s, 6H), 0.85 (t, J = 7.4Hz, 6H), 
0.84 (t, J = 7.0 Hz, 6H).  31P NMR (121.5 MHz, CDCl3): δ 123.1 (d, JP-Rh = 219.7 Hz). 









Neat DIBAL (3.4 mL, 19 mmol, 120 mol%) was added dropwise using a syringe 
pump to a solution of methyl N-methylindole-3-acetate (3.24 g, 16 mmol, 100 mol%) in 
DCM (0.08 M) at -78 °C over 30 minutes. The solution was allowed to stirr at -78 °C for 
1 hour, at which point a cold (5 oC) saturated aqueous solution tartaric acid (200 mL) was 
added. The organic layer was separated and the aqueous layer was extracted with DCM 
(200 mL × 3). The combined organic layers were dried (MgSO4), filtered and the 
resulting solution was subjected to rotary evaporation under reduced pressure to provide 
an oily residue, which upon purification by flash chromatography (SiO2, 10% EtOAc/ 
Hexanes) followed by Kügelrohr distillation (180 °C/ 0.5 mmHg) provides the title 
compound in 72% yield as a pale green oil (2.0 g, 11.5 mmol).  
1H NMR (400 MHz, CDCl3): δ 9.73 (t, J = 2.5 Hz, 1H), 7.52 (ddd, J = 7.8, 1.0, 1.0 Hz, 
1H), 7.32 (ddd, J = 8.2, 1.0, 0.8 Hz, 1H), 7.26 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H), 7.14 (ddd, J 
= 8.0, 7.0, 1.2 Hz, 1H), 6.99 (s, 1H), 3.78 (dd, J = 2.5, 0.8 Hz, 2H), 3.77 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ 199.8, 137.3, 128.3, 122.3, 119.7(2C), 118.8, 109.7, 104.6, 
40.5, 33.0. HRMS calcd for C11H12NO (M+1): 174.0919, Found: 174.0922. FTIR (neat): 
3054, 2934, 2822, 2719, 1721, 1616, 1550, 1474, 1425, 1373, 1350, 1330, 1251, 1156, 













1H NMR (400 MHz, CDCl3): δ 7.88-7.84 (m, 2H), 7.74-7.72 (m, 2H), 4.30-4.25 (m, 1H), 
3.85 (dd, J = 14.2, 7.4 Hz, 1H), 3.75 (dd, J = 14.4, 4.4 Hz, 1H), 2.95-2.93 (m, 1H), 2.68 
(dq, J = 4.2, 7.2 Hz, 1H), 2.23 (s, 3H), 1.29 (d, J = 7.5 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 212.4, 169.0, 134.4, 132.1, 123.7, 69.9, 49.4, 41.7, 29.2, 10.9. HRMS Calcd 
for C14H15NO4 (M+1): 261.1001, Found: 261.1004. FTIR (neat): 3435, 3053, 2978, 2935, 
2872, 2306, 1640, 1446, 1383, 1351, 1266, 1114, 1076, 896, 743 cm-1. Mp: 140-141 oC. 
HPLC: (Chiralpak AD-H column, 10% i-PrOH/ hexanes, 1 mL/ min, 254 nm), tmajor = 










1H NMR (400 MHz, CDCl3): 7.26-7.36 (m, 5H), 4.51 (s, 2H), 4.09-4.10 (m, 1H), 3.41-
3.53 (m, 2H), 2.90 (d, J = 2.7 Hz, 1H), 2.61-2.77 (dq, J = 7.2, 5.1 Hz, 1H), 2.16 (s, 3H), 
1.14 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): 212.2, 137.7, 128.3, 127.7, 127.6, 
73.3, 71.6, 70.2, 48.6, 29.2, 11.0. HRMS Calcd for C13H18O3 (M+1): 223.1334, Found: 
223.1330. FTIR (neat): 3439, 3031, 2920, 2867, 1704, 1455, 1360, 1252, 1207, 1181, 
1094, 1028, 957, 916, 739, 699 cm-1. HPLC: (Chiralpak AS-H column, 10% i-PrOH/ 
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hexanes, 0.8 mL/ min, 254 nm), tmajor = 9.7 min, tminor = 11.3 min; ee = 91%. [α]D25 -5o, c 













1H NMR (400 MHz, CDCl3): δ 7.87-7.83 (m, 2H), 7.75-7.71 (m, 2H), 3.93-3.77 (m, 3H), 
3.20 (d, J = 3.8 Hz, 1H), 2.61 (dq, J = 3.8, 7.2 Hz, 1H), 2.19 (s, 3H), 1.85-1.67 (m, 2H), 
1.17 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 212.8, 168.6, 134.0, 131.9, 
123.2, 68.4, 51.1, 34.8, 33.0, 29.3, 10.5. HRMS: Calcd [M] for C15H17NO4: 275.1158; 
Found: 275.1156. FTIR (film): 3469, 3054, 2986, 2305, 2254, 1771, 1710, 1468, 1397, 
1372, 1265, 1177, 951, 910, 741 cm-1. HPLC: (Chiralpak AD-H column, 5% i-PrOH/ 












1H NMR (400 MHz, CDCl3): δ 1.23 (d, J = 7.2 Hz, 3H), 2.16 (s, 3H), 2.56 (dq, J = 3.4, 
7.2 Hz, 1H), 2.67-2.68 (br, 1H), 2.69 (dd, J = 13.7, 5.8 Hz, 1H), 2.79 (dd, J = 13.7, 7.9 
Hz, 1H), 4.18-4.22 (m, 1H), 7.20-7.26 (m, 3H), 7.28-7.33 (m, 2H). 13C NMR (100 MHz, 
CDCl3): δ 213.4, 138.1, 129.2, 128.5, 126.5, 72.0, 49.9, 40.3, 29.1, 9.9. HRMS Calcd for 
C12H16O2 (M+1): 193.1229, Found: 193.1227. FTIR (neat): 3501, 3054, 2985, 2685, 
2306, 1701, 1603, 1496, 1455, 1358, 1266, 1171, 1031, 909, 896, 734 cm-1. HPLC: 
(Chiralpak OJ-H column, 7% i-PrOH/ hexanes, 0.8 mL/ min, 254 nm), tminor = 15.0 min, 















1H NMR (400 MHz, CDCl3): δ 7.39 (s, 1H), 7.31 (s, 1H), 6.32 (s, 1H), 4.15-4.11 (m, 
1H), 2.65-2.50 (m, 4H), 2.19 (s, 3H), 1.61 (dd, J = 7.6 Hz, 0.8 Hz, 3H). 13C NMR (75 
MHz, CDCl3): δ 213.4, 143.1, 140.0, 120.9, 111.1, 70.9, 49.9, 29.5, 29.1, 9.8. HRMS 
calcd for C10H15O3 (M+1): 183.1021, Found: 183.1025. FTIR (neat): 3445, 2922, 1699, 
1457, 1360, 1157, 1067, 1024, 874, 787, 734, 601 cm-1. HPLC: (Chiralpak AD-H 
column, 2% i-PrOH/ hexanes, 1 mL/ min, 230 nm), tmajor = 12.3 min, tminor = 13.9 min; ee 













1H NMR (400 MHz, CDCl3): δ 7.59 (ddd, J = 7.9, 1.9, 1.2 Hz, 1H), 7.28 (ddd, J = 8.2, 
1.8, 1.0 Hz, 1H), 7.22 (ddd, J = 7.9, 6.8, 1.0 Hz, 1H), 7.10 (ddd, J = 7.9, 6.9, 1.2 Hz, 1H), 
6.90 (s, 1H), 4.26 (m, 1H), 3.72 (s, 3H), 2.88 (s, 1H), 2.86 (dd, J = 1.6, 0.6, 1H), 2.62 (qd, 
J = 7.3, 4.0, 1H), 2.57 (m, 1H), 2.14 (s, 3H), 1.23 (d, J = 7.2, 3H). 13C NMR (100 MHz, 
CDCl3): δ 213.5, 137.4, 128.1, 127.7, 122.0, 119.2(2C), 110.6, 109.6, 71.4, 50.6, 32.9, 
30.4, 29.5, 10.5. HRMS calcd for C15H20NO2 (M+1): 246.1494, Found: 246.1491. FTIR 
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(neat): 3446, 3053, 2935, 1704, 1615, 1472, 1425, 1375, 1357, 1328, 1250, 1173, 1155, 
1126, 1091, 1070, 1032, 1012, 981 cm-1. HPLC: (Chiralpak OD-H column, 5% i-PrOH/ 
hexanes, 0.5 mL/ min, 254 nm), tminor = 67.2 min, tmajor = 71.4 min; ee = 86%.  
1H NMR 
 






1H NMR (400 MHz, CDCl3): 7.36-7.26 (m, 5H), 4.51 (s, 2H), 4.13-4.10 (m, 1H), 3.71-
3.60 (m, 2H), 3.28 (d, J = 2.1, 1 H), 2.66-2.57 (m, 1H), 2.18 (s, 3H), 1.82-1.73 (m, 1H), 
1.68-1.61 (m, 1H), 1.14 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): 212.8, 137.8, 
128.3, 127.6, 127.5, 73.2, 70.5, 68.5, 51.5, 33.6, 29.3, 10.6. HRMS Calcd [M+1] for 
C14H20O3: 237.1491, Found: 237.1496. FTIR (film): 3433, 3031, 2924, 2868, 1701, 1455, 
1362, 1207, 1181, 1098, 1028, 737, 699 cm-1. HPLC: (Chiralpak AS-H column, 10% i-













1H NMR (400 MHz, CDCl3): δ 7.88-7.83 (m, 2H), 7.76-7.71 (m, 2H), 4.28-4.23 (m, 1H), 
3.85 (dd, J = 14.0, 7.5 Hz, 1H), 3.73 (dd, J = 14.2, 4.6 Hz, 1H), 3.10 (d, J = 3.8 Hz, 1H), 
2.69 (dq, J = 4.3, 7.2 Hz, 1H), 2.60 (dq, J = 18.1, 7.2 Hz, 1H), 2.51 (dq, J = 18.1, 7.2 Hz, 
1H), 1.27 (d, J = 7.2 Hz, 3H), 1.05 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 
214.8, 168.6, 134.0, 131.8, 123.3, 69.6, 48.2, 41.3, 34.7, 10.9, 7.4. HRMS Calcd for 
C15H17NO4 (M+1): 275.1158, Found: 275.1158. FTIR (neat): 3454, 3054, 2986, 2305, 
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2254, 1773, 1714, 1642, 1422, 1397, 1265, 909, 748 cm-1. HPLC: (Chiralpak AD-H 
column, 4% i-PrOH/ hexanes, 1.0 mL/ min, 254 nm), tminor = 91.4 min, tmajor = 97.1 min; 
ee = 96%. [α]D25 +1.4, c = 1.4 in DCM  
1H NMR 
 






1H NMR (400 MHz, CDCl3): 7.26-7.36 (m, 5H), 4.50 (s, 2H), 4.05 (q, J = 5.4, 1H), 3.40-
3.47 (m, 2H), 2.93 (s, 1H), 2.73-2.80 (dq, J = 5.1, 7.2 Hz, 1H), 2.40-2.57 (m, 2H), 1.12 
(d, J = 7.2 Hz, 3H), 1.00 (t, J = 7.4, 3H). 13C NMR (100 MHz, CDCl3): 214.9, 137.7, 
128.3, 127.7, 73.3, 71.6, 70.5, 47.6, 35.2, 11.5, 7.4. HRMS Calcd for C14H20O3 (M+1): 
237.1491, Found: 237.1488. FTIR (neat): 3502, 3064, 3031, 2977, 2938, 1705, 1497, 
1455, 1410, 1376, 1250, 1208, 1099, 1028, 976, 915, 738, 699 cm-1. HPLC: (Chiralpak 
OD-H column, 5% i-PrOH/ hexanes, 0.5 mL/ min, 254 nm), tminor = 20.8 min, tmajor = 26.4 











1H NMR (400 MHz, CDCl3): δ 7.87-7.81 (m, 2H), 7.75-7.71 (m, 2H), 3.91-3.71 (m, 3H), 
3.34 (d, J = 4.1 Hz, 1H), 2.64 (dq, J = 4.4, 7.2 Hz, 1H), 2.57 (dq, J = 18.1, 7.3 Hz, 1H), 
2.49 (dq, J = 18.1, 7.2 Hz, 1H), 1.84-1.67 (m, 2H), 1.15 (d, J = 7.2 Hz, 3H), 1.03 (t, J = 
7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 215.5, 138.6, 133.9, 131.9, 123.2, 68.6, 
50.1, 35.3, 34.8, 33.0, 11.0, 7.4. HRMS: Calcd [M] for C16H19NO4: 289.1314; Found: 
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289.1316. FTIR (film): 3466, 3054, 2985, 2305, 2254, 1771, 1710, 1468, 1397, 1265, 
952, 911, 741 cm-1. HPLC: (Chiralpak AS-H column, 5% i-PrOH/ hexanes, 0.5 mL/ min, 












1H NMR (400 MHz, CDCl3): δ 7.33-7.20 (m, 5H), 4.19-4.14 (m, 1H), 2.79 (dd, J = 13.7, 
8.2 Hz, 1H), 2.72-2.72 (m, 1H), 2.68 (dd, J = 13.5, 6.0 Hz, 1H), 2.59 (dq, J = 3.4, 7.2 Hz, 
1H), 2.52 (dq, J = 18.1, 7.3 Hz, 1H), 2.43 (dq, J = 18.1, 7.3 Hz, 1H), 1.22 (d, J = 7.2 Hz, 
3H), 1.03 (t, J = 7.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 216.1, 138.2, 129.1, 128.4, 
126.4, 72.2, 48.8, 40.3, 35.0, 10.3, 7.5. HRMS Calcd for C13H18O2 (M+1): 207.1385, 
Found: 207.1385. FTIR (neat): 3943, 3512, 3054, 2984, 2941, 2685, 2305, 1698, 1604, 
1496, 1455, 1421, 1379, 1265, 1110, 1030, 976, 896, 737 cm-1. HPLC: (Chiralpak OD-H 
column, 2% i-PrOH/ hexanes, 1.0 mL/ min, 254 nm), tminor = 12.6 min, tmajor = 14.6 min; 










1H NMR (400 MHz, CDCl3): δ 7.39–73.7 (m, 1H), 7.31–7.29 (m, 1H), 6.32–6.30 (m, 
1H), 4.11–4.06 (m, 1H), 2.88–2.73 (bs, 1H), 2.66–2.42 (m, 5H), 1.18 (d, J = 7.2 Hz, 3H), 
1.05 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 216.2, 143.1, 140.1, 121.0, 
111.1, 71.1, 48.8, 35.2, 29.5, 10.3, 7.6. HRMS calcd for C11H17O3 (M+1): 197.1178, 
Found: 197.1180. FTIR (neat): 3441, 2977, 2938, 1709, 1502, 1461, 1378, 1157, 1109, 
1502, 1461, 1378, 1157, 1109, 1024, 976, 874, 786 cm-1. HPLC: (Chiralpak AD-H 
column, 5% i-PrOH/ hexanes, 1 mL/ min, 230 nm), tminor = 11.6 min, tmajor = 13.6 min; ee 














1H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 7.9 Hz, 1H), 7.28 (m, 1H), 7.22 (m, 1H), 7.10 
(m, 1H), 6.90 (s, 1H), 4.24 (ddd, J = 10.4, 6.3, 4.2 Hz, 1H), 3.72 (s, 3H), 2.88 (s, 1H), 
2.86 (d, J = 3.2 Hz, 1H), 2.65 (m, 2H), 2.47 (m, 2H), 1.22 (d, J = 7.2 Hz, 3H), 1.01 (t, J = 
7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 216.3, 137.4, 128.2, 127.7, 122.0, 119.3, 
119.2, 110.7, 109.6, 71.7, 49.6, 35.4, 32.9, 30.4, 11.0, 7.8. HRMS calcd for C16H22NO2 
(M+1): 260.1651, Found: 260.1649. FTIR (neat): 3474, 3054, 2975, 2036, 1704, 1615, 
1552, 1473, 1425, 1376, 1328, 1250, 1155, 1132, 1061, 1012, 974, 741 cm-1. HPLC: 
(Chiralpak OJ-H column, 10% i-PrOH/ hexanes, 1 mL/ min, 254 nm), tminor = 17.5 min, 























Chapter 3 Enantioselecive Iridium-Catalyzed Carbonyl Allylation via 
Transfer Hydrogenation 
3.1 ENANTIOSELECIVE IRIDIUM-CATALYZED CARBONYL CROTYLATION  
3.1.1 Background 
Carbonyl crotylation is the one of the most important reactions for the generation 
of polypropionate units of natural products.1 Most enantioselective crotylation methods 
employ chirally modified, preformed metal reagents. A variety of such reagents have 
been developed over the past few decades, including Boron-crotyl reagents (Hoffmann2a, 
Brown2b,c, Roush2d,e, Masamune2f, and Soderquist2g), Ti-crotyl reagents (Duthaler2h,i) and  
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Scheme 3.1 Representative examples of chirally modified crotyl metal reagents for use in 
enantioselective carbonyl crotylation. 
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Scheme 3.2 Multi-step preparation of Brown’s crotylating reagent and reaction with 
aldehyde. 
 
Si-crotyl reagents (Panek2j,k and Leighton2l) (Scheme 3.1). However, most chirally 
modified crotyl metal reagents generate stoichiometric byproducts and require multiple 
modified crotyl metal reagents generate stoichiometric byproducts and require multiple 
steps for preparation. For example, the commonly used Brown’s crotylating reagent is 
prepared from potassiation of butane with Schlosser’s base 3  and subsequent 
transmetalation to boron (Scheme 3.2). These manipulations require stoichiometric 
reagents such as n-BuLi, KOtBu and Ipc2BOMe and inevitably generate stoichiometric 
byproducts in the form of metal salts. Moreover, two equivalents of isopinocampheol are 
produced as one crotyl moiety is delivered, which must be separated from the product. 
Separation of these superstoichiometric quantities of secondary alcohol byproduct from 
the product, a secondary alcohol, may not be a trivial procedure. 
There have been efforts to address these issues by developing catalytic protocols 
for carbonyl crotylation, which avoid the stoichiometric use of chirally modified crotyl 
metal reagents. Lewis acids (Yamamoto4a-c, Mikami4d, Nishiyama4e, Evans4f and Hall4g,h) 
and bases (Denmark 5 a,b, Iseki5c, Nakajima5d and Kočovsky5e) can be used for 
enantioselective crotylations. Additionally, a chiral diol (Schaus6) is reported as a catalyst  
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for allylboration of ketones (Scheme 3.3). Alternate catalytic methods, including the 
enantioselective variants of the Nozaki-Hiyama reaction, are reported. 7 , 8  In this 
approach, reductive generation of crotylmetal reagents from the corresponding halides is 
used. Although these methods effectively produce the crotylation product, they remain 
dependent on preformed crotyl metal reagents, which generate stoichiometric amount of 
waste. For example, the protocol for allyl stannane production generates tin byproducts, 
and allyl trichlorosilanes used in the Denmark allylation produce stoichiometric amounts 
of hydrochloric acid upon hydrolysis. In the case of the catalytic variants of Nozaki-
Hiyama-Kischi reactions, stoichiometric amounts of metallic reductants, such as SnCl2, 
SmI2, Et2Zn, and Et3B must be employed for catalytic turnover. 
Based on recently developed iridium catalyzed enantioselective allylation 
reaction,2 enantioselective carbonyl crotylations which employ α-methyl allyl acetate 
were sought (Scheme 3.4). This catalytic transformation does not employ any 
stoichiometric organometallic reagents and achieves highly enantioselective carbonyl 
crotylation from the alcohol or aldehyde oxidation level. 
 
 
Scheme 3.4 Iridium catalyzed carbonyl crotylation. 
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3.1.2 Reaction Optimization 
The initial screen for the crotylation began with an attempt to couple α-methyl 
allyl acetate and alcohol under our first-generation catalytic system,2 which employs an 








m-nitrobenzoci acid (10 mol%)
Cs2CO3 (20 mol%)




1000 mol% 100 mol% 85% Yield, 2:1 dr  
Scheme 3.5 Carbonyl crotylation with iridium complex generated in situ. 
 
This reaction gave carbonyl crotylation product with complete branch 
regioselectivity in 85% yield. However, poor anti-diastereoselectivities (2:1 dr) were 
observed. The subsequent discovery that the active catalyst is an ortho-cyclometallated 
iridium C,O-benzoate2 unveiled new opportunities to direct diastereoselectivity involving 
modification of the cyclometallating agent. Accordingly, a range of substituted benzoic 
acids were assayed to increase the diastereoselectivity (Table 3.1). This assay focused 
primarily on 4-substituted-3-nitrobenzoic acids, as substitution at the 2-, 5- and 6-
positions substantially diminished the reactivity of the resulting catalytic complex. 
Among 4-substituted-3-nitrobenzoic acids, the 4-cyano-3-nitrobenzoic acid (Table 3.1, 
entry 9) and 3, 4-dinitrobenzoic acid (Table 3.1, entry 10) gave the highest 
diastereoselectivity with 3.0:1 and 3.5:1 respectively. Alternative cyclometallating agents 
were ineffective (Table 3.1, entry 12-14).  
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Table 3.1 Assay of substituted benzoic acids.  
 
Having these acids in hand, different loadings of α-methyl allyl acetate were 
tested (Table 3.2). Interestingly, a reduction in the loading of α-methyl allyl acetate from 
1000 to 500 to 200 mol % was found to increase the level of anti-diastereoselection from 
3.0:1 to 3.7:1 to 4.3:1, respectively (Table 3.2, entry 1, 2 and 3). Remarkably, at 200 
mol % loadings of α-methyl allyl acetate, both diastereoselectivity and isolated yield 
were found to improve substantially with increasing concentration. At 0.2, 0.5, and 1.0 M 
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concentrations, anti-diastereoselectivities increased from 4.3:1 to 4.8:1 to 7.1:1, 
respectively (Table 3.2, entry 3, 4 and 5). However, further concentration to 2.0 M did 
not give a better result (Table 3.2, entry 6). Finally, by decreasing reaction temperature 
from 100 to 90 °C, the homoallylic alcohol product was formed in 78% yield with 7.5:1 
anti-diastereoselectivity (Table 3.2, entry 5 and 7). Notably, the catalyst modified by 3,4-
dinitrobenzoic acid was highly sensitive to reaction temperature, and under identical 
conditions at 90 °C, the homoallylic alcohol was produced in only 42% yield with 7.6:1 
anti-diastereoselectivity (Table 3.2, entry 9). 
 
Table 3.2 Optimization of iridium catalyzed carbonyl croylation. 
 
At this point, chirally modified catalysts were assayed (Table 3.3). Although 
catalysts incorporating the ligands (S)-BINAP, (S)-MeO-BIPHEP, and (S)-Cl,MeO-
BIPHEP were found to enforce high levels of absolute stereocontrol, significant erosion 
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of diastereoselectivity was observed (Table 3.3, entries 1-3). Using a catalyst modified by 
(S)-SEGPHOS, the carbonyl crotylation product is formed in 70% isolated yield with 
7.4:1 anti-diastereoselectivity and 95% enantiomeric excess (Table 3.3, entries 4). The 
TUNEPHOS ligands of Zhang9 also were assayed (Table 3.3, entries 5-7). Here, (S)-C3-
TUNEPHOS was found to provide the carbonyl crotylation product in 77% isolated yield 
with 8:1 anti-diastereoselectivity and 97% enantiomeric excess (Table 3.3, entry 6). 
 
Table 3.3 Assay of chirally modified catalysts. 
Having the optimized condition in hand, a range of alcohols was subjected to 
carbonyl crotylation (Table 3.4). In terms of scope, diverse substituted benzylic alcohols 
3.1a-3.1f were converted to the corresponding carbonyl crotylation products 3.3a-3.3f in 
good to excellent yield, very good levels of anti-diastereoselectivity and with exceptional 
levels of absolute stereocontrol (Table 3.4, entries 1-5). Heteroaromatic alcohol 1.1f also 
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gave the corresoponding product with excellent level of selectivity (Table 3.4, entry 6). 
As demonstrated by the conversion of cinnamyl alcohol 3.1g to homoallylic alcohol 3.3g, 
allylic alcohols also participate in the coupling (Table 3.4, entry 7). Finally, unactivated 
aliphatic alcohols 3.1h-3.1j are transformed to the corresponding carbonyl crotylation 
products 3.3h-3.3j in good yield with equally high levels of relative and absolute 
stereocontrol (Table 3.4, entries 8-10). 
 
Table 3.4 Iridium catalyzed asymmetric crotylation from the alcohol oxidation level. 
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Carbonyl crotylation from the aldehyde oxidation level employing isopropanol as 
the terminal reductant also was explored (Table 3.5). To our delight, under conditions 
identical to those cited in Table 3.5, but in the presence of isopropanol (200 mol%), aryl 
aldehydes 3.2a-3.2f, cinnamaldehyde 3.2g, and unactivated aliphatic aldehydes 3.2h-3.2j 
were converted to the corresponding carbonyl crotylation products 3.3a-3.3f with 
complete levels of regioselectivity, very good levels of anti-diastereoselectivity and with 
exceptional levels of enantioselectivity. Thus, carbonyl crotylation was achieved from the 




































































































Entry Product Yield (%) anti:synAldehyde ee (%)
3.2a, R = Ph
3.2f, R = 2-(N-Me-indole)
3.1b, R = 3-MeOPh
3.1g, R = CH=CHPh
3.1c, R = 4-MeOPh
3.1h, R = 2-phenyl-1-ethyl
3.1d, R = 4-BrPh
3.1i, R = 3-(benzyloxy)propyl
3.1e, R = 4-(CO2Me)Ph
3.1j, R = (CH2)7CH3
a Reactions were performed in 13 x 100 mm pressure tubes. Cited yields are of material isolated by silica gel chromatography. Enantiomeric excess was
determined by chiral stationary phase HPLC analysis via comparison to racemic diastereomeric mixtures. See experimental section for further details. b 80 oC, 72
h. c (S)-C3-TUNEPHOS was used as ligand.d conducted by In Su Kim  
Table 3.5 Iridium catalyzed asymmetric crotylation from aldehyde oxidation level. 
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3.1.3 Mechanism Studies 
In prior studies of the parent allylation reaction,9  intervention of symmetric 
iridium π-allyl intermediates or rapid interconversion of σ-allyl haptomers by means of a 
symmetric π-allyl was inferred on the basis of isotopic labeling studies. To evaluate the 
nature of the purported π-crotyl iridium intermediate, optically enriched allylic acetate 
3.4 (98% ee) was coupled to alcohol 3.1e under standard conditions employing the 
achiral ligand BIPHEP. The product, homoallylic alcohol 3.5, was produced in 48% 
isolated yield with 9:1 anti-diastereoselectivity and 14% enantiomeric excess (Scheme 
3.6, eqn. 1.2). These data suggest racemization via π-facial interconversion of the kinetic 
π-crotyl iridium complex occurs at a rate only marginally slower than the rate of carbonyl 
addition. To further probe the origins of stereoselection, optically enriched allylic acetate 
3.4 (98% ee) was coupled to alcohol 3.1e under standard conditions employing iridium 
catalysts modified by (S)-SEGPHOS and (R)-SEGPHOS (Scheme 3.6, eqn. 3 and 4, 
respectively). In the former case, excellent levels of relative and absolute stereocontrol 
were observed. In the later case, diminished efficiencies and reduced levels of diastereo- 
and enantioselectivity were evident. In both cases, recovered allylic acetate 3.4 exhibited 
significant erosion of optical purity. These experiments suggest that ionization of the (R)-
allylic acetate 3.4 by the (S)-SEGPHOS modified iridium catalyst represents the lower 
energy diastereomeric pathway, that is, a stereochemically matched ionization mode. 
Partial racemization of recovered allylic acetate 3.4 suggests that ionization occurs 
reversibly with incomplete kinetic stereoselectivity. Finally, in reactions employing 
racemic allylic acetate 3.4 and the iridium catalyst modified by (S)-SEGPHOS, recovered 
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3.4 exhibited a substantial degree of optical enrichment favoring the (S)-enantiomer 
(Scheme 3.6, eqn. 5). This result is consistent with the notion that consumption of the 
(R)-allylic acetate 3.4 by the (S)-SEGPHOS modified iridium catalyst represents a more 
rapid stereochemically matched reaction pathway. Notably, the degree of optical 
enrichment of recovered (S)-3.4 does not increase as a function of conversion due to 
erosion of the optical purity of unreacted allylic acetate 3.4 via reversible ionization, as 






























12:1 dr, 95% ee
Recovered 3.4








4.6:1 dr, 73% ee
Recovered 3.4
















59% Yield, 22% ee
53% Yield, 27% ee
52% Yield, 22% ee
48% Yield, 21% ee
Compound 3.5
37% Yield, 95% ee, 11.3:1 dr
45% Yield, 95% ee, 12.6:1 dr
48% Yield, 94% ee, 11.3:1 dr




















a conducted by In Su Kim  
Scheme 3.6. Experiments aimed at probing the origins of stereoselection in Ir-catalyzed 
transfer hydrogenative crotylation (Ar = (4-(CO2Me)Ph).  
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The observed anti-diastereoselectivity presumably arises via kinetic formation of 
the cis-π-crotyl complex,10 which engages the carbonyl partner by way of an (E)-crotyl 
iridium intermediate (Scheme 3.7). Erosion of diastereoselectivity may result via 
isomerization to the trans-π-crotyl complex, which engages the carbonyl partner by way 
of the (Z)-crotyl iridium complex to form the syn-diastereomer. This interpretation may 
account for the fact that couplings to aldehydes exhibit uniformly higher levels of 
diastereoselectivity. For the aldehyde couplings, carbonyl addition is anticipated to be 
faster as higher concentrations of aldehyde are present throughout the course of the 
reaction, promoting rapid capture of the kinetic allyliridium intermediate. The 
observation that diastereoselectivity increases with increasing concentration in couplings 
of alcohols further supports the veracity of this interpretation. 
 
Scheme 3.7. Stereochemical features associated with formation and isomerization of the 
purported crotyl iridium intermediates (*Ln = (S)-SEGPHOS and C,O-benzoate of 4-
cyano-3-nitrobenzoic acid ).   
 
Exposure of α-methyl allyl acetate to equimolar quantities of 3.1a and 3.2e under 
standard conditions employing BIPHEP as ligand provided 3.3a and 3.3e in 83% yield in 
a 1:2.3 ratio, respectively. Exposure of α-methyl allyl acetate to equimolar quantities of 
3.2a and 3.1e under otherwise identical conditions provided 3.3a and 3.3e in 74% yield in  
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Scheme 3.8. Experiments establishing rapid redox equilibration in advance of carbonyl 
addition (Ar = (4-(CO2Me)Ph).  
 
a 1:1.1 ratio, respectively. These experiments demonstrate rapid redox equilibration in 
advance of carbonyl addition, which is relevant to crotylations conducted from the 
alcohol oxidation level (Scheme 3.8). 
A simplified catalytic mechanism consistent with our collective results is depicted 
in Scheme 3.9. The ortho-cyclometallated iridium hydride I undergoes deprotonation in 
the presence of Cs2CO3 to furnish the anionic iridium(I) C,O-benzoate II.11 Oxidative 
addition to α-methyl allyl acetate delivers the iridium π-crotyl complex III. The parent 
BINAP-ligated iridium π-allyl C,O-benzoate complex has been characterized by single-
crystal X-ray diffraction and has been demonstrated to be catalytically relevant9b 
Aldehyde addition by way of the (E)-σ-crotyliridium complex IV through a closed chair-
like transition structure delivers the anti-homoallyl iridium alkoxide V. This intermediate 
is stable with respect to β-hydride elimination of the carbinol C-H due to occupation of 
 155
the remaining coordination site at iridium(III) by the olefin moiety of the homoallylic 
alcohol. Exchange of the homoallylic alcohol for isopropanol or a reactant alcohol 
provides VI, which has an open coordination site and, consequently, β-hydride eliminates 
to regenerate the ortho-cyclometallated complex I. A stereochemical model accounting 
for the observed stereochemistry is analogous to that previously proposed (Scheme 3.9, 
right). 
 
Scheme 3.9. Left: Simplified catalytic mechanism proposed for the iridium catalyzed 
transfer hydrogenative crotylation. Right: Model accounting for the observed sense of 
relative and absolute stereocontrol.  
 
3.1.4 Summary 
Anti-diastereo- and enantioselective carbonyl crotylation from the alcohol or 
aldehyde oxidation level under the conditions of iridium-catalyzed transfer hydrogenation 
was developed. This method circumvents the use of chirally modified crotylmetal 
reagents or metallic terminal reductants and, consequently, avoids generation of 
stoichiometric metallic byproducts. Furthermore, the ability to conduct carbonyl 
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crotylation directly from alcohol oxidation level allows one to bypass the oxidation 



















3.2 ENANTIOSELECIVE IRIDIUM-CATALYZED CARBONYL SILYLALLYLATION 
3.2.1 Background 
A carbonyl silylallylation reaction has been attractive for many years due to the 
significance of the product as an important synthetic intermediate in organic reaction 
(Scheme 3.10).12 For example, Roush utilized (E)-γ-(alkoxysilyl)allyl boronate for the 
construction of diols. Since then, various reagents have been developed from the same 
group to increase the selectivity. Recently, a chiral silyl allyl Titanium reagent was used 
to produce β-hydroxyallylsilanes with high reactivity and selectivity. These types of 
reagents share common drawbacks such as the generation of stoichiometric amounts of 
byproducts and multiple steps for preparation. 
 
 
Scheme 3.10 Representative examples of chirally modified metal reagents for use in 
enantioselective carbonyl silylallylation. 
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In connection with studies aimed at the discovery of hydrogen-mediated reductive 
C-C bond formations beyond hydroformylation, a broad family of C-C bond forming 
transfer hydrogenations promoted by iridium catalyst was reported.13 A remarkable 
feature of these processes resides in the ability to achieve carbonyl addition from the 
aldehyde or alcohol oxidation level. In the former case, isopropanol or formic acid 
mediate reductive C-C coupling. In the latter case, dehydrogenation of the primary 
alcohol reactants generates aldehyde electrophiles, while simultaneously driving 
reductive generation of nucleophilic organometallics from unsaturated reactants.  Unlike 
conventional methods for carbonyl allylation, these processes circumvent use of 
premetallated nucleophiles and metallic reductants. In this fashion, α-(trimethylsilyl)allyl 
acetate can serve as a alternative to previously reported silicon-containing 1,3- or 1,1-
bimetallic allyl transfer agents.  
3.2.2 Reaction optimization 
Our study began with the attempted (trimethylsilyl)allylation of alcohol 3.4b. 
Using the ortho-cyclometallated catalyst generated in situ from [Ir(cod)Cl]2, 4-cyano-3-
nitrobenzoic acid, BIPHEP and allyl acetate, neither the desired (trimethylsilyl)allylation 
product 3.5b nor resulting Peterson olefination product was detected (eqn. 1). Using the 
isolated π-allyl iridium precatalyst (BIPHEP)-I in the presence of Cs2CO3 (eqn. 2), the 




quantities of Peterson olefination product. Having these preliminary results, various 
inorganic bases and reaction temperature were screened to suppress the Peterson 
olefination product (Table 3.6). After screening various inorganic bases, additives and 
temperatures, it was found that Peterson olefination was suppressed using K3PO4 (1.0 
equiv.) in the presence of water (5.0 equiv.) for reactions conducted at 70 oC (Table 3.6, 
entry 9). 
 
Table 3.6 Optimization of inorganic base and temperature. 
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After identification of the reaction condition for anti-diastereoselective 
(trimethylsilyl)allylation, enantioselective variants of this process were explored. 
Accordingly, representative C2-symmetric phosphine ligands were used to prepare a 
small set of chiral iridium C,O-benzoate complexes that were assayed for their ability to 
promote efficient anti-diastereo- and enantioselective (trimethylsilyl)allylation (Table 
3.7). 
The complex (Ligand)-I with (R)-SEGPHOS proved superior to all others 
assayed and was used to establish the reaction scope. Under these conditions, α-
(trimethylsilyl)allyl acetate was coupled to a structurally diverse set of alcohols 3.4a-3.4i 
(Table 3.8). In terms of scope, diverse substituted benzylic alcohols 3.4a-c were 
converted to the corresponding carbonyl α-(trimethylsilyl)allylation products 3.5a-c in 
good to excellent yield, very high levels of anti-diastereoselectivity and with exceptional 
 
Table 3.7 Assay of chirally modified catalysts. 
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levels of absolute stereocontrol (Table 3.8, entries 1-3). As demonstrated by the 
conversion of cinnamyl alcohol 3.4d to homoallylic alcohol 3.5d, allylic alcohols 
participate in the coupling (Table 3.8, entry 4). Heteroaromatic alcohol 3.4e also gave the 
corresponding product with excellent level of selectivity (Table 3.8, entry 5). Finally, 
unactivated aliphatic alcohols 3.4f-i were transformed to the corresponding products 3.5f-
i in good yield with equally high levels of relative and absolute stereocontrol (Table 3.8, 
entries 6-9). 
 
Table 3.8 Enantioselective α-(trimethylsilyl)allylation from the alcohol oxidation level. 
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In the presence of isopropanol, but under otherwise identical conditions, α-
(trimethylsilyl)allylation occurs from the aldehyde oxidation level to furnish an identical 
set of adducts 3.6a-i (Table 3.9). Again, good isolated yields were accompanied by 
exceptional levels of diastereo- and enantioselectivity. Thus, unlike corresponding 
protocols involving allylmetal reagents,12 carbonyl α-(trimethylsilyl)allylation occurs 
with equal facility from the alcohol or aldehyde oxidation level. 
 
 
Table 3.9 Enantioselective α-(trimethylsilyl)allylation from the aldehyde oxidation level. 
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The mechanism for catalytic carbonyl (trimethylsilyl)allylation is analogous to 
that previously proposed for related crotylation.14 However, complete levels of anti-
diastereoselectivity were observed in nearly all cases, suggesting carbonyl addition 
occurs exclusively from the (E)-σ-allyl through a chair-like transition structure. Notably, 
although the catalyst dehydrogenated primary alcohols 3.4a-3.4i, the reaction products 
3.5a-3.5i, which are homoallylic alcohols, were not oxidized under the coupling 
conditions and, hence, do not experience any erosion of enantiomeric purity by way of 
redox equilibration. This result is remarkable as 2-propanol, a secondary alcohol, was  
 
 
Scheme 3.11 Proposed catalytic mechanism and stereochemical model for carbonyl 
(trimethylsilyl)allylation from the alcohol or aldehyde oxidation level. 
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oxidized under the coupling conditions when aldehydes 3.6a-3.6i were employed as 
reactants. As indicated in the proposed catalytic mechanism (Scheme 3.11), coordination 
of iridium to the homoallylic olefin of reaction products 3.5a-3.5i provides a hexa-
coordinate, 18-electron complex that cannot engage in β-hydride elimination due to the 
absence of an open coordination site. 
3.2.3 Application 
To evaluate the utility of the coupling products 3.5a-3.5i, adducts 3.5a, 3.5f, 3.5g 
and 3.5i were subjected to DMDO-mediated oxidative elimination.12l,m The 1,4-ene-diols 
3.7a, 3.7f, 3.7g and 3.7i were produced in excellent yield with high levels of E:Z 



























3.5a, 3.5f, 3.5g, 3.5i
a conducted by Xin Gao  
Scheme 3.12 Dioxirane mediated oxidative desilylation of adducts 3.5a, 3.5f, 3.5g and 
3.5i to furnish the corresponding 1,4-ene-diols 3.7a, 3.7f, 3.7g and 3.7i. 
 
Proto-desilylation was attempted next. Under nearly all conditions assayed, 
exclusive formation of Peterson olefination products was observed. However, upon 
exposure of adduct 3.5g to TiCl4 in the presence of exogenous aldehyde, the product of 
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proto-desilylation 3.8g was generated in 73% yield with complete E:Z selectivity 
(Scheme 3.13). In the absence of aldehyde, Peterson olefination was again the exclusive 
reaction product, suggesting exogenous aldehyde protects the hydroxyl moiety of 3.5g 
through formation of a titanium bound hemi-acetal. Notably, compound 3.8g was 
previously prepared in 7-steps from malic acid.15 Thus far, the protodesilylation is most 
efficient for the benzyl ether-containing adduct 3.5g. 
 
 
Scheme 3.13 Protodesilylation of 3.5g requires exogenous aldehyde to suppress Peterson 
olefination. 
 
Finally, under condition similar to those described by Woerpel,16 exposure of 
3.5g-OAc to chlorosulfonyl isocyanate delivered the product of [3+2] cycloaddition, the 
4,5-trans-disubstituted pyrrolidinone 3.9g, as a single diastereomer. Lactone formation 
was not observed. Formation of the 3.9g suggests a mechanism involving stereoselective 
addition of chlorosulfonyl isocyanate to the allylsilane anti-periplanar with respect to the 
silyl group to generate the indicated β-silyl carbocation. Exclusive N-cyclization 
accompanied by 1,2-silyl migration delivered the 4,5-trans-substituted pyrrolidinone 
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3.9g. In the absence of NaHCO3, a mixture of lactone and lactam products was observed. 
These data suggest that partitioning of the N- and O-cyclization pathways is not dictated 
primarily by steric factors as proposed by Woerpel,16b but that the acidity of the medium 
plays a dominant role (Scheme 3.14) 
 
 
Scheme 3.14 Reaction of adduct 3.5g with chlorosulfonyl isocyanate to furnish the 
product of formal [3+2] cycloaddition 3.9g. 
 
3.2.4 Summary 
In summary, a highly anti-diastereo- and enantioselective carbonyl 
(trimethylsilyl)allylation under the conditions of iridium catalyzed transfer hydrogenation 
employing a single-component catalyst, the ortho-cyclometallated complex (R)-I was 
reported. Notably, identical sets of adducts 3.5a-3.5i were formed with comparable levels 
of selectivity from the aldehyde or alcohol oxidation level in the absence of Peterson 
olefination. Oxidative desilylation of adducts 3.5a, 3.5f, 3.5g and 3.5i employing DMDO 
provided access to highly enantiomerically enriched 1,4-ene-diols 3.7a, 3.7f, 3.7g and 
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3.7i. Furthermore, conditions for proto-desilylation with allylic transposition have been 
identified for adduct 3.8g in the absence of a hydroxyl protecting group. Finally, 
exposure of adduct 3.5g to chlorosulfonyl isocyanate delivered 4,5-trans-disubstituted 

















3.3 ENANTIOSELECIVE IRIDIUM-CATALYZED CARBONYL ALKOXYALLYLATION 
3.3.1 Background 
Among allylation protocols, enantioselective aldehyde α-alkoxyallylation 
provides an efficient means of generating allylic vicinal diol substructures. These vicinal 
diol structures are very common in many natural products (Figure 3.1). 
 
Figure 3.1 Representative vicinal diol motif containing natural products. 
 
To date, asymmetric syn-additions of this type have employed chirally modified 
alkoxy-substituted allylmetal reagents based on boron, 17  aluminum, 18  titanium,2i 
indium,19 or tin.20 (Scheme3.15) 
Indirect enantioselective aldehyde α-alkoxyallylation can be achieved using 
chirally modified reagents that promote aldehyde α-silylallylation or α-borylallylation 
followed by oxidation of the C-Si or C-B bond, respectively (Scheme 3.16).21 
For direct methods, stereocontrolled access to anti-alkoxyallylation products is 
problematic because of difficulties encountered in the synthesis of the requisite E-
configured allylmetal reagents.22 This fact has motivated alternate approaches to the 
anti-1-ene-2,3-diol functional group array. For example, when enantioselective catalytic 
dihydroxylation of conjugated dienes was attempted,23 syn-1-ene-2,3-diols were formed.  
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Scheme 3.15 Representative examples of chirally modified alkoxy-substituted allylmetal 
reagents for use in enantioselective carbonyl α-alkoxyallylation. 
 
 
Scheme 3.16 Representative examples of indirect enantioselective aldehyde α-
alkoxyallylation. 
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To our knowledge, only Duthaler’s chiral allyltitanium reagent2i has been employed in 
direct enantioselective anti-alkoxyallylation; however, only a single highly 
stereoselective example was reported, and use of this allylmetal reagent is attended by 
considerable “preactivation”.24 To date, catalytic enantioselective methods for aldehyde 
syn-or anti-α-alkoxyallylation remain elusive. 25  Based on the iridium catalyzed 
entioselective allylation2a,b,26 and crotylation reaction14,27, enantioselective carbonyl anti-




3.3.2 Reaction optimization 
In an initial experiment, acrolein gem-diacetate 3.10a was subjected to isopropyl 
alcohol-mediated transfer hydrogenation in the presence of aldehyde 3.11c employing the 
ortho-cyclometalated iridium C,O-benzoate BIPHEP-I derived from [Ir(cod)Cl]2, 4-
cyano-3-nitrobenzoic acid, allyl acetate, and 2,2′-bis(diphenylphosphino)biphenyl 
(BIPHEP). To our delight, the product of reductive coupling was obtained in 74% yield 
with complete branched regioselectivity as a 4:1 mixture of diastereomers favoring the 
anti-stereoisomer. Because partial migration of the acetyl moiety was observed under the 
reaction conditions, exhaustive acetylation was performed in situ upon complete 
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Scheme 3.17 Initial alkoxyallylation of aldehydes employing gem-diacetate and 
acetylation. 
 
In an effort to enhance the diastereoselectivity, a series of acrolein gem-
dicarboxylates were assayed under identical conditions. It was hoped that a sufficiently 
large carboxy group would direct the partitioning of (E)- and (Z)-σ-allyl iridium 
intermediates to favor the (E)-σ-allyl isomer, which upon addition to the aldehyde 
through a Zimmerman-Traxler-type transition structure 28  would deliver the anti-
diastereomer. Indeed, gem-dicarboxylates 3.10a-d, which incorporate acetyl, propionyl, 
isobutyryl, and pivaloyl moieties, respectively, delivered products of alkoxyallylation 
with increasing levels of anti-diastereoselectivity. However, decreasing conversion in 
response to the increased steric demand of the carboxy moiety was observed. As earlier 
studies suggest that carbonyl addition is turnover-limiting,14,29 it is likely that increased 
steric demand of the carboxy group impedes carbonyl addition. The best level of anti-
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diastereoselectivity and conversion was observed using gem-dibenzoate 3.10e (11:1 dr), 
perhaps because it is large enough to direct formation of the (E)-σ-allyl isomer yet does 




Table 3.10 Optimizing anti-diastereoselectivity in the alkoxyallylation of aldehydes 
employing gem-dicarboxylates derived from acrolein (Ar=p-PhCO2Me). 
 
After identification of acrolein gem-dibenzoate 3.10e as an effective reagent for 
anti-diastereoselective alkoxyallylation, enantioselective variants of this process were 
explored. Accordingly, representative C2-symmetric phosphine ligands were used to 
prepare a small set of chiral iridium C,O-benzoate complexes that were assayed for their 





Table 3.11 Assay of chirally modified catalysts. 
 
The complex (R)-SEGPHOS-I proved superior to all others assayed and was 
used to establish the reaction scope. It was found that aromatic, heteroaromatic, α,β-
unsaturated, and aliphatic aldehydes 3.11a-i were converted to the corresponding 
alkoxyallylation products 3.12a-i in good isolated yields (63-82%) with good to excellent 
diastereoselectivities (10:1 to 18:1 dr) and exceptional enantioselectivities (90-99% ee) 
(Table 3.12). Generation of the cyclometalated catalyst in situ, as previously 
reported,14,29,30 led to poor isolated yields of product. In the absence of isopropyl alcohol, 





















77% Yield, 11:1 dr
99% ee, 3.12d
82% Yield, 16:1 dr
94% ee, 3.12fa
70% Yield, 16:1 dr
90% ee, 3.12b
63% Yield, 18:1 dr
99% ee, 3.12aa
76% Yield, 14:1 dr
99% ee, 3.12c
CO2Me





71% Yield, 13:1 dr
98% ee, 3.12ga











a, R = Ph
d, R = p-NO2Ph
g, R = CH=CHCH2Me
b, R = p-BrPh
e, R = 6-Br-2-Pyr
h, R = (CH2)3OTBS
c, R = p-(CO2Me)Ph
f, R = CH=CHPh














a conducted by Hoon Han  
 
Table 3.12 anti-Diastereo and enantioselective alkoxyallylation of aldehydes employing 
gem-dibenzoate 3.10e derived from acrolein. 
 
To access the diol products directly, an alternate protocol involving saponification 
in situ was explored. Here, aldehydes 3.11a, 3.11e, 3.11f, and 3.11i were exposed to the 
standard reaction conditions employing gem-dibenzoate 3.10e as the allyl donor. Upon 
complete consumption of the aldehyde, methanol and potassium carbonate were added to 
the reaction mixture. The diol-containing products 3.13a, 3.13e, 3.13f, and 3.13i were 
obtained in good isolated yields and with anti-diastereo- and enantioselectivities roughly 
equivalent with those observed for the corresponding dibenzoates 3.12a, 3.12e, 3.12f, and 









In summary, under the conditions of iridium-catalyzed transfer hydrogenation 
employing isopropyl alcohol as the terminal reductant, gem-dibenzoate 3.10e reductively 
couples to aldehydes 3.11a-i to furnish products of anti-alkoxyallylation with excellent 
relative and absolute stereocontrol. This protocol provides an alternative to the use of 
premetalated nucleophiles and chiral auxiliaries in asymmetric carbonyl alkoxyallylation, 
providing direct stereocontrolled access to the anti- 1-ene-2,3-diol functional group array 







3.4 ENANTIOSELECIVE IRIDIUM-CATALYZED CARBONYL REVERSEPRENYLATION 
3.4.1 Background 
 
The gem-dimethyl moiety is a very common structure in many natural products. 
For example, mycalamid A, epothilone, acutiphycin and bryostatin 1each have a gem-





Figure 3.2 Representative natural products containing a gem-dimethyl motif. 
 
Among the methods to construct gem-dimethyl, carbonyl prenylation has been 
extensively studied. However, most of the reactions were studied in the course of 
allylation reactions and only few reactions were conducted asymmetrically (Scheme 
3.19).31  
In the course of studies aimed at the development of C-C bond- forming 
hydrogenations, highly enantioselective carbonyl allylation29,30, crotylation14, 
(trimethylsilyl)allylation32 and alkoxyallylation33 employing various substituted allyl 
acetates were achieved under the conditions of iridium-catalyzed transfer hydrogenation. 
With catalytic asymmetric methods for polyacetate and polypropionate construction in 




Scheme 3.19 Representative examples of enantioselective carbonyl reverseprenylation. 
 
alternative to the use of stoichiometric metallic reagents in enantioselective carbonyl 
reverse prenylation.31 
 
3.4.2 Reaction optimization 
 
Attempted use of allylic acetates (2-methyl- 3-butenyl acetate or 3-methyl-2-
butenyl acetate) as prenyl donors was unsuccessful. A potential solution to this problem 
resides in the use of 1,1-dimethylallene 3.14 as a prenyl donor. However, in earlier 
studies on the iridium-catalyzed reductive coupling of 3.14 to aldehydes mediated by 
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gaseous hydrogen, it was found that highly activated aldehydes were required, and 
despite an extensive assay of chiral phosphine ligands, only low levels of enantiomeric  
 
 
Table 3.13 Assay of chirally modified catalysts. 
 
enrichment were observed.34 To increase the enantioselectivity of the transformation, an 
ortho-cyclometalated iridium C,O-benzoate catalyst recently developed32,33 was exploited 
for enantioselective catalytic carbonyl reverse prenylation employing 3.14 as the prenyl 
donor under transfer hydrogenation conditions. Various chiral ligand-Ir complexes were 
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synthesized and tested in the reverse prenylation reacdtion (Table 3.13). After extensive 
study involving an assay of commercial chelating chiral phosphine ligands, optimal 
results (70% yield, 87% ee, Table 3.13, entry 7) were achieved upon exposure of a 
toluene solution of 3.14 and 3.15f to the cyclometalated iridium C, O-benzoate derived 
from allyl acetate, m-nitrobenzoic acid, and (S)-SEGPHOS, 35  designated “(S)-Ir-
Complex I” (eqn. 1), in the presence of 2-propanol (200 mol %). In contrast to related 
allyl acetate-mediated allylations and crotylations, 3.14 couples at relatively low 





To explore the scope of this process, 3.14 was coupled to a structurally diverse set 
of aldehydes 3.15a-i (Table 3.14). Aromatic aldehydes 3.15a-c, α,β-unsaturated 
aldehydes 3.15d-e, and aliphatic aldehydes 3.15f-i were subject to reverse prenylation to 
furnish adducts 3.16a-i in good to excellent isolated yields (65-96%) and 
enantioselectivities (87-93% ee). 
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85% Yield (48 hrs)
93% ee (50 oC)3.16ea
a, R = Ph
d, R = CH=CHPh
g, R = (CH2)2OBn
b, R = p-BrPh
e, R = Geranyl
h, R = (CH2)3OBn
c, R = p-(CO2Me)Ph
f, R = (CH2)2Ph
i, R = (CH2)7Me
(CH2)2Ph
81% Yield (48 hrs)
93% ee (40 oC),3.16da
84% Yield (72 hrs)
87% ee (60 oC), 3.16f
96% Yield (48 hrs)
90% ee (40 oC), 3.16b
94% Yield (48 hrs)
89% ee (40 oC), 3.16a
88% Yield (20 hrs)
89% ee (40 oC), 3.16ca
CO2Me
86% Yield (48 hrs)
93% ee (50 oC),3.16ha
(CH2)2OBn (CH2)3OBn
65% Yield (72 hrs)
89% ee (60 oC), 3.16gb
71% Yield (48 hrs)
92% ee (50 oC), 3.16ib
(CH2)7Me
Br
Me Me Me Me Me Me
Me MeMe Me











Table 3.14 Enantioselective carbonyl reverse prenylation from the aldehyde oxidation 
level. 
 
In the absence of 2-propanol, enantioselective carbonyl reverse prenylation 
occurred directly from the alcohol oxidation level to furnish an identical set of adducts 
3.16a-i, once again with good to excellent isolated yields (68-94%) and 
enantioselectivities (86-91% ee) (Table 3.15). Especially noteworthy is the conversion of 





Table 3.15 Enantioselective carbonyl reverse prenylation from the alcohol oxidation 
level. 
 
To gain further mechanistic insight, a crossover experiment was performed at 
50 °C in the absence of 2-propanol using the achiral cyclometalated iridium C,O-
benzoate derived from allyl acetate, m-nitrobenzoic acid, and BIPHEP. Exposure of 3.14 
to equimolar quantities of 3.15a and 3.17b under the aforementioned conditions provided 
3.16a and 3.16b, respectively, in 87% combined yield in a 1:1.2 ratio (eqn. 2 in Scheme 
3.16). Exposure of 3.14 to equimolar quantities of 3.17a and 3.15b under otherwise 
identical conditions provided 3.16a and 3.16b, respectively, in 95% yield in a 1:1.6 ratio 
(eqn. 3 in Scheme 3.16). These experiments suggest rapid alcohol-aldehyde redox 
equilibration in advance of carbonyl addition. Isotopic labeling experiments also were 
performed at 50 °C using the achiral cyclometalated iridium C,O-benzoate derived from 
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allyl acetate, m-nitrobenzoic acid, and BIPHEP. When 2-propanol-d8 was used as the 
terminal reductant, aldehyde 3.15a was transformed to deuterio-3.16a, which 
incorporates deuterium at the interior vinylic position (97% 2H) and the terminal vinylic 
position (3% 2H) (eqn. 4 in Scheme 3.16). Use of deuterio-3.17a in the absence of 2-
propanol delivered deuterio-3.16a, which incorporates deuterium at the interior vinylic 
position (95% 2H) and the carbinol methine (>99% 2H) (eqn. 5 in Scheme 3.16). High-
fidelity incorporation of deuterium suggests that capture of the kinetically formed π-allyl 








In summary, the first use of allenes in enantioselective C-C bond-forming transfer 
hydrogenation, as demonstrated by the development of an effective protocol for carbonyl 

















3.5 ENANTIOSELECIVE IRIDIUM-CATALYZED ALLYLATION, CROTYLATION AND 
REVERSE PRENYLATION OF SUBSTITUTED ISATINS 
3.5.1 Background 
3-Substituted-3-hydroxy-oxindoles appear as substructures within a fascinating 
array of natural products, including the convulutamydines, 36 a,b maremycins,36c,d 
donaxaridines,36e,f dioxibrassinins,36g,h,i celogentin K,36j hydroxyglucoisatisins36k and 




Figure 3.3 Examples of naturally occurring 3-substituted-3-hydroxy-oxindoles.  
 
Whereas catalytic asymmetric additions to isatins are known, 37  highly 
enantioselective catalytic allylation, crotylation, and reverse prenylation of isatins have 
remained elusive. In the course of developing hydrogen-mediated C-C couplings beyond 
hydroformylation, chiral ortho-cyclometalated iridium C,O-benzoates were found to 
catalyze highly enantioselective carbonyl allylation,29,30 crotylation,14 and reverse 
prenylation38 under transfer-hydrogenation conditions. In contrast to classical allylation 
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procedures which employ stoichiometric organometallic reagents, transfer-hydrogenation 
protocols exploit allyl acetate, α-methyl allyl acetate, and 1,1-dimethyl allene as 
precursors to transient allyl-, crotyl-, and prenyl metal intermediates, respectively. To 
further evaluate the scope of this emergent methodology, catalytic enantioselective 
additions to ketones were explored. 
3.5.2 Reaction optimization 
 
Our initial studies focused on the allylation of N-benzyl isatin 3.18a. Using the 
cyclometalated C,O-benzoate generated in situ from [Ir(cod)Cl]2, BIPHEP, and 4-chloro-
3-nitrobenzoic acid, the coupling of allyl acetate (1000 mol%) to 3.18a at 100 oC in THF 
(0.2 M) delivered the tertiary homoallylic alcohol 3.19a in 42% yield upon isolation 
(Table 3.16, entry 1). At lower loadings of allyl acetate (200 mol%) with higher reaction 
temperature (120 oC) and extended reaction time (43 hr), the yield of homoallylic alcohol 
3.19a was increased to 69% (Table 3.17, entry 4). Further optimization of reaction 
concentration gave the product 3.19a with 77% yield (Table 3.16, entry 6). 
 
Table 3.16 Allylation of N-benzyl isatin 3.18a.  
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Having these results in hand, an assay of chelating chiral phosphine ligands was 
undertaken. (R)-BINAP liagnd produced 3.19a with 47% yield and 79% ee.(Table 3.17, 
entry 1) Among the various chiral ligands screening, CTH-(R)-P-PHOS gave the best 
selectivity (81% ee) and reactivity (78% yield) (Table 3.17, entry 14). However, the 
selectivity was not satisfactory and further optimization was necessary. 
Changing additive from 4-Cl-3-NO2-BzOH to 4-CN-3-NO2-BzOH showed better 
reactivity (Table 3.18, entry 2). Decreasing the reaction temperature revealed dramatic 
enhancement in the level of asymmetric induction (92% ee). However, lower 
temperatures also diminished conversion to 53% yield (Table 3.18, entry 3). This impasse 
was resolved by increasing the loading of isopropanol from 200 mol% to 400 mol%, 
which enabled conversion of N-benzyl isatin 3.18a to the homoallylic alcohol 3.19a in 
73%yield and 91% enantiomeric excess using cth-(R)-p-phos (cth-(R)-p-phos = (R)-(+)-
2,2’,6,6’-tetramethoxy-4,4’-bis(diphenyl-phosphino)-3,3’-bipyridine) as the ligand. 
Notably, under analogous reaction conditions employing our initially disclosed iridium 
catalyst modified by 3-nitrobenzoic acid, 3.19a was obtained in 61%yield and 90% 
enantiomeric excess. These data further illustrate how catalyst performance is enhanced 






Table 3.17 Assay of chiral ligands in allylation reaction.  
 
 
Table 3.18 Optimization of allylation reaction. 
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Optimal reaction conditions identified for the conversion of N-benzyl isatin 3.18 
to the hydroxy oxindole 3.19a were applied to substituted isatins 3.18a–3.18g (Table 
3.19). Various 5, 6 and 7-substituted groups on the aromatic ring were tested. For 
example, 5-bromo substituted isatin 3.18b gave 83% yield of the corresponding product  
3.19b with excellent selectivity (95 %ee) (Table 3.19, entry 2). Electron donating groups 
such as 5-methyl 3.18c and methoxy substitution 3.18d produce the products with great 
reactivity and selectivity (Table 3.19, entry 3, 4). Substitution on 6, 7 (3.18e-g) also 
produce the alcohol with high yield and excellent selectivity (Table 3.19, entry 5, 6 and 




aAll reactions were performed in 13 x 100 mm pressure tubes. Cited yields are of material isolated by silica gel chromatography. 
Enantiomeric excess was determined by chiral stationary phase HPLC analysis. See supporting information for further details. b10 
mol% loading of Cs2CO3 was used and the reaction was conducted for 72 hours. c400 mol% loading of allyl acetate was used.d 
conducted by Junji Itoh. 
Table 3.19 Catalytic enantioselective allylation N-benzyl isatins 3.18a-g via iridium 
catalyzed C-C bond forming transfer hydrogenation. 
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determined for the 5-bromo derivative 3.19b by single-crystal X-ray diffraction analysis 
using the anomalous dispersion method. 
Given these favorable results, the crotylation of substituted isatins 3.18a–g was 
attempted under identical conditions employing α-methyl allyl acetate as the crotyl donor 
(Table 3.20). The products of ketone crotylation, 3.20a–g, were produced in moderate to 
excellent yields upon isolation (64–87%) with moderate to excellent levels of optical 
enrichment (80–92%ee). In general, crotylation required longer reaction times (Table 




aAs described in Table 3.20 footnotes. b10 mol% loading of Cs2CO3 was used. c400 mol% loading of allyl acetate was used. dThe 
reaction was run for 40 hr. eMe-THF was used as the solvent.f 5 mol% loading of [Ir(cod)Cl]2 , 10 mol% of cth-(R)-p-phos, and 20 
mol% loading of 4-CN-3-NO2-BzOH were used.g conducted by Junji Itoh. 
Table 3.20 Catalytic enantioselective crotylation of N-benzyl isatins 3.18a–g by iridium-
catalyzed C-C bond-forming transfer hydrogenation. 
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increased conversion in certain cases (Table 3.20, entries 1, 5 and 7). The absolute 
stereochemical assignment of adducts 3.20a–g are based upon that determined for the 5-
bromo derivative 3.20b by single-crystal X-ray diffraction analysis using the anomalous 
dispersion method. 
Finally, the reverse prenylation of substituted isatins 3.18a–g was attempted 
(Table 3.21). To our delight, adducts 3.21a–g were generated in uniformly high yields 
(70–90%) and high levels of optical enrichment (90–96%ee) under mild reaction 
conditions. Notably, this transformation enables the creation of two contiguous 




aAs described in Table 1 footnotes. bThe reaction was run for 72 h 
Table 3.21 Catalytic enantioselective prenylation of N-benzyl isatins 3.18a–g by iridium-
catalyzed C-C bond-forming transfer hydrogenation. 
 191
are based upon that determined for the 5-bromo derivative 3.21b by single- crystal X-ray 
diffraction analysis using the anomalous dispersion method. 
3.5.3 Summary 
 
In summary, the first enantioselective allylations, crotylations, and prenylations of 
isatin, which are achieved by isopropanol-mediated transfer hydrogenation, was reported. 
Unlike conventional allylation methodologies which employ stoichiometric quantities of 
allyl–metal reagents, the present method exploits allyl acetate, α-methyl allyl acetate, and 
1,1-dimethylallene as precursors to transient allyl-, crotyl-, and prenyl metal 
intermediates, respectively. To our knowledge, these studies represent the first examples 
of catalytic enantioselective ketone allylation, crotylation, and prenylation in the absence 












3.6 EXPERIMENTAL SECTIONS 
 
General procedure for anti-Diastereo- and Enantioselective Crotylation from the 
Alcohol Oxidation Level 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 2.5 mol%), (S)-SEGPHOS (12.2 mg, 0.02 mmol, 5 
mol%), Cs2CO3 (26.1 mg, 0.08 mmol, 20 mol%) and 4-cyano-3-nitrobenzoic acid (7.7 
mg, 0.04 mmol, 10 mol%) was added THF (0.2 mL) followed by acetic acid 3-buten-2-yl 
ester (91.3 mg, 0.8 mmol, 200 mol%). The reaction mixture was allowed to stir at 90 oC 
for 0.5 hr and cooled to room temperature. Alcohol substrate (0.4 mmol, 100 mol%) in 
THF (0.2 mL) was added to the reaction mixture and the reaction mixture was allowed to 
stir at 90 oC for 48 hr, at which point the reaction mixture was evaporated onto silica gel. 
Purification of the product by column chromatography provided the corresponding 
product. 
 
General procedure for anti-Diastereo- and Enantioselective Crotylation from the 
Aldehyde Oxidation Level 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 2.5 mol%), (S)-SEGPHOS (12.2 mg, 0.02 mmol, 5 
mol%), Cs2CO3 (26.1 mg, 0.08 mmol, 20 mol%) and 4-cyano-3-nitrobenzoic acid (7.7 
mg, 0.04 mmol, 10 mol%) was added THF (0.2 mL) followed by acetic acid 3-buten-2-yl 
ester (91.3 mg, 0.8 mmol, 200 mol%). The reaction mixture was allowed to stir at 90 oC 
for 0.5 hr and cooled to room temperature. Aldehyde substrate (54.5 mg, 0.4 mmol, 100 
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mol%) in THF (0.2 mL) and isopropanol (59.8 μL, 0.8 mmol, 200 mol%) were added to 
the reaction mixture and the reaction mixture was allowed to stir at 90 oC for 48 hr, at 
which point the reaction mixture was evaporated onto silica gel. Purification of the 





TLC (SiO2): Rf = 0.26 (ethyl acetate:hexanes, 1:15). 1H NMR (400 MHz, CDCl3): δ 7.26-
7.38 (m, 5H), 5.86-5.76 (m, 1H), 5.24-5.17 (m, 2H), 4.35 (d, J = 8.0 Hz, 1H), 2.52-2.45 
(m, 1H), 2.07 (br s, 1H), 0.87 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 142.6, 
140.9, 128.5, 127.9, 127.1, 117.1, 78.1, 46.6, 16.8. HPLC: (Chiralcel OD-H column, 
hexanes:i-PrOH = 99:1, 0.5 mL/min, 210 nm), tmajor = 27.5 min, tminor = 30.8 min; ee = 















1H NMR  
 
 








TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.27-
7.23 (m, 1H), 6.92-6.80 (m, 3H), 5.85-5.76 (m, 1H), 5.22-5.16 (m, 2H), 4.32 (d, J = 8.0 
Hz, 1H), 3.80 (s, 3H), 2.50-2.44 (m, 1H), 2.22 (br s, 1H), 0.87 (d, J = 6.8 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): δ 159.8, 144.4, 140.9, 129.4, 119.5, 117.0, 113.3, 112.5, 78.0, 
55.5, 46.4, 16.8. HPLC: (Chiralpak AD-H column, hexanes:i-PrOH = 96:4, 0.5 mL/min, 
254 nm), tminor = 24.5 min, tmajor = 28.0 min; ee = 95% (alcohol), 98% (aldehyde). 
 










TLC (SiO2): Rf = 0.28 (ethyl acetate:hexanes, 1:15). 1H NMR (400 MHz, CDCl3): δ 7.25 
(d, J = 8.0 Hz, 2H), 6.87 (d, J = 8.0 Hz, 2H), 5.86-5.76 (m, 1H), 5.23-5.16 (m, 2H), 4.29 
(d, J = 8.4 Hz, 1H), 3.80 (s, 3H), 2.48-2.42 (m, 1H), 2.15 (br s, 1H), 0.83 (d, J = 6.8 Hz, 
3H). 13C NMR (100 MHz, CDCl3): δ 159.3, 141.2, 134.8, 128.2, 117.0, 113.9, 77.7, 55.5, 
46.7, 16.8. HPLC: (Chiralpak AD-H/AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 
230 nm), tminor = 41.2 min, tmajor = 48.9 min; ee = 90% (alcohol), 97% (aldehyde). 
 
 197
1H NMR  
 
 







TLC (SiO2): Rf = 0.26 (ethyl acetate:hexanes, 1:15). 1H NMR (400 MHz, CDCl3): δ 7.46 
(d, J = 8.0 Hz, 2H), 7.18 (d, J = 8.0 Hz, 2H), 5.81-5.71 (m, 1H), 5.22-5.16 (m, 2H), 4.32 
(d, J = 7.6 Hz, 1H), 2.45-2.37 (m, 1H), 2.20 (br s, 1H), 0.87 (d, J = 6.8 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): δ 141.4, 140.1, 131.3, 128.6, 121.4, 117.3, 77.1, 46.4, 16.4. 
HPLC: (Chiralpak AS-H/AS-H column, hexanes:i-PrOH = 98:2, 0.5 mL/min, 254 nm), 
tminor = 30.0 min, tmajor = 34.4 min; ee = 95% (alcohol), 97% (aldehyde). 
 






13C NMR  
 
 
Methyl 4-((1S,2S)-1-hydroxy-2-methylbut-3-enyl)benzoate  
 
3.3e 
TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:6). 1H NMR (400 MHz, CDCl3): δ 7.97 
(d, J = 8.0 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 5.79-5.69 (m, 1H), 5.17-5.12 (m, 2H), 4.40 
(d, J = 7.2 Hz, 1H), 3.88 (s, 3H), 2.49-2.36 (m, 2H), 0.86 (d, J = 6.8 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): δ 167.2, 147.9, 140.1, 129.7, 129.6, 127.0, 117.5, 77.3, 52.3, 46.5, 
16.6. HPLC: (Chiralpak AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 254 nm), 
tminor = 25.3 min, tmajor = 30.3 min; ee = 97% (alcohol), 97% (aldehyde). 
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TLC (SiO2): Rf = 0.26 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.62 
(d, J = 8.0 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 7.26 (t, J = 8.0 Hz, 1H), 7.14 (t, J = 8.0 Hz, 
1H), 6.48 (s, 1H), 5.98-5.88 (m, 1H), 5.33-5.25 (m, 2H), 4.60 (d, J = 8.4 Hz, 1H), 3.81 (s, 
3H), 2.86-2.78 (m, 1H), 2.22 (br s, 1H), 1.03 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 140.7, 140.3, 138.2, 127.5, 121.9, 120.9, 119.8, 117.4, 109.4, 100.8, 71.4, 44.3, 
30.7, 17.5. FTIR (neat): υ 3512, 3415, 3052, 2972, 2929, 1638, 1611, 1540, 1468, 1416, 
1316, 1233, 1138, 1102, 1010, 918, 842, 785, 750, 735, 672 cm-1. HRMS (CI) Calcd. for 
C14H18NO (M+1): 202.1388, Found: 202.1389. HPLC: (Chiralcel OJ-H column, 
hexanes:i-PrOH = 93:7, 0.5 mL/min, 254 nm), tmajor = 62.8 min, tminor = 78.9 min; ee = 



























TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.41-
7.23 (m, 5H), 6.61 (d, J = 16.0 Hz, 1H), 6.21 (dd, J = 16.0, 7.2 Hz, 1H), 5.88-5.78 (m, 
1H), 5.21-5.16 (m, 2H), 4.06 (t, J = 6.8 Hz, 1H), 2.41-2.35 (m, 1H), 1.99 (br s, 1H), 1.06 
(d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 140.4, 136.9, 132.0, 130.4, 128.8, 
127.9, 126.8, 117.0, 76.4, 44.9, 16.3. HPLC: (Chiralpak AS-H/AS-H column, hexanes:i-
PrOH = 98:2, 0.5 mL/min, 254 nm), tminor = 29.2 min, tmajor = 35.4 min; ee = 90% 
(alcohol), 98% (aldehyde). 











TLC (SiO2): Rf = 0.31 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.31-
7.17 (m, 5H), 5.80-5.70 (m, 1H), 5.15-5.10 (m, 2H), 3.43-3.40 (m, 1H), 2.89-2.81 (m, 
1H), 2.72-2.64 (m, 1H), 2.26-2.20 (m, 1H), 1.89-1.80 (m, 1H), 1.75-1.62 (m, 2H), 1.03 
(d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 142.6, 140.4, 128.7, 128.6, 126.0, 
116.8, 74.2, 44.6, 36.4, 32.4, 16.5. HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 
97:3, 0.7 mL/min, 254 nm), tminor = 11.2 min, tmajor = 17.4 min; ee = 97% (alcohol), 97% 
(aldehyde). 
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TLC (SiO2): Rf = 0.26 (ethyl acetate:hexanes, 1:12). 1H NMR (400 MHz, CDCl3): δ 7.37-
7.25 (m, 5H), 5.82-5.73 (m, 1H), 5.12-5.06 (m, 2H), 4.51 (s, 2H), 3.51 (t, J = 6.4 Hz, 
2H), 3.45-3.39 (m, 1H), 2.27-2.17 (m, 1H), 2.12 (br s, 1H), 1.82-1.62 (m, 3H), 1.49-1.38 
(m, 1H), 1.03 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 140.5, 138.3, 128.4, 
127.7, 127.6, 115.9, 74.5, 72.9, 70.4, 44.1, 31.3, 26.2, 16.2. HPLC: Enantiomeric excess 
was determined by HPLC analysis of the 2-naphthoate derivative of the product 
(Chiralcel OJ-H column, hexanes:i-PrOH = 98.5:1.5, 1.0 mL/min, 230 nm), tmajor = 16.4 
min, tminor = 25.8 min; ee = 97% (alcohol), 97% (aldehyde). 
1H NMR  
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TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:20). 1H NMR (400 MHz, CDCl3): δ 5.79-
5.70 (m, 1H), 5.12-5.07 (m, 2H), 3.40-3.35 (m, 1H), 2.20-2.16 (m, 1H), 1.59 (br s, 1H), 
1.53-1.26 (m, 14H), 1.01 (d, J = 6.8 Hz, 3H), 0.86 (t, J = 6.8 Hz, 3H). 13C NMR (100 
MHz, CDCl3): δ 140.6, 116.4, 74.9, 44.3, 34.5, 32.1, 30.0, 29.8, 29.5, 26.0, 22.9, 16.5, 
14.3. HPLC: Enantiomeric excess was determined by HPLC analysis of the 2-naphthoate 
derivative of the product (Chiralpak AD-H column, hexanes:i-PrOH = 99.5:0.5, 0.4 
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mL/min, 254 nm), tminor = 12.9 min, tmajor = 18.3 min; ee = 97% (alcohol), 97% 
(aldehyde). 




13C NMR  
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Detailed Procedure and Spectral Data for Experiments Aimed at Probing the 
Origins of Stereoselection 




To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 2.5 mol%), BIPHEP (10.5 mg, 0.02 mmol, 5 mol%), 
Cs2CO3 (26.1 mg, 0.08 mmol, 20 mol%) and 4-cyano-3-nitrobenzoic acid (7.7 mg, 0.04 
mmol, 10 mol%) was added THF (0.2 mL) followed by (R)-oct-1-en-3-yl acetate (3.4) 
(136 mg, 0.8 mmol, 200 mol%). The reaction mixture was allowed to stir at 90 oC for 0.5 
hr and cooled to room temperature. Methyl 4-(hydroxymethyl)benzoate 3.1e (66.5 mg, 
0.4 mmol, 100 mol%) in THF (0.2 mL) was added to the reaction mixture and the 
reaction mixture was allowed to stir at 90 oC for 48 hr, at which point the reaction 
mixture was evaporated onto silica gel. Purification of the product by column 
chromatography (SiO2: ethyl acetate:hexanes, 1:10) provided 3.5 (53.1 mg, 0.192 mmol, 
anti:syn = 9:1) as a pale yellow oil in 48% yield. 
TLC (SiO2): Rf = 0.26 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 8.00 
(d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 5.62 (ddd, J = 16.0, 10.0, 7.6 Hz, 1H), 5.24 
(d, J = 10.0, 7.6 Hz, 1H), 5.17 (dd, J = 16.0, 7.6 Hz, 1H), 4.45 (d, J = 7.6 Hz, 1H), 3.90 
(s, 3H), 2.29-2.23 (m, 2H), 1.27-1.07 (m, 8H), 0.81 (t, J = 7.2 Hz, 3H). 13C NMR (100 
MHz, CDCl3): δ 167.2, 148.1, 139.0, 129.8, 129.6, 127.1, 119.4, 76.4, 53.0, 52.3, 31.9, 
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30.6, 27.1, 22.7, 14.2. FTIR (neat): υ 3481, 2953, 2928, 2857, 2161, 1979, 1722, 1638, 
1611, 1576, 1435, 1416, 1275, 1191, 1176, 1109, 1050, 1018, 999, 967, 913, 859, 809, 
774, 736, 721, 709, 667 cm-1. HPLC: (Chiralpak AD-H column, hexanes:i-PrOH = 95:5, 
0.5 mL/min, 254 nm), tminor = 17.2 min, tmajor = 23.4 min; ee = 14%. 
1H NMR  
 




To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 2.5 mol%), (S)-SEGPHOS (12.2 mg, 0.02 mmol, 5 
mol%), Cs2CO3 (26.1 mg, 0.08 mmol, 20 mol%) and 4-cyano-3-nitrobenzoic acid (7.7 
mg, 0.04 mmol, 10 mol%) was added THF (0.2 mL) followed by (R)-oct-1-en-3-yl 
acetate (3.4) (136 mg, 0.8 mmol, 200 mol%). The reaction mixture was allowed to stir at 
90 oC for 0.5 hr and cooled to room temperature. Methyl 4-(hydroxymethyl)benzoate 1e 
(66.5 mg, 0.4 mmol, 100 mol%) in THF (0.2 mL) was added to the reaction mixture and 
the reaction mixture was allowed to stir at 90 oC for 48 hr, at which point the reaction 
mixture was evaporated onto silica gel. Purification of the product by column 
chromatography (SiO2: ethyl acetate:hexanes, 1:30-1:10) provided 3.5 (68.3 mg, 0.247 
mmol, 62% yield, anti:syn = 11.9:1) and 3.4 (62.5 mg, 0.367 mmol, 46% recovered 
yield), respectively. 
HPLC for 3.5: (Chiralpak AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 254 nm), 
tminor = 16.4 min, tmajor = 22.1 min; ee = 95%. 
HPLC for 3.4: Enantiomeric excess was determined by HPLC analysis of the 3,5-
dinitrobenzoate derivative of the alcohol obtained from deacetylation of 4 (Chiralcel OJ-
H column, hexanes:i-PrOH = 99:1, 1.0 mL/min, 254 nm), tmajor = 10.3 min, tminor = 11.3 






To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 2.5 mol%), (R)-SEGPHOS (12.2 mg, 0.02 mmol, 5 
mol%), Cs2CO3 (26.1 mg, 0.08 mmol, 20 mol%) and 4-cyano-3-nitrobenzoic acid (7.7 
mg, 0.04 mmol, 10 mol%) was added THF (0.2 mL) followed by (R)-oct-1-en-3-yl 
acetate9 (3.4) (136 mg, 0.8 mmol, 200 mol%). The reaction mixture was allowed to stir at 
90 oC for 0.5 hr and cooled to room temperature. Methyl 4-(hydroxymethyl)benzoate 1e 
(66.5 mg, 0.4 mmol, 100 mol%) in THF (0.2 mL) was added to the reaction mixture and 
the reaction mixture was allowed to stir at 90 oC for 48 hr, at which point the reaction 
mixture was evaporated onto silica gel. Purification of the product by column 
chromatography (SiO2: ethyl acetate:hexanes, 1:30-1:10) provided ent-3.5 (37.8 mg, 
0.137 mmol, 34% yield, anti:syn = 4.6:1) and 3.4 (80.3 mg, 0.472 mmol, 59% recovered 
yield), respectively. 
HPLC for ent-5: (Chiralpak AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 254 
nm), tmajor = 17.6 min, tminor = 21.8 min; ee = 73%. 
HPLC for 4: Enantiomeric excess was determined by HPLC analysis of the 3,5-
dinitrobenzoate derivative of the alcohol obtained from deacetylation of 4 (Chiralcel OJ-
H column, hexanes:i-PrOH = 99:1, 1.0 mL/min, 254 nm), tmajor = 10.0 min, tminor = 11.0 





Competition Experiment Establishing Rapid Redox Equilibration  
Reaction between Alcohol (3.1a) and Aldehyde (3.2e)  
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 2.5 mol%), BIPHEP (10.5 mg, 0.02 mmol, 5 mol%), 
Cs2CO3 (26.1 mg, 0.08 mmol, 20 mol%) and 4-cyano-3-nitrobenzoic acid (7.7 mg, 0.04 
mmol, 10 mol%) was added THF (0.2 mL) followed by acetic acid 3-buten-2-yl ester 
(91.3 mg, 0.8 mmol, 200 mol%). The reaction mixture was allowed to stir at 90 oC for 0.5 
hr and cooled to room temperature. Benzyl alcohol 3.1a (43.3 mg, 0.4 mmol, 100 mol%) 
and methyl 4-formylbenzoate 3.2e (65.7 mg, 0.4 mmol, 100 mol%) in THF (0.2 mL) 
were added to the reaction mixture and the reaction mixture was allowed to stir at 90 oC 
for 48 hr, at which point the reaction mixture was evaporated onto silica gel. Purification 
of the product by column chromatography (SiO2: ethyl acetate:hexanes, 1:20-1:10) 
provided 3a (22.1 mg, 0.136 mmol, 34% yield, anti:syn = 8:1) and 3.3e (42.8 mg, 0.194 





Reaction between Aldehyde (3.2a) and Alcohol (3.1e)  
 
To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 2.5 mol%), BIPHEP (10.5 mg, 0.02 mmol, 5 mol%), 
Cs2CO3 (26.1 mg, 0.08 mmol, 20 mol%) and 4-cyano-3-nitrobenzoic acid (7.7 mg, 0.04 
mmol, 10 mol%) was added THF (0.2 mL) followed by acetic acid 3-buten-2-yl ester 
(91.3 mg, 0.8 mmol, 200 mol%). The reaction mixture was allowed to stir at 90 oC for 0.5 
hr and cooled to room temperature. Benzaldehyde 3.2a (42.4 mg, 0.4 mmol, 100 mol%) 
and methyl 4-(hydroxymethyl)benzoate 3.1e (66.5 mg, 0.4 mmol, 100 mol%) in THF (0.2 
mL) were added to the reaction mixture and the reaction mixture was allowed to stir at 90 
oC for 48 hr, at which point the reaction mixture was evaporated onto silica gel. 
Purification of the product by column chromatography (SiO2: ethyl acetate:hexanes, 
1:20-1:10) provided 3.3a (22.7 mg, 0.140 mmol, 35% yield, anti:syn = 10:1) and 3e (34.1 











Trirmethylsilyl allyl ether (10.0 g, 0.076 mol, 100 mol%) was dissolved in THF 
(250 mL, 0.3 M), and then cooled to -78 oC. 1.7 M solution of t-butyllithium in pentane 
(51 mL, 0.087 mol, 115 mol%) was added dropwise over 15 min and the resulting bright 
yellow solution was stirred for 2 hr at -78 oC. The reaction mixture was quenched with 
acetic anhydride (8.025 g, 0.079 mol, 105 mol%) at -78 oC and then stirred at ambient 
temperature overnight. Thre resulting mixture was diluted with water (50 mL) and 
pentane (100 mL).  The organic phase was separated and washed with water (3 times) 
and brine. The resulting solution was dried over Na2SO4, filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; Pentane: Ether, 
20:1) provied 1a (9.2 g, 0.053 mmol) as a pale yellow oil in 70% yield. 
TLC (SiO2): Rf = 0.6 (ethyl acetate: hexanes, 1:30). 1H NMR (400 MHz, CDCl3): δ 5.88-
5.80 (m, 1H), 5.18 (dt, J = 5.6, 2.0 Hz, 1H), 5.00 (dt, J = 8.4, 2.0 Hz, 1H), 4.97-4.95 (m, 
1H), 2.09 (s, 3H), 0.05 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 170.7, 134.9, 111.2, 70.5, 
21.0, -4.1. FTIR (neat): υ 2960, 1739, 1634, 1408, 1369, 1230, 1159, 1086, 1017, 991, 






1H NMR  
 
13C NMR  
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Preparation of (R)-I 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (R)-SEGPHOS 
(159 mg, 0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-
NO2BzOH (100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 
mol%) in a sealed tube under N2 atmosphere was added THF (2.6 mL, 0.05 M). The 
reaction mixture was stirred for 30 min at ambient temperature and heated for 1.5 hr at 80 
oC, at which point the reaction mixture was allowed to cool to ambient temperature. The 
reaction mixture was filtered and washed with THF (10 mL). The filtrate was 
concentrated in vacuo and desolved in THF (2 mL), then hexanes (50 mL) was added. A 
yellow precipitate formed, which was collected by filtration and dried under vacuum (101 
mg, 0.098 mmol, 75% yield).  
 
Preparation of (R)-C3-TUNEPHOS 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (R)-C3-
TUNEPHOS (155 mg, 0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 
4-CN-3-NO2BzOH (100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 
mmol, 500 mol%) in a sealed tube under N2 atmosphere was added THF (2.6 mL, 0.05 
M). The reaction mixture was stirred for 30 min at ambient temperature and heated for 
1.5 hr at 80 oC, at which point the reaction mixture was allowed to cool to ambient 
temperature. The reaction mixture was filtered and washed with THF (10 mL). The 
filtrate was concentrated in vacuo and desolved in THF (2 mL), then hexanes (50 mL) 
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was added. A yellow precipitate formed, which was collected by filtration and dried 
under vacuum (103 mg, 0.101 mmol, 78% yield).  
 
General procedure for anti-Diastereo- and Enantioselective Carbonyl 
(Trimethylsilyl)allylation from the Alcohol Oxidation Level 
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with alcohol (0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), K3PO4 (43 
mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 μL, 1.0 mmol, 500 mol%) 
and α-(trimethylsilyl)allyl acetate (103 mg, 0.60 mmol, 300 mol%) were added and the 
mixture was stirred at ambient temperature for 0.5 hr. The reaction mixture was allowed 
to stir at 70 oC for 48 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the residue by column the corresponding product. 
 
General procedure for anti-Diastereo- and Enantioselective Carbonyl 
(Trimethylsilyl)allylation from the Aldehyde Oxidation Level 
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with aldehyde (0.20 mmol, 100 mol%), (R)-I (10.3 mg, 0.01 mmol, 5 mol%), K3PO4 (43 
mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 μL, 1.0 mmol, 500 mol%), 
isopropanol (24 mg, 0.4 mmol, 200 mol%)  and  α-(trimethylsilyl)allyl acetate (103 
mg, 0.60 mmol, 300 mol%) were added and the mixture was stirred at ambient 
temperature for 0.5 hr. The reaction mixture was allowed to stir at 70 oC for 48 hr, at 
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which point the reaction mixture was concentrated in vacuo. Purification of the residue 





TLC (SiO2): Rf = 0.3 (ethyl acetate: hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.36-
7.24 (m, 5H), 5.86 (dt, J = 17.2, 10.4 Hz, 1H), 5.11 (dd, J = 10.4, 1.6 Hz, 1H), 5.05-5.00 
(m, 1H), 4.80 (dd, J = 8.4, 1.6 Hz, 1H), 2.21 (d, J = 1.6 Hz, 1H), 2.10-2.05 (m, 1H), -0.20 
(s, 9H). 13C NMR (100 MHz, CDCl3): δ 143.6, 136.6, 128.4, 127.8, 126.9, 116.0, 74.5, 
45.6, -2.4. HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 
nm), tminor = 11.0 min, tmajor = 11.6 min; ee = 96% (alchol), 96% (aldehyde). [α]D25= 
+47.01 (c =2.8, CHCl3). To corroborate the assignement of absolute stereochemistry, the 
optical rotation was correlated with a known compound (A. Hafner, R. O. Duthaler, R. 
Marti, G. Rihs, P. Rothe-Streit, F. Schwarzenbach, J. Am. Chem. Soc. 1992, 114, 2321.). 
FTIR (neat): υ 3426, 2953, 2896, 1626, 1494, 1455, 1386, 1247, 1196, 1153, 1089, 1050, 
1028, 988, 906, 835, 786, 763, 718, 698 cm-1. HRMS (CI) Calcd. for C13H21OSi [M+H]+: 
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TLC (SiO2): Rf = 0.3 (ethyl acetate: hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.46 
(d, J = 8.4, 2H),  7.46 (d, J = 8.4, 2H), 5.82 (dt, J = 17.2, 10.4 Hz, 1H), 5.10 (dd, J = 
10.4, 1.6 Hz, 1H), 5.03 (d, J = 17.2 Hz, 1H), 4.78 (d, J = 7.6 Hz, 1H), 2.20 (br, 1H), 2.02-
1.97 (m, 1H), -0.16 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 142.8, 135.9, 131.4, 128.5, 
121.4, 116.3, 73.8, 45.5, -2.6.HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 
1.0 mL/min, 210 nm), tminor = 11.9 min, tmajor = 12.9 min; ee = 96% (alcohol), 98% 
(aldehyde). [α]D25= +37.4 (c =0.62, CH2Cl2). FTIR (neat): υ 3430, 2953, 1625, 1592, 
1485, 1408, 1247, 1191, 1155, 1088, 1070, 1010, 908, 833, 785, 753, 737, 691 cm-1. 
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TLC (SiO2): Rf = 0.2 (ethyl acetate: hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 8.01-
7.99 (m, 2H), 7.41-7.39 (m, 2H), 5.83 (dt, J = 16.8, 10.4 Hz, 1H), 5.08 (dd, J = 10.4, 1.6 
Hz, 1H), 4.99-4.94 (m, 1H), 4.88 (d, J = 7.6 Hz, 1H), 3.91 (s, 3H), 2.27 (br, 1H), 2.04-
2.00 (m, 1H), -0.15 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 166.9, 149.0, 135.7, 129.7, 
129.4, 126.7, 116.4, 74.1, 52.1, 45.5, -2.4. HPLC: (Chiralcel OD-H column, hexanes:i-
PrOH = 95:5, 1.0 mL/min, 230 nm), tminor = 12.7 min, tmajor = 14.3 min; ee = 98% 
(alcohol), 98% (aldehyde). [α]D25= +16.1 (c =0.23, CH2Cl2). FTIR (neat): υ 3501, 2954, 
2889, 1698, 1624, 1609, 1433, 1390, 1346, 1307, 1155, 1018, 1005, 977, 955, 895, 835, 
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TLC (SiO2): Rf = 0.2 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.39-
7.22 (m, 5H),  6.58 (d, J = 15.6 Hz, 1H), 6.22 (dd, J = 15.6, 7.6 Hz, 1H), 5.84 (dt, J = 
16.8, 10.4 Hz, 1H), 5.10 (dd, J = 10.0, 2.0 Hz, 1H), 5.02 (ddd, J = 16.8, 2.0, 0.8 Hz, 1H), 
4.43 (td, J = 7.6, 1.2 Hz, 1H), 1.90-1.86 (m, 2H), 0.05 (s, 9H). 13C NMR (100 MHz, 
CDCl3): δ 136.6, 136.1, 131.9, 130.8, 128.6, 127.7, 126.5, 115.7, 73.2, 44.1, -1.9. HPLC: 
(Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 13.6 min, 
tmajor = 14.8 min; ee = 92% (alcohol), 94% (aldehyde). [α]D25= +38.8 (c =0.21, CH2Cl2). 
FTIR (neat): υ 3428, 3026, 2954, 1625, 1494, 1449, 1379, 1246, 1105, 1035, 1003, 964, 
897, 860, 853, 784, 748, 724, 691 cm-1. HRMS (CI) Calcd. for C15H23OSi [M+H]+: 
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TLC (SiO2): Rf = 0.2 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.51 
(t, J = 7.6 Hz, 1H), 7.34 (dd, J = 7.6, 0.4 Hz, 1H), 7.20 (dt, J = 7.6, 0.4 Hz, 1H), 5.71 (dt, 
J = 17.2, 10.4 Hz, 1H), 4.94 (t, J = 4.4 Hz, 1H), 4.85 (dd, J = 10.4, 2.4 Hz, 1H), 4.76 
(ddd, J = 17.2, 2.4, 0.8 Hz, 1H), 3.59 (d, J = 4.4 Hz, 1H), 2.07 (dd, J = 10.4, 4.4 Hz, 1H), 
0.05 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 164.1, 140.7, 138.8, 134.7, 126.3, 119.6, 
114.9, 73.0, 43.4, -2.3. HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 98:2, 1.0 
mL/min, 254 nm), tmajor = 6.6 min , tminor = 7.9 min; ee = 99% (alcohol), 99% (aldehyde). 
[α]D25= -44.6 (c =0.40, CH2Cl2). FTIR (neat): υ 3348, 2922, 1583, 1556, 1441, 1406, 
1377, 1286, 1241, 1163, 1212, 1080, 1057, 999, 930, 903, 838, 806, 779, 748, 677. 
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TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.30-
7.26 (m, 2H), 7.20-7.17 (m, 3H), 5.79 (dt, J = 17.2, 10.8 Hz, 1H), 5.06 (dd, J = 10.4, 2.0 
Hz, 1H), 4.95 (dd, J = 17.2, 2.0 Hz, 1H), 3.84-3.82 (m, 1H), 2.76-2.63 (m, 2H), 1.84-1.71 
(m, 3H), 0.04 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 142.1, 135.7, 128.4, 128.3, 125.8, 
115.3, 71.0, 42.7, 39.1, 32.3, -2.0. HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 
95:5, 0.5 mL/min, 210 nm), tmajor = 12.1 min, tminor = 16.8 min ; ee = 97% (alcohol), 98% 
(aldehyde). [α]D25= +13.3 (c =0.60, CH2Cl2). FTIR (neat): υ 3448, 3027, 2951, 1624, 
1603, 1495, 1454, 1414, 1246, 1167, 1098, 1044, 999, 897, 835, 748, 698. HRMS (CI) 















1H NMR  
 
 







TLC (SiO2): Rf = 0.3 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.37-
7.29 (m, 5H), 5.90 (dt, J = 17.2, 10.4 Hz, 1H), 4.99 (dd, J = 10.4, 2.4 Hz, 1H), 4.87 (ddd, 
J = 17.2, 2.4, 0.8 Hz, 1H), 4.52 (s, 2H), 4.08-4.01 (m, 1H), 3.72-3.61 (m, 2H),  2.74-
2.73 (m, 1H), 1.95-1.85 (m, 1H),  1.65-1.58 (m, 2H), 0.05 (s, 9H). 13C NMR (100 MHz, 
CDCl3): δ 138.0, 136.1, 128.4, 127.7, 127.6, 114.1, 73.2, 71.3, 69.4, 43.2, 36.8, -2.1. 
HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 97.5:2.5, 0.5 mL/min, 210 nm), tmajor 
= 11.8 min, tminor = 13.3 min; ee = 97% (alcohol), 98% (aldehyde). [α]D25= +26.7 (c 
=0.64, CH2Cl2). FTIR (neat): υ 3511, 2951, 2860, 1623,1496, 1454, 1414, 1362, 1244, 
1205, 1088, 1027, 1004, 896, 835, 780, 733, 696. HRMS (CI) Calcd. for C16H25O2Si [M-














1H NMR  
 
 







TLC (SiO2): Rf = 0.4 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.37-
7.26 (m, 5H), 5.83 (dt, J = 16.8, 10.4 Hz, 1H), 5.02 (dd, J = 10.4, 2.4 Hz, 1H), 4.91 (ddd, 
J = 16.8, 2.4, 0.8 Hz, 1H), 4.52 (m, 2H), 3.86-3.80 (m, 1H), 3.52-3.48 (m, 2H),  2.13 (d, 
J = 4.0 Hz, 1H), 1.75-1.49 (m, 5H), 0.04 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 138.3, 
136.0, 128.4, 127.6, 127.5, 114.7, 72.9, 71.2, 70.4, 42.8, 34.5, 26.4, -2.1. HPLC: 
(Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 10.9 
min, tmajor = 12.2 min; ee = 95% (alcohol), 98% (aldehyde). [α]D25= +41.2 (c =0.63, 
CH2Cl2). FTIR (neat): υ 3448, 2950, 2857, 1624, 1496, 1454, 1362, 1244, 1204, 1097, 
1028, 950, 895, 835, 782, 734, 696. HRMS (CI) Calcd. for C17H27O2Si [M-H]+: 














1H NMR  
 
 







TLC (SiO2): Rf = 0.4 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 5.79 
(dt, J = 17.2, 10.4 Hz, 1H), 5.03 (d, J = 10.4 Hz, 1H), 4.92 (d, J = 17.2 Hz, 1H), 3.84-
3.74 (m, 1H), 1.69-1.65 (m, 1H), 1.49-1.26 (m, 15H), 0.88 (t, J = 6.8 Hz, 3H),  0.04 (s, 
9H). 13C NMR (100 MHz, CDCl3): δ 135.9, 115.0, 71.5, 42.6, 37.3, 31.9, 29.6, 29.3, 
25.8, 22.7, 14.1, -2.0. HPLC: Enantiomeric excess was determined by HPLC analysis of 
the 3,5-nitrobenzoate derivative of the product (Chiralcel OD-H column, hexanes:i-PrOH 
= 95:5, 0.5 mL/min, 254 nm), tminor = 10.7 min, tmajor = 11.3 min; ee = 95% (alcohol), 
90% (aldehyde). [α]D25= +21.2 (c =0.57, CH2Cl2). FTIR (neat): υ 3463, 2955, 2924, 
2854, 1716, 1624, 1465, 1378, 1246, 1167, 1049, 1004, 895, 836, 750, 723, 690. HRMS 










1H NMR  
 
13C NMR  
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Detailed Procedure and Spectral Data for Oxidative Elimination of Adducts 3.5a, 




A flask was charged with 3.5a (33.1 mg, 0.15 mmol, 100 mol%), K2CO3 (103.7 
mg, 0.75 mmol, 500 mol%) and acetone (1.25 mL). The mixture was cooled to -20 oC, 
and then 0.08 M solution of dimethyl dioxirane in acetone (3.75 mL, 0.3 mmol, 200 
mol%) was added. The resulting mixture was warmed to 0 oC and stirred until no starting 
material left (checked by TLC). The mixture was filtered through a pad of celite, 
concentrated, and treated with a solution of HOAc (0.5 mL) in MeOH (3 mL) for 30 min. 
The solution was diluted with ether and washed with sat’d aqueous NaHCO3 solution. 
The aqueous layer was extracted with ether. The combined organic layers was dried over 
Na2SO4, filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ether) provided 3.7a (19.5 mg, 0.119 mmol) as a colorless oil in 
79% yield. (E:Z = 5:1) 
TLC (SiO2): Rf = 0.4 (ethyl acetate:ether, 1:40). 1H NMR for the major product (400 
MHz, CDCl3): δ 7.37-7.27 (m, 5H), 5.93-5.92 (m, 2H), 5.25-5.20 (m, 1H), 4.15 (d, J = 
2.0 Hz, 2H), 2.32 (br, 1H), 1.77 (br, 1H). 13C NMR for the major product (100 MHz, 
CDCl3): δ 142.7, 133.4, 130.2, 128.6, 127.8, 126.2, 74.8, 63.1. FTIR (neat): υ 3304, 
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3029, 2859, 1492, 1452, 1261, 1193, 1086, 970, 912, 846, 751. HRMS (CI) Calcd. for 
C10H11O2 [M-H]+: 163.0759, Found: 163.0760. 
1H NMR  
 






A flask was charged with 3.5f (37.3 mg, 0.15 mmol, 100 mol%), K2CO3 (103.7 
mg, 0.75 mmol, 500 mol%) and acetone (1.25 mL).  The mixture was cooled to -20 oC, 
and then 0.08 M solution of dimethyl dioxirane in acetone (3.75 mL, 0.3 mmol, 200 
mol%) was added. The resulting mixture was warmed to 0 oC and stirred until no starting 
material left (checked by TLC). The mixture was filtered through a pad of celite, 
concentrated, and treated with a solution of HOAc (0.5 mL) in MeOH (3 mL) for 30 min. 
The solution was diluted with ether and washed with sat’d aqueous NaHCO3 solution. 
The aqueous layer was extracted with ether. The combined organic layers was dried over 
Na2SO4, filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ether) provided 3.7f (24.2 mg, 0.126 mmol) as a colorless oil in 
84% yield. (E:Z = 10:1) 
TLC (SiO2): Rf = 0.4 (ethyl acetate:ether, 1:40). 1H NMR (400 MHz, CDCl3): δ 7.36-7.31 
(m, 2H), 7.26-7.22 (m, 2H), 5.93-5.87 (m, 1H), 5.84-5.78 (m, 1H), 4.24-4.19 (m, 3H), 
2.84-2.70 (m, 2H), 1.99-1.86 (m, 2H), 1.85 (br, 1H), 1.71 (br, 1H). 13C NMR (100 MHz, 
CDCl3): δ 141.7, 134.1, 130.0, 128.4, 128.4, 125.9, 71.6, 62.9, 38.6, 31.6. FTIR (neat): υ 
3323, 3026, 2924, 2859, 1496, 1454, 1093, 998, 972, 912, 746, 699. HRMS (CI) Calcd. 
for C12H16O2 [M]+: 192.1150, Found: 192.1151. 
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1H NMR  
 
 






A flask was charged with 3.5g (41.8 mg, 0.15 mmol, 100 mol%), K2CO3 (103.7 
mg, 0.75 mmol, 500 mol%) and acetone (1.25 mL).  The mixture was cooled to -20 oC, 
and then 0.08 M solution of dimethyl dioxirane in acetone (3.75 mL, 0.3 mmol, 200 
mol%) was added. The resulting mixture was warmed to 0 oC and stirred until no starting 
material left (checked by TLC). The mixture was filtered through a pad of celite, 
concentrated, and treated with a solution of HOAc (0.5 mL) in MeOH (3 mL) for 30 min. 
The solution was diluted with ether and washed with sat’d aqueous NaHCO3 solution. 
The aqueous layer was extracted with ether. The combined organic layers was dried over 
Na2SO4, filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ether) provided 3.7g (29.3 mg, 0.132 mmol) as a colorless oil in 
88% yield. (E:Z = ≥20:1) 
TLC (SiO2): Rf = 0.4 (ethyl acetate:ether, 1:40). 1H NMR (400 MHz, CDCl3): δ 7.83-7.30 
(m, 5H), 5.87 (dtd, J = 15.6, 5.2, 1.2 Hz, 1H), 5.74 (ddt, J = 15.6, 6.0, 1.2 Hz, 1H), 4.52 
(s, 2H), 4.41-4.34 (m, 1H), 4.17-4.12 (m, 2H), 3.74-3.61 (m, 2H), 3.00 (d, J = 3.6 Hz, 
1H), 1.88-1.79 (m, 2H), 1.46 (br, 1H). 13C NMR (100 MHz, CDCl3): δ 137.8, 133.6, 
129.5, 128.5, 127.8, 127.7, 73.3, 71.2, 68.4, 63.0, 36.4. FTIR (neat): υ 3346, 2921, 2860, 
1496, 1454, 1414, 1364, 1310, 1206, 1072, 1004, 969, 909, 802, 736. HRMS (CI) Calcd. 
for C13H17O3 [M-H]+: 221.1178, Found: 222.1181. 
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1H NMR  
 






A flask was charged with 3.5i (38.5 mg, 0.15 mmol, 100 mol%), K2CO3 (103.7 
mg, 0.75 mmol, 500 mol%) and acetone (1.25 mL).  The mixture was cooled to -20 oC, 
and then 0.08 M solution of dimethyl dioxirane in acetone (3.75 mL, 0.3 mmol, 200 
mol%) was added. The resulting mixture was warmed to 0 oC and stirred until no starting 
material left (checked by TLC). The mixture was filtered through a pad of celite, 
concentrated, and treated with a solution of HOAc (0.5 mL) in MeOH (3 mL) for 30 min. 
The solution was diluted with ether and washed with sat’d aqueous NaHCO3 solution. 
The aqueous layer was extracted with ether. The combined organic layers was dried over 
Na2SO4, filtered and concentrated in vacuo. Purification of the residue by column 
chromatography (SiO2; ether) provided 3.7i (26.1 mg, 0.131 mmol) as a colorless oil in 
87% yield. (E:Z = 10:1) 
TLC (SiO2): Rf = 0.5 (ethyl acetate:ether, 1:40). 1H NMR (400 MHz, CDCl3): δ 5.89-5.79 
(m, 1H), 5.76-5.69 (m, 1H), 4.15-4.09 (m, 3H), 1.90 (br, 2H), 1.57-1.45 (m, 2H), 1.33-
1.20  (m, 12H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 134.5, 129.7, 
72.3, 62.9, 37.2, 31.8, 29.5, 29.2, 25.4, 25.3, 22.6, 14.1. FTIR (neat): υ 3332, 2854, 1465, 




1H NMR  
 








A flask was charged with 3.5g (30.2 mg, 0.11 mmol, 100 mol%), 4-
nitrobenzaldehyde (18.1 mg, 0.12 mmol, 110 mol%) and DCM (1.2 mL, 0.9 M). The 
mixture was cooled to -78 oC, and then 1.0 M solution of TiCl4 in DCM (0.14 mL, 0.14 
mmol, 130 mol%) was added dropwise over 3 min. The resulting mixture was stirred 
until no starting material left (checked by TLC). The mixture was quenched with sat’d 
aqueous ammonium chloride solution (3 mL) at -78 oC, and then diluted with DCM (3 
mL). The resulting biphasic solution was warmed to ambient temperature and stirred for 
10 min. The organic phase was separated and the aqueous was washed with DCM. The 
combined organic layers was dried over Na2SO4, filtered and concentrated in vacuo. 
Purification of the residue by column chromatography (SiO2; ether:hexanes, 1:4) 
provided 3.8g (16.6 mg, 0.08 mmol) as a colorless oil in 73% yield.  
TLC (SiO2): Rf = 0.15 (ethyl acetate:hexanes, 1:4). 1H NMR (400 MHz, CDCl3): δ 7.28-
7.37 (m, 5H), 5.67 (dqd, J = 15.2, 6.4, 0.8 Hz, 1H), 5.49 (dqd, J = 15.2, 6.4, 1.6 Hz, 1H), 
4.52 (s, 2H), 4.25-4.31 (m, 1H), 3.72-3.66 (m, 1H), 3.65-3.59 (m, 1H), 2.67 (d, J = 3.2 
Hz, 1H), 1.85-1.75 (m, 2H), 1.69 (ddd, J = 6.8, 1.6, 0.8 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 138.0, 133.5, 128.4, 127.7, 127.6, 126.4, 73.2, 71.8, 68.4, 36.7, 17.7. FTIR 
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(neat): υ 3414, 3029, 2916, 2857, 1496, 1453, 1364, 1309, 1205, 1096, 966, 923, 801, 
736. HRMS (CI) Calcd. for C13H17O2 [M-H]+: 205.1229, Found: 205.1227. 
1H NMR  
 
 








To a cooled (0 oC) suspension of 3.5g (100 mg, 0.36 mmol, 100 mol%), DMAP 
(4.4 mg, 0.036 mmol, 10 mol%) and Et3N (72.9 mg, 0.72 mmol, 200 mol%)  in DCM 
(4.0 mL, 0.09 M) was added acetic anhydride (73.8 mg, 0.72 mmol, 200 mol%). The 
reaction mixture was allowed to warm to ambient temperature and stirred overnight. The 
mixture was washed with sat’d aqueous NaHCO3, dried over MgSO4, filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate: hexanes, 1:30 with 0.1% TEA) provided 3.5g-OAc (114.2 mg, 0.36 mmol) as a 
colorless oil in 99% yield.  
TLC (SiO2): Rf = 0.70 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.37-
7.25 (m, 5H), 5.80 (dt, J = 17.2, 10.4 Hz, 1H), 5.28 (dq, J = 6.0, 3.6 Hz, 1H), 5.00 (dd, J 
= 10.4, 2.0 Hz, 1H), 4.85 (ddd, J = 17.2, 2.0, 0.4 Hz, 1H), 4.51 (d, J = 12.0 Hz, 1H), 4.43 
(d, J = 12.0 Hz, 1H), 3.45 (t, J = 6.4 Hz, 2H), 2.05-1.92 (m, 1H), 2.00 (s, 3H), 1.84-1.74 
(m, 2H), 0.01 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 170.3, 138.4, 135.0, 128.3, 127.8, 
127.5, 115.2, 72.9, 71.9, 66.7, 40.0, 34.3, 21.3, -2.4. FTIR (neat): υ 3031, 2954, 2860, 




1H NMR  
 
 






To a cooled (0 oC) suspension of 3.5g-OAc (15 mg, 0.047 mmol, 100 mol%) and 
NaHCO3 (10 mg, 0.12 mmol, 250 mol%) in toluene (0.5 mL, 0.1 M) was added 
chlorosulfonyl isocynate (10.9 mg, 0.071 mmol, 150 mol%). The reaction mixture was 
warmed slowly to ambient temperature and stirred for 10 hr. Sat’d aqueous NaHSO3 (0.5 
mL) was added and stirred 16 hr, at which point the layers were separated and the 
aqueous was extracted with EtOAc. The combined organic layers was dried over Na2SO4, 
filtered and concentrated in vacuo. Purification of the residue by column chromatography 
(SiO2; ethyl acetate: hexanes, 1:2.5) provided 3.9g (13.3 mg, 0.037 mmol) as a colorless 
oil in 78% yield.  
TLC (SiO2): Rf = 0.2 (ethyl acetate:hexanes, 1:1). 1H NMR (400 MHz, CDCl3): δ 7.36-
7.27 (m, 5H), 6.41 (br, 1H), 4.95-4.91 (m, 1H), 4.49 (d, J = 12.0 Hz, 1H), 4.44 (d, J = 
12.0 Hz, 1H), 3.63 (t, J = 4.0 Hz, 1H), 3.56-3.42 (m, 2H), 2.55 (dd, J = 17.6, 11.2 Hz, 
1H), 2.10 (dd, J = 17.6, 4.8, 1H), 2.04 (s, 3H), 1.94-1.81 (m, 2H), 1.32 (ddd, J = 11.2, 
4.8, 4.0 Hz, 1H), 0.01 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 178.2, 170.6, 137.8, 128.4, 
127.9, 127.8, 73.8, 73.4, 66.1, 57.7, 31.4, 31.3, 22.0, 21.1, -3.8. FTIR (neat): υ 3211, 
2953, 1737, 1691, 1496, 1454, 1370, 1232, 1096, 1027, 964, 837, 738, 698. HRMS (CI) 
Calcd. for C19H30NO4Si [M+H]+: 364.1944, Found: 364.1946. 
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NOE experiment was performed for 3.9g using a pure sample. TMS irradiated: Ha 
(0.62%), HC (1.03%). (Note: The observation of nOe between TMS and Hc and the 
absence of nOe between TMS and the OAc suggest a 1,2 trans configuration which is 
corresponding to the coupling constant calculation and the stereochemistry model 
proposed by Woerpel.) 
 






13C NMR  
 
 
Preparation of BIPHEP-I 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), BIPHEP (136 mg, 
0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-NO2BzOH 
(100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 mol%) in a 
sealed tube under N2 atmosphere was added THF (2.6 mL, 0.05 M). The reaction mixture 
was stirred for 30 min at ambient temperature and heated for 1.5 hr at 80 oC, at which 
point the reaction mixture was allowed to cool to ambient temperature. The reaction 
mixture was filtered and washed with THF (10 mL). The filtrate was concentrated in 
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vacuo and hexanes (50 mL) was added. A yellow precipitate formed, which was collected 
by filtration and dried under vacuum (108 mg, 0.11 mmol, 88% yield).  
 
Preparation of (R)-SEGPHOS-I 
To a mixture of [Ir(cod)Cl]2 (87.3 mg, 0.13 mmol, 100 mol%), (R)-SEGPHOS 
(159 mg, 0.26 mmol, 200 mol%), Cs2CO3 (169 mg, 0.52 mmol, 400 mol%), 4-CN-3-
NO2BzOH (100 mg, 0.52 mmol, 400 mol%) and allyl acetate (65 mg, 0.65 mmol, 500 
mol%) in a sealed tube under N2 atmosphere was added THF (2.6 mL, 0.05 M). The 
reaction mixture was stirred for 30 min at ambient temperature and heated for 1.5 hr at 80 
oC, at which point the reaction mixture was allowed to cool to ambient temperature. The 
reaction mixture was filtered and washed with THF (10 mL). The filtrate was 
concentrated in vacuo and hexanes (50 mL) was added. A yellow precipitate formed, 





An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with BIPHEP-I (9.5 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). Methyl 4-
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formylbenzoate 3.11c (32.8 mg, 0.2 mmol, 100 mol%), acrolein gem-diacetate 3.10a (63 
mg, 0.4 mmol, 200 mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 100 mol%) and 
isopropanol (24 mg, 0.4 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 60 oC for 48 hr, at which point the reaction mixture was cooled to 
ambient temperature. Acetyl chloride (71 µL, 1.0 mmol, 500 mol%), Et3N (270 µL , 2.0 
mmol, 1000 mol%), DMAP (1.2 mg , 0.01 mmol, 5 mol%) and CH2Cl2 (0.6 mL) were 
added. The reaction mixture was allowed to stir at ambient temperature for 20 hr, at 
which point the reaction mixture was quenched with aqueous NH4Cl (3 mL) and 
extracted with CH2Cl2. The organic layer was dried (MgSO4), filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate:hexanes, 1:7) provided 3.12c (a) (45 mg, 0.148 mmol) as a colorless oil in 74% 
yield (4:1 dr). 
1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 5.99 (d, 
J = 4.8 Hz, 1H), 5.79-5.70 (m, 1H), 5.55-5.53 (m, 1H), 5.26-5.18 (m, 2H), 3.91 (s, 3H), 
2.14 (s, 3H), 2.02 (s, 3H). 13C NMR (100 MHz, CDCl3): δ169.7, 166.7, 141.1, 131.1, 
130.1, 129.7, 129.5, 127.2, 120.2, 75.6, 75.0, 52.2, 21.0, 20.9. FTIR (neat): 1721, 1437, 


















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with BIPHEP-I (9.5 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). Methyl 4-
formylbenzoate 3.11c (32.8 mg, 0.2 mmol, 100 mol%), acrolein gem-dipropionate 3.10b 
(74 mg, 0.4 mmol, 200 mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 100 mol%) and 
isopropanol (24 mg, 0.4 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 60 oC for 48 hr, at which point the reaction mixture was cooled to 
ambient temperature. Propionyl chloride (87 µL, 1.0 mmol, 500 mol%), Et3N (270 µL, 
2.0 mmol, 1000 mol%), DMAP (1.2 mg , 0.01 mmol, 5 mol%) and CH2Cl2 (0.6 mL) were 
added. The reaction mixture was allowed to stir at ambient temperature for 20 hr, at 
which point the reaction mixture was quenched with aqueous NH4Cl (3 mL) and 
extracted with CH2Cl2. The organic layer was dried (MgSO4), filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate:hexanes, 1:9) provided 3.12c (b) (43 mg, 0.13 mmol) as a colorless oil in 65% 
yield (5:1 dr). 
1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 8.4 Hz, 2H), 7.42 (d, J = 8.4 Hz, 2H), 6.01 (d, 
J = 5.2 Hz, 1H), 5.79-5.71 (m, 1H), 5.58-5.55 (m, 1H), 5.26-5.19 (m, 2H), 3.91 (s, 3H), 
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2.41 (qd, J = 7.6, 2.8 Hz, 2H), 2.28 (qd, J = 7.6, 2.0 Hz, 2H), 1.16 (t, J = 7.6 Hz, 3H), 
1.08 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ173.1 (two carbons are 
overlapped), 166.7, 141.3, 131.2, 130.0, 129.5, 127.2, 120.0, 75.4, 74.8, 52.2, 27.7, 27.6, 
9.0, 8.9. FTIR (neat): 1724, 1437, 1281, 1181, 1113, 1083, 1019, 905, 726 cm-1. 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with BIPHEP-I (9.5 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). Methyl 4-
formylbenzoate 3.11c (32.8 mg, 0.2 mmol, 100 mol%), acrolein gem-diisobutyrate 3.10c 
(86 mg, 0.4 mmol, 200 mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 100 mol%) and 
isopropanol (24 mg, 0.4 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 60 oC for 48 hr, at which point the reaction mixture was cooled to 
ambient temperature. Isobutyryl chloride (105 µL, 1.0 mmol, 500 mol%), Et3N (270 µL , 
2.0 mmol, 1000 mol%), DMAP (1.2 mg , 0.01 mmol, 5 mol%) and CH2Cl2 (0.6 mL) were 
added. The reaction mixture was allowed to stir at ambient temperature for 20 hr, at 
which point the reaction mixture was quenched with aqueous NH4Cl (3 mL) and 
extracted with CH2Cl2. The organic layer was dried (MgSO4), filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate:hexanes, 1:15) provided 3.12c (c) (23 mg, 0.064 mmol) as a colorless oil in 32% 
yield (8:1 dr). 
1H NMR (400 MHz, CDCl3): δ 8.00 (d, J = 8.4 Hz, 2H), 7.42 (d, J = 8.4 Hz, 2H), 5.98 (d, 
J = 5.2 Hz, 1H), 5.79-5.70 (m, 1H), 5.56-5.53 (m, 1H), 5.25-5.19 (m, 2H), 3.90 (s, 3H), 
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2.65-2.45 (m, 2H), 1.20-1.16 (m, 6H), 1.10-1.15 (m, 6H). 13C NMR (100 MHz, CDCl3): δ 
175.5, 175.4, 166.6, 141.4, 131.4, 130.0, 129.4, 127.2, 119.8, 75.2, 74.6, 52.1, 34.0 (two 
carbons are overlapped), 18.9, 18.8. FTIR (neat): 1725, 1470, 1437, 1388, 1281, 1189, 
1149, 1112, 1069, 1020, 989, 906, 854, 727 cm-1. 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with BIPHEP-I (9.5 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). Methyl 4-
formylbenzoate 3.11c (32.8 mg, 0.2 mmol, 100 mol%), acrolein gem-dipivalate 3.10d (97 
mg, 0.4 mmol, 200 mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 100 mol%) and 
isopropanol (24 mg, 0.4 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 60 oC for 48 hr, at which point the reaction mixture was cooled to 
ambient temperature. Pivaloyl chloride (123 µL, 1.0 mmol, 500 mol%), Et3N (270 µL , 
2.0 mmol, 1000 mol%), DMAP (1.2 mg , 0.01 mmol, 5 mol%) and CH2Cl2 (0.6 mL) were 
added. The reaction mixture was allowed to stir at ambient temperature for 20 hr, at 
which point the reaction mixture was quenched with aqueous NH4Cl (3 mL) and 
extracted with CH2Cl2. The organic layer was dried (MgSO4), filtered and concentrated in 
vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate:hexanes, 1:20) provided 3.12c (d) (12 mg, 0.003 mmol) as a colorless oil in 15% 
yield (10:1 dr). 
1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 8.4 Hz, 2H), 7.42 (d, J = 8.4 Hz, 2H), 5.97 (d, 
J = 5.2 Hz, 1H), 5.79-5.71 (m, 1H), 5.55-5.52 (m, 1H), 5.26-5.19 (m, 2H), 3.91(s, 3H), 
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1.23 (s, 9H), 1.12 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 177.0, 176.8, 166.7, 141.5, 
131.4, 129.8, 129.5, 127.2, 119.6, 75.3, 74.8, 52.2, 38.9, 38.8, 27.1, 27.0. FTIR (neat): 
1725, 1479, 1437, 1397, 1279, 1140, 1020, 988, 907, 729 cm-1. 
1H NMR  
 






3 drops of H2SO4 were added to a solution of benzoic anhydride (22.6 g, 100 
mmol, 100 mol%) in CH2Cl2 (1.0 M, 100 mL). A solution of freshly distilled acrolein (10 
mL, 150 mmol, 150 mol%) in CH2Cl2 (10 mL) was added drop by drop, at a rate slow 
enough to maintain the solution at ambient temperature. The reaction mixture was stirred 
at ambient temperature for 72 hr and filtered through a short pad of K2CO3. The solvent 
was removed in vacuo and the residue was disolved in hexane. Filtration, evaporation in 
vacuo and purification of the residue by column chromatography (SiO2; hexanes: TEA, 
150:1) provided 3.10e (14 g, 50 mmol) as a colorless oil in 50% yield. 
1H NMR (400 MHz, CDCl3): δ 8.11-8.07 (m, 4H), 7.70-7.68 (m, 1H), 7.61-7.56 (m, 2H), 
7.48-7.43 (m, 4H), 6.18 (dq, J = 17.2, 5.2 Hz, 1H), 5.76 (dt, J = 17.2, 1.2 Hz, 1H), 5.43 
(dt, J = 10.8, 1.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 164.3, 133.5, 131.4, 130.0, 
129.1, 128.4, 120.7, 90.0. FTIR (neat): 1736, 1601, 1452, 1316, 1274, 1243, 1178, 1115, 
1079, 1059, 1023, 949, 906, 801, 729, 707, 686 cm-1.HRMS (CI) Calcd. for C17H14O4 
















General procedure for anti-Diastereo- and Enantioselective Carbonyl 
Alkoxyallylation 
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with (R)-SEGPHOS-I (10.3 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). 
Aldehyde (0.2 mmol, 100 mol%), acrolein gem-dibenzoate 3.10e (113 mg, 0.4 mmol, 200 
mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 100 mol%) and isopropanol (24 mg, 0.4 
mmol, 200 mol%) were added and the reaction mixture was allowed to stir at 60 oC for 
72 hr, at which point the reaction mixture was cooled to ambient temperature. Benzoyl 
chloride (116 µL, 1.0 mmol, 500 mol%), Et3N (270 µL , 2.0 mmol, 1000 mol%), DMAP 
(1.2 mg , 0.01 mmol, 5 mol%) and CH2Cl2 (0.6 mL) were added. The reaction mixture 
was allowed to stir at ambient temperature for 20 hr, at which point the reaction mixture 
was quenched with aqueous NH4Cl (3 mL) and extracted with CH2Cl2. The organic layer 
was dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue by 
column chromatography (SiO2; ethyl acetate:hexanes, 1:10) provided the corresponding 
product.  
 
(1S, 2R)-1-phenylbut-3-ene-1, 2-diyl dibenzoate 
 
3.12a 
1H NMR (400 MHz, CDCl3): δ 8.11-8.08 (m, 2H), 8.00-7.98 (m, 2H), 7.60-7.26 (m, 
11H), 6.34 (d, J = 4.4 Hz, 1H), 6.02-5.93 (m, 2H), 5.42-5.31 (m, 2H). 13C NMR (100 
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MHz, CDCl3): δ 165.3, 136.1, 133.2, 133.1, 131.5, 129.9, 129.8, 129.7, 129.6, 128.5, 
128.4, 128.3, 128.2, 127.2, 119.9, 76.4, 76.3. HPLC: (Chiralcel OJ-H + OJ-H columns, 
hexanes:i-PrOH = 93:7, 0.5 mL/min, 230 nm), tmajor = 47.5 min, tminor = 51.7 min; ee = 
99%. [α]D25= -7.30 (c =1.31, CH2Cl2). FTIR (neat): 1711, 1601, 1451, 1314, 1264, 1176, 
1106, 1068, 1026, 989, 964, 932, 858, 763, 736, 704, 685 cm-1. HRMS (CI) Calcd. for 
C24H21O4 [M+H]+: 373.1440, Found: 373.1444. 
 













13C NMR  
 
 
(1S, 2R)-1-(4-bromophenyl)but-3-ene-1, 2-diyl dibenzoate 
 
3.12b 
1H NMR (400 MHz, CDCl3): δ 8.08-8.05 (m, 2H), 8.00-7.97 (m, 2H), 7.61-7.55 (m, 2H), 
7.51-7.42 (m, 6H), 7.39-7.26 (m, 2H),  6.26 (d, J = 4.0 Hz, 1H), 6.00-5.90 (m, 2H), 
5.42-5.33 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 165.2, 165.1, 135.2, 133.4, 133.3, 
131.5, 131.3, 129.8, 129.7, 129.6, 129.0, 128.5, 128.4, 122.5, 120.3, 76.0, 75.8. HPLC: 
(Chiralcel AD-H + OD-H columns, hexanes:i-PrOH = 96:4, 0.5 mL/min, 230 nm), tmajor = 
38.4 min, tminor = 46.1 min; ee = 90%. [α]D25= -7.5 (c =1.73, CH2Cl2). FTIR (neat): 1721, 
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1602, 1489, 1451, 1315, 1264, 1177, 1107, 1096, 1070, 1026, 1012, 987, 938, 895, 830, 
734, 709 cm-1. HRMS (CI) Calcd. for C24H20O4Br [M+H]+: 451.0545, Found: 451.0555. 
1H NMR  
 
13C NMR  
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(1S, 2R)-1-(4-(methoxycarbonyl)phenyl)but-3-ene-1, 2-diyl dibenzoate 
 
3.12c 
1H NMR (400 MHz, CDCl3): δ 8.11-8.03 (m, 4H), 8.00-7.97 (m, 2H), 7.62-7.54 (m, 4H), 
7.49-7.37 (m, 4H), 6.37 (d, J = 4.0 Hz, 1H), 6.00-5.92 (m, 2H), 5.41-5.32 (m, 2H), 3.91 
(s, 3H). 13C NMR (100 MHz, CDCl3): δ 166.6, 165.2, 165.1, 141.1, 133.4, 133.3, 131.1, 
130.2, 129.8, 129.7, 129.6, 128.5, 128.4, 128.3, 127.2, 126.2, 120.3, 76.1, 76.0, 52.2. 
HPLC: (Chiralcel OJ-H + OD-H columns, hexanes:i-PrOH = 95:5, 0.5 mL/min, 230 nm), 
tmajor = 47.7 min, tminor = 52.9 min; ee = 99%. [α]D25= +4.05 (c =1.42, CH2Cl2). FTIR 
(neat): 1719, 1601, 1451, 1436, 1314, 1263, 1178, 1106, 1069, 1026, 987, 937, 855, 803, 



















1H NMR  
 
13C NMR  
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(1S, 2R)-1-(4-nitrophenyl)but-3-ene-1, 2-diyl dibenzoate 
 
3.12d 
1H NMR (400 MHz, CDCl3): δ 8.25-8.22 (m, 2H), 8.09-8.06 (m, 2H), 7.99-7.96 (m, 2H), 
7.68-7.66 (m, 2H), 7.62-7.56 (m, 2H), 7.50-7.42 (m, 4H), 6.36 (d, J = 4.4 Hz, 1H), 6.02-
5.92 (m, 2H), 5.41-5.36 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 165.1, 147.9, 143.3, 
133.7, 133.5, 130.9, 129.8, 129.6, 129.4, 129.2, 128.7, 128.6, 128.2, 123.6, 120.7, 75.8, 
75.6. HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 230 nm), 
tminor = 35.7 min, tmajor = 44.1 min; ee = 99%. [α]D25= -25.3 (c =0.75, CH2Cl2). FTIR 
(neat): 1721, 1602, 1522, 1451, 1347, 1315, 1262, 1177, 1095, 1069, 1026, 987, 937, 




13C NMR  
 
 
(1S, 2R)-1-(6-bromopyridin-2-yl)but-3-ene-1, 2-diyl dibenzoate 
 
3.12e 
1H NMR (400 MHz, CDCl3): δ 8.13-8.10 (m, 2H), 7.99-7.97 (m, 2H), 7.63-7.60 (m, 1H), 
7.57-7.47 (m, 4H), 7.43-7.38 (m, 4H), 6.41 (d, J = 4.8 Hz, 1H), 6.19-6.16 (m, 1H), 6.06-
5.98 (m, 1H), 5.42-5.32 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 165.2, 165.1, 157.4, 
141.5, 138.8, 133.5, 133.1, 131.2, 129.9, 129.8, 129.7, 129.4, 128.6, 128.4, 127.7, 120.3, 
120.1, 76.3, 75.6. HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 
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230 nm), tmajor = 20.4 min, tminor = 33.5 min; ee = 99%. [α]D25= +1.96 (c =1.53, CH2Cl2). 
FTIR (neat): 1721, 1601, 1582, 1558, 1451, 1436, 1409, 1315, 1263, 1177, 1157, 1105, 
1094, 1069, 1026, 986, 937, 795, 735, 708, 687, 670 cm-1. HRMS (CI) Calcd. for 
C23H19NO4Br [M+H]+: 452.0497, Found: 452.0501. 
1H NMR 
 
13C NMR  
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(3S, 4R, E)-1-phenylhexa-1,5-diene-3, 4-diyl dibenzoate 
 
3.12f 
1H NMR (400 MHz, CDCl3): δ 8.07-8.04 (m, 4H), 7.59-7.55 (m, 2H), 7.47-7.40 (m, 6H), 
7.35-7.26 (m, 3H), 6.83 (d, J = 16.0 Hz, 1H), 6.34 (dd, J = 17.2, 7.6 Hz, 1H), 6.11-6.03 
(m, 1H), 6.00-5.97 (m, 1H), 5.90-5.87 (m, 1H), 5.52 (dt, J = 17.2, 1.2 Hz, 1H), 5.41 (dt, J 
= 10.4, 1.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 165.4, 135.9, 135.3, 133.2, 131.8, 
130.0, 129.9, 129.7, 128.6, 128.4, 128.3, 126.8, 122.6, 120.0, 75.8, 75.5. HPLC: 
(Chiralcel OD-H + OD-H columns, hexanes:i-PrOH = 95:5, 0.3 mL/min, 254 nm), tminor 
= 39.4 min, tmajor = 40.7 min; ee = 94%. [α]D25= +14.26 (c =2.23, CH2Cl2). FTIR (neat): 
1720, 1602, 1451, 1315, 1264, 1177, 1108, 1069, 1026, 967, 734, 708 cm-1. HRMS (CI) 




13C NMR  
 
(3R, 4S, E)-octa-1,5-diene-3,4-diyl dibenzoate 
 
3.12g 
1H NMR (400 MHz, CDCl3): δ 8.05-8.02 (m, 4H), 7.58-7.54 (m, 2H), 7.45-7.41 (m, 4H), 
6.05-5.96 (m, 2H), 5.78-5.74 (m, 2H), 5.63-5.57 (m, 1H), 5.47 (dt, J = 17.2, 1.2 Hz, 1H), 
5.37 (dt, J = 10.4, 1.2 Hz, 1H), 2.13-2.06 (m, 2H), 0.98 (t, J = 7.2 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): δ 165.4, 139.1, 133.1, 133.0, 131.9, 130.2, 130.1, 129.7, 128.4, 
122.4, 119.7, 75.8, 75.6, 25.4, 13.1. HPLC: (Chiralcel AD-H + AD-H columns, 
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hexanes:i-PrOH = 98:2, 0.5 mL/min, 230 nm), tmajor = 35.3 min, tminor = 37.6 min; ee = 
98%. [α]D25= +9.0 (c =2.00, CH2Cl2). FTIR (neat): 1720, 1452, 1315, 1264, 1212, 1175, 
1109, 1070, 1039, 1026, 970, 734, 705 cm-1. HRMS (CI) Calcd. for C22H23O4 [M+H]+: 
351.1596, Found: 351.1599. 
1H NMR 
 
13C NMR  
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(3R, 4S)-7-(tert-butyldimethylsilyloxy)hept-1-ene-3,4-diyl dibenzoate 
 
3.12h 
1H NMR (400 MHz, CDCl3): δ 8.04-8.00 (m, 4H), 7.58-7.53 (m, 2H), 7.45-7.39 (m, 4H), 
6.05-5.97 (m, 1H), 5.75-5.72 (m, 1H), 5.50-5.45 (m, 2H), 5.37 (dt, J = 10.4, 1.2 Hz, 1H), 
3.69-3.59 (m, 2H), 1.93-1.86 (m, 2H), 1.66-1.56 (m, 2H), 0.87 (s, 9H), 0.02 (s, 6H). 13C 
NMR (100 MHz, CDCl3): δ 166.0, 165.4, 133.0, 132.0, 130.1, 129.7, 128.4, 119.7, 75.9, 
74.3, 62.4, 28.6, 26.3, 25.9, 18.3, -5.3. HPLC: (Chiralcel AD-H + AD-H columns, 
hexanes:i-PrOH = 99.5:0.5, 0.3 mL/min, 230 nm), tmajor = 43.9 min, tminor = 51.9 min; ee 
= 94%. [α]D25= +6.93 (c =2.02, CH2Cl2). FTIR (neat): 1717, 1451, 1315, 1273, 1247, 
1177, 1097, 1059, 1024, 949, 834, 776, 737, 708, 687 cm-1. HRMS (CI) Calcd. for 




13C NMR  
 
 
(3R, 4S)-dodec-1-ene-3, 4-diyl dibenzoate 
 
3.12i 
1H NMR (400 MHz, CDCl3): δ 8.05-8.00 (m, 4H), 7.59-7.53 (m, 2H), 7.47-7.40 (m, 4H), 
6.07-5.98 (m, 1H), 5.73-5.70 (m, 1H), 5.49-5.45 (m, 2H), 5.37 (dt, J = 10.4, 1.2 Hz, 1H), 
1.84-1.74 (m, 2H), 1.45-1.24 (m, 12H), 0.86 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 166.0, 165.4, 133.0, 132.9, 132.0, 130.2, 130.1, 130.0, 128.4, 119.7, 75.9, 74.5, 
31.8, 30.0, 29.4, 29.3, 29.2, 25.4, 22.6, 14.1. HPLC: (Chiralcel AD-H + OD-H columns, 
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hexanes:i-PrOH = 99:1, 0.3 mL/min, 230 nm), tmajor = 39.3 min, tminor = 42.4 min; ee = 
97%. [α]D25= +8.47 (c =1.77, CH2Cl2). FTIR (neat): 1721, 1602, 1452, 1315, 1264, 1177, 
1108, 1080, 1060, 1024, 949, 802, 736, 708, 687 cm-1. HRMS (CI) Calcd. for C26H33O4 
[M+H]+: 409.2379, Found: 409.2379. 
1H NMR 
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with (R)-SEGPHOS-I (10.3 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). 
Benzaldehyde 3.11a (21 mg, 0.2 mmol, 100 mol%), acrolein gem-dibenzoate 3.10e (113 
mg, 0.4 mmol, 200 mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 100 mol%) and 
isopropanol (24 mg, 0.4 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 60 oC for 48 hr, at which point the reaction mixture was cooled to 
ambient temperature. K2CO3 (55 mg, 0.4 mmol, 200 mol%) and MeOH (2.0 mL) were 
added. The reaction mixture was allowed to stir at ambient temperature for 18 hr, at 
which point the reaction mixture was quenched with aqueous NH4Cl (3 mL) and 
extracted with ethyl acetate. The organic layer was dried (MgSO4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate:hexanes, 1:10) provided 3.13a (25 mg, 0.154 mmol) as a colorless oil in 77% 
yield (17:1 dr). 
1H NMR (400 MHz, CDCl3): δ 7.37-7.30 (m, 5H), 5.89-5.74 (m, 1H), 5.38-5.22 (m, 2H), 
4.77 (d, J = 4.4 Hz, 1H), 4.35-4.31 (m, 1H), 2.46 (br, 1H), 2.08 (br, 1H).13C NMR (100 
MHz, CDCl3): δ 139.7, 135.8, 128.3, 127.9, 126.6, 117.9, 76.5 (two carbons are 
overlapped). GC: (Cyclosil-B: initial temperature: 100 oC (5 min hold), final temperature: 
220 oC (2 min hold), rate: 2 oC/min): tmajor = 37.2 min, tminor = 37.5 min; ee = 99%. 
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[α]D25= +71.0 (c =0.91, CHCl3). (The absolute configuration of the product is determined 
by correlation with a known compound). FTIR (neat): 3388, 2920, 1494, 1452, 1427, 
1197, 1122, 1091, 1063, 1028, 995, 927, 863, 830, 763, 724, 700 cm-1. HRMS (CI) 
Calcd. for C10H11O2 [M-H]+: 163.0759, Found: 163.0757. 
1H NMR 
 
13C NMR  
 
 280
(1S, 2R)-1-(6-bromopyridin-2-yl)but-3-ene-1, 2-diol 
 
3.13e 
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with (R)-SEGPHOS-I (10.3 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). 6-
Bromopyridine-2-carboxaldehyde 3.11e (37 mg, 0.2 mmol, 100 mol%), acrolein gem-
dibenzoate 3.10e (113 mg, 0.4 mmol, 200 mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 
100 mol%) and isopropanol (24 mg, 0.4 mmol, 200 mol%) were added and the reaction 
mixture was allowed to stir at 60 oC for 48 hr, at which point the reaction mixture was 
cooled to ambient temperature. K2CO3 (55 mg, 0.4 mmol, 200 mol%) and MeOH (2.0 
mL) were added. The reaction mixture was allowed to stir at ambient temperature for 18 
hr, at which point the reaction mixture was quenched with aqueous NH4Cl (3 mL) and 
extracted with ethyl acetate. The organic layer was dried (MgSO4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate:hexanes, 1:10) provided 3.13e (30 mg, 0.124 mmol) as a colorless oil in 62% 
yield (7:1 dr). 
1H NMR (400 MHz, CDCl3): δ 7.58-7.55 (m, 1H), 7.44-7.41 (m, 1H), 7.36-7.33 (m, 1H), 
5.84-5.76 (m, 1H), 5.29 (dt, J = 17.6, 1.6 Hz, 1H), 5.22 (dt, J = 10.8, 1.6 Hz, 1H), 4.74 
(d, J = 4.8 Hz, 1H), 4.45-4.23 (m, 1H), 3.57 (br, 1H), 2.87 (br, 1H). 13C NMR (100 MHz, 
CDCl3): δ 160.4, 140.9, 139.0, 135.7, 127.2, 120.6, 117.9, 76.1, 74.8. GC: (Cyclosil-B: 
 281
initial temperature: 120 oC (10 min hold), final temperature: 180 oC (5min hold), rate: 1.5 
oC/min): tminor = 47.7 min, tmajor = 48.2 min; ee = 96%. [α]D25= +20.8 (c =0.90, CH2Cl2). 
FTIR (neat): 2304, 1557, 1440, 1265, 896, 733, 704 cm-1. HRMS (CI) Calcd. for 
C9H11NO2Br [M+H]+: 243.9973, Found: 243.9975. 
1H NMR 
 




(3S, 4R, E)-1-phenylhexa-1,5-diene-3, 4-diol 
 
3.13f 
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with (R)-SEGPHOS-I (10.3 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). 
Cinnamaldehyde 3.11f (26 mg, 0.2 mmol, 100 mol%), acrolein gem-dibenzoate 3.10e 
(113 mg, 0.4 mmol, 200 mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 100 mol%) and 
isopropanol (24 mg, 0.4 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 60 oC for 48 hr, at which point the reaction mixture was cooled to 
ambient temperature. K2CO3 (55 mg, 0.4 mmol, 200 mol%) and MeOH (2.0 mL) were 
added. The reaction mixture was allowed to stir at ambient temperature for 18 hr, at 
which point the reaction mixture was quenched with aqueous NH4Cl (3 mL) and 
extracted with ethyl acetate. The organic layer was dried (MgSO4), filtered and 
concentrated in vacuo. Purification of the residue by column chromatography (SiO2; ethyl 
acetate:hexanes, 1:10) provided 3.13f (26 mg, 0.136 mmol) as a colorless oil in 68% 
yield (18:1 dr). 
1H NMR (400 MHz, CDCl3): δ 7.33-7.16 (m, 5H), 6.60 (dd, J = 16.0, 0.8 Hz, 1H), 6.17 
(dd, J = 16.0, 6.4 Hz, 1H), 5.90-5.82 (m, 1H), 5.31 (dd, J = 17.2, 1.6 Hz, 1H), 5.22 (dd, J 
= 10.4, 1.2 Hz, 1H), 4.32-4.20 (m, 2H), 2.19 (br, 2H). 13C NMR (100 MHz, CDCl3): δ 
136.3, 136.0, 132.8, 128.6, 127.9, 126.9, 126.6, 117.7, 75.7, 75.3. GC: (Cyclosil-B: initial 
temperature: 100 oC (5 min hold), final temperature: 200 oC (5 min hold), rate: 2.5 
 283
oC/min): tmajor = 41.0 min, tminor = 41.3 min; ee = 97%. [α]D25= +15.4 (c =0.80, CH2Cl2).  
FTIR (neat): 3388, 1699, 1494, 1450, 1265, 1026, 993, 969, 931, 734, 702 cm-1. HRMS 
(CI) Calcd. for C12H15O2 [M+H]+: 191.1072, Found: 191.1074. 
1H NMR 
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with (R)-SEGPHOS-I (10.3 mg, 0.01 mmol, 5 mol%) and THF (1.0 M, 0.2 mL). 
Nonanal 3.11i (28 mg, 0.2 mmol, 100 mol%), acrolein gem-dibenzoate 3.10e (113 mg, 
0.4 mmol, 200 mol%), anhydrous K3PO4 (43 mg, 0.2 mmol, 100 mol%) and isopropanol 
(24 mg, 0.4 mmol, 200 mol%) were added and the reaction mixture was allowed to stir at 
60 oC for 48 hr, at which point the reaction mixture was cooled to ambient temperature. 
K2CO3 (55 mg, 0.4 mmol, 200 mol%) and MeOH (2.0 mL) were added. The reaction 
mixture was allowed to stir at ambient temperature for 18 hr, at which point the reaction 
mixture was quenched with aqueous NH4Cl (3 mL) and extracted with ethyl acetate. The 
organic layer was dried (MgSO4), filtered and concentrated in vacuo. Purification of the 
residue by column chromatography (SiO2; ethyl acetate:hexanes, 1:10) provided 3.13i (28 
mg, 0.14 mmol) as a colorless oil in 70% yield (14:1 dr). 
1H NMR (400 MHz, CDCl3): δ 5.97-5.89 (m, 1H), 5.37-5.27 (m, 2H), 4.12-4.09 (m, 1H), 
3.72-3.68 (m, 1H),1.50-1.24 (m, 14H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 135.7, 117.4, 75.6, 73.7, 31.8, 31.5, 29.3, 29.2, 28.9, 25.5, 22.3, 13.8. GC: 
(Cyclosil-B: initial temperature: 150 oC (5 min hold), final temperature: 200 oC (5 min 
hold), rate: 2.0 oC/min): tmajor = 12.5 min, tminor = 12.8 min; ee = 99%. [α]D25= +7.9 (c 
=0.65, CH2Cl2). FTIR (neat): 3298, 2953, 2917, 2851, 1705, 1467, 1378, 1317, 1264, 
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1118, 1072, 1028, 1006, 926, 737, 711cm-1. HRMS (CI) Calcd. for C10H11O2 [M-H]+: 
199.1698, Found: 199.1695. 
1H NMR 
 
13C NMR  
 
 286
Preparation of (S)-Ir-Complex I 
To a mixture of [Ir(cod)Cl]2 (100 mg, 0.15 mmol, 100 mol%), (S)-SEGPHOS 
(183 mg, 0.3 mmol, 200 mol%), Cs2CO3 (195 mg, 0.6 mmol, 400 mol%) and m-
nitrobenzoic acid (100 mg, 0.6 mmol, 400 mol%) in a sealed tube under N2 atmosphere 
was added THF (3 mL, 0.05 M). The reaction mixture was heated at 80 oC for 30 min and 
was then allowed to cool to ambient temperature. Allyl  acetate (75 mg, 0.75 mmol, 500 
mol%) was added and the reaction mixture was allowed to stir for an additional 90 min at 
80 ºC, at which point the reaction mixture was allowed to cool to the ambient 
temperature. The reaction mixture was filtered and washed with THF (15 mL) until all 
yellow residue was dissolved. The filtrate was concentrated in vacuo and hexanes (50 
mL) was added. A yellow precipitate formed, which was collected by filtration and dried 
under vacuum (233 mg, 0.231 mmol, 77% yield).  
The yellow solid was dissolved in THF and diethyl ether was allowed to diffuse 
into the THF solution at the ambient temperature, resulting in the formation of crystals. 
Single crystal X-ray diffraction data for (S)-Ir-Complex I has been deposited in the 
CCDB.  
 
General procedure for Enantioselective Carbonyl Reverse Prenylation from the 
Alcohol Oxidation Level 
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with (S)-Ir-complex I (25 mg, 0.025 mmol, 5 mol%) and toluene (1.0 M, 0.5 mL). 
Alcohol (0.5 mmol, 100 mol%), 1,1-dimethylallene (68 mg, 1.0 mmol, 200 mol%) and 
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propionaldehyde (1.5 mg, 0.025 mmol, 5 mol%) were added and the reaction mixture 
was allowed to stir at 40 oC for 15 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the product by column chromatography provided 
the corresponding product. 
 
General procedure for Enantioselective Carbonyl Reverse Prenylation from the 
Aldehyde Oxidation Level 
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with (S)-Ir-complex I (25 mg, 0.025 mmol, 5 mol%) and toluene (1.0 M, 0.5 mL). 
Aldehyde (0.5 mmol, 100 mol%), 1,1-dimethylallene (68 mg, 1.0 mmol, 200 mol%) and 
isopropanol (60 mg, 1.0 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 40 oC for 48 hr, at which point the reaction mixture was concentrated in 






TLC (SiO2): Rf = 0.26 (ethyl acetate:hexanes, 1:20). 1H NMR (400 MHz, CDCl3): δ 7.29-
7.23 (m, 5H), 5.90 (dd, J = 17.6, 10.8 Hz, 1H), 5.12 (d, J = 10.8 Hz, 1H), 5.06 (d, J = 
17.6 Hz, 1H), 4.39 (s, 1H), 2.10 (s, 1H), 1.00 (s, 3H), 0.95 (s, 3H). 13C NMR (100 MHz, 
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CDCl3): δ 145.0, 140.7, 127.7, 127.4, 127.3, 113.8, 80.5, 42.2, 24.4, 21.0. HPLC: 
(Chiralcel OD-H column, hexanes:i-PrOH = 98:2, 1 mL/min, 210 nm), tminor = 9.1 min, 










TLC (SiO2): Rf = 0.25 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.29 
(d, J = 8.4 Hz, 2H), 7.16 (d, J = 8.4 Hz, 2H), 5.88 (dd, J = 17.6, 10.8 Hz, 1H), 5.15 (d, J 
= 10.8 Hz, 1H), 5.07 (d, J = 17.6 Hz, 1H), 4.37 (s, 1H), 2.07 (d, J = 2.4 Hz, 1H), 0.99 (s, 
3H), 0.93 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 144.6, 139.6, 130.5, 129.4, 121.2, 
114.3, 79.9, 42.2, 24.3, 20.8. HRMS (CI) Calcd. for C12H16OBr (M+H)+: 255.0385 
Found: 255.0381. FTIR (neat): 3447, 2968, 2871, 1637, 1591, 1487, 1378, 1362, 1284, 
1183, 1104, 1070, 1052, 1030, 1009, 915, 884, 836, 817, 754, 694, 670 cm-1.HPLC: 
(Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), tminor = 13.9 




13C NMR  
 
 
(R)-Methyl 4-(1-hydroxy-2,2-dimethylbut-3-enyl)benzoate  
 
3.16c 
TLC (SiO2): Rf = 0.25 (ethyl acetate:hexanes, 1:10). 1H NMR (400 MHz, CDCl3): δ 7.95 
(d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.4 Hz, 2H), 5.88 (dd, J = 17.6, 10.8 Hz, 1H), 5.14 (dd, J 
= 10.8, 1.2 Hz, 1H), 5.05 (dd, J = 17.6, 1.2 Hz, 1H), 4.46 (s, 1H), 3.90 (s, 3H), 2.34(br, 
1H), 1.00 (s, 3H), 0.95 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 167.0, 146.0, 144.5, 
129.1, 128.7, 127.7, 114.2, 80.1, 52.0, 42.2, 24.2, 21.0. HPLC: (Chiralcel OJ-H column, 
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hexanes:i-PrOH = 95:5, 1.0 mL/min, 254 nm), tminor = 12.7 min, tmajor = 17.9 min; ee = 












TLC (SiO2): Rf = 0.25 (ethyl acetate:hexanes, 1:15). 1H NMR (400 MHz, CDCl3): δ 7.39-
7.21 (m, 5H), 6.59 (d, J = 16.0 Hz, 1H), 6.24 (dd, J = 16.0, 6.8 Hz, 1H), 5.91 (dd, J = 
17.6, 10.8 Hz, 1H), 5.14 (dd, J = 10.8, 1.2 Hz, 1H), 5.11 (dd, J = 17.6, 1.2 Hz, 1H), 3.97 
(dd, J = 6.8, 1.2 Hz, 1H), 1.08 (s, 3H), 1.06 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 
144.8, 136.8, 132.0, 128.6, 128.5, 127.5, 126.4, 113.8, 79.2, 41.9, 23.8, 21.8. HPLC: 
(Chiralcel OD-H column, hexanes:i-PrOH = 98:2, 1.0 mL/min, 254 nm), tmajor = 13.5 min, 











TLC (SiO2): Rf = 0.37 (ethyl acetate:hexanes, 1:20). 1H NMR (400 MHz, CDCl3): δ 5.89 
(dd, J = 17.6, 10.8 Hz, 1H), 5.19-5.16 (m, 1H), 5.11-5.04 (m, 1H), 4.06 (d, J = 9.6 Hz, 
1H), 2.14-2.03 (m, 4H), 1.68 (s, 3H), 1.67 (s, 3H), 1.60 (s, 3H), 1.52 (br, 1H), 1.00 (s, 
3H), 0.98 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 145.1, 139.6, 131.5, 124.1, 124.0, 
113.3, 74.4, 42.0, 39.9, 26.3, 25.7, 23.9, 21.0, 17.6, 16.8. HRMS (CI) Calcd. for C15H27O 
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(M+H)+: 223.2062, Found: 223.2057. FTIR (neat): 3415, 2965, 2915, 1667, 1638, 1445, 
1414, 1377, 1360, 1266, 1182, 1099, 1009, 990, 909, 817, 741, 691 cm-1. HPLC: 
Enantiomeric excess was determined by HPLC analysis of the 3,5-nitrobenzoate 
derivative of the product (Chiralcel AD-H column, hexanes:i-PrOH = 99.5:0.5, 0.5 






















TLC (SiO2): Rf = 0.25 (ethyl acetate:hexanes, 1:15). 1H NMR (400 MHz, CDCl3): δ 7.30-
7.17 (m, 5H), 5.79 (dd, J = 17.6, 10.8 Hz, 1H), 5.09 (dd, J = 10.8, 1.2 Hz, 1H), 5.05 (dd, 
J = 17.6, 1.2 Hz, 1H), 3.28 (dd, J = 10.8, 1.6 Hz, 1H), 2.96-2.89 (m, 1H), 2.65-2.58 (m, 
1H), 1.89-1.79 (m, 1H), 1.62-1.52 (m, 1H), 1.00 (s, 6H).  13C NMR (100 MHz, CDCl3): 
δ 145.3, 142.4, 128.5, 128.4, 125.8, 113.6, 77.5, 41.7, 33.3, 33.2, 23.1, 21.9. HPLC: 
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(Chiralcel OJ-H column, hexanes:i-PrOH = 97:3, 0.5 mL/min, 254 nm), tminor  = 11.6 
min, tmajor = 12.6 min; ee = 87% (aldehyde), 91% (alcohol). 
1H NMR 
 






TLC (SiO2): Rf = 0.35 (ethyl acetate:hexanes, 1:7). 1H NMR (400 MHz, CDCl3): δ 7.36-
7.25 (m, 5H), 5.86 (dd, J = 17.6, 10.8 Hz, 1H), 5.04 (dd, J = 10.8, 1.6 Hz, 1H), 5.02 (dd, 
J = 17.6, 1.6 Hz, 1H), 4.51 (d, J = 1.2 Hz, 2H), 3.74-3.49 (m, 2H), 3.51 (dt, J = 10.4, 2.4 
Hz, 1H), 2.81(d, J = 2.8 Hz, 1H), 1.80-1.73 (m, 1H), 1.68- 1.58 (m, 1H), 1.02 (s, 6H).  
13C NMR (100 MHz, CDCl3): δ 145.4, 137.9, 128.4, 127.7, 112.6, 77.7, 73.3, 69.9, 41.2, 
31.2, 22.7, 22.5. HRMS (CI) Calcd. for C15H23O2 (M+H)+: 235.1698, Found: 235.1696. 
FTIR (neat): 3480, 2962, 2864, 1638, 1496, 1454, 1415, 1362, 1309, 1205, 1078, 1028, 
1005, 970, 911, 735, 696 cm-1. HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 99:1, 











TLC (SiO2): Rf = 0.35 (ethyl acetate:hexanes, 1:5). 1H NMR (400 MHz, CDCl3): δ 7.34-
7.24 (m, 5H), 5.82 (dd, J = 17.6, 10.8 Hz, 1H), 5.06 (dd, J = 10.8, 1.2 Hz, 1H), 5.03 (dd, 
J = 17.6, 1.2 Hz, 1H), 4.51 (s, 1H), 3.49 (t, J = 6.0 Hz, 2H), 3.25  (dd, J = 10.8, 1.2 Hz, 
1H), 2.17 (br, 1H), 1.86-1.81 (m, 1H), 1.72- 1.63 (m, 2H), 1.32-1.24 (m, 1H), 1.00 (s, 
6H). 13C NMR (100 MHz, CDCl3): δ 145.5, 138.3, 128.3, 127.6, 127.5, 112.9, 78.0, 72.8, 
70.3, 41.5, 28.5, 27.2, 22.8, 22.4. HRMS (CI) Calcd. for C16H25O2 (M+H)+: 249.1855, 
Found: 249.1857. FTIR (neat): 3478, 2959, 2862, 1637, 1496, 1454, 1414, 1361, 1274, 
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1204, 1091, 1028, 1005, 972, 910, 734, 696 cm-1. HPLC: (Chiralcel OJ-H column, 
hexanes:i-PrOH = 97:3, 0.7 mL/min, 210 nm), tminor  = 11.6 min , tmajor = 12.3 min; ee = 
93% (aldehyde), 91% (alcohol). 
1H NMR 
 






TLC (SiO2): Rf = 0.39 (ethyl acetate:hexanes, 1:20). 1H NMR (400 MHz, CDCl3): δ 5.82 
(dd, J = 17.6, 10.8 Hz, 1H), 5.08 (d, J = 10.8 Hz, 1H), 5.04 (d, J = 17.6 Hz, 1H), 3.24 (d, 
J = 9.2 Hz, 1H), 1.56-1.46 (m, 2H), 1.34-1.22 (m,12H), 1.00 (s, 6H), 0.88 (t, J = 6.4 Hz, 
3H). 13C NMR (100 MHz, CDCl3): δ 145.5, 113.2, 78.2, 41.6, 31.9, 31.4, 29.7, 29.6, 
29.3, 27.1, 23.1, 22.7, 22.0, 14.1. HPLC: Enantiomeric excess was determined by HPLC 
analysis of the 3,5-nitrobenzoate derivative of the product (Chiralcel OD-H column, 
hexanes:i-PrOH = 99:1, 0.5 mL/min, 230 nm), tmajor = 16.7 min, tminor  = 19.1 min; ee = 




13C NMR  
 
 
Procedure for the Preparation of Ir-Complex II 
To a mixture of [Ir(cod)Cl]2 (100 mg, 0.15 mmol, 100 mol%), BIPHEP (157 mg, 
0.3 mmol, 200 mol%), Cs2CO3 (195 mg, 0.6 mmol, 400 mol%) and m-nitrobenzoic acid 
(100 mg, 0.6 mmol, 400 mol%) in a sealed tube under N2 atmosphere was added THF (3 
mL, 0.05 M). The reaction mixture was heated at 80 oC for 30 min and was then allowed 
to cool to the ambient temperature. Allyl  acetate (75 mg, 0.75 mmol, 500 mol%) was 
added and the reaction mixture was allowed to stir for an additional 90 min at 80 ºC, at 
which point the reaction mixture was allowed to cool to the ambient temperature. The 
reaction mixture was filtered and washed with THF (15 mL) until all yellow residue was 
dissolved. The filtrate was concentrated in vacuo and hexanes (50 mL) was added. A 
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yellow precipitate formed, which was collected by filtration and dried under vacuum (213 




An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with Ir-complex II (23 mg, 0.025 mmol, 5 mol%) and toluene (1.0 M, 0.5 mL). 
Benzaldehyde 3.15a (53 mg, 0.5 mmol, 100 mol%), 1,1-dimethylallene (68 mg, 1.0 
mmol, 200 mol%) and 4-bromobenzyl alcohol 3.17b (94 mg, 0.5 mmol, 100 mol%) were 
added and the reaction mixture was allowed to stir at 50 oC for 48 hr, at which point the 
reaction mixture was concentrated in vacuo. Purification of the product by column 
chromatography (SiO2; ethyl acetate:hexanes, 1:50) provided a 1:1.2 mixture of 3.16a 
and 3.16b (95 mg, ca. 87%) as a colorless oil. (N.B. yield is based upon 100 mol% of 




An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with Ir-complex II (23 mg, 0.025 mmol, 5 mol%) and toluene (1.0 M, 0.5 mL). 4-
Bromobenzaldehyde 3.15b  (93 mg, 0.5 mmol, 100 mol%), 1,1-dimethylallene (68 mg, 
1.0 mmol, 200 mol%) and benzyl alcohol 3.17a (54 mg, 0.5 mmol, 100 mol%) were 
added and the action mixture was allowed to stir at 50 oC for 48 hr, at which point the 
reaction mixture was concentrated in vacuo. Purification of the product by column 
chromatography (SiO2; ethyl acetate:hexanes, 1:50) provided a 1:1.6 mixture of 3.16a 
and 3.16b (107 mg, ca. 95%) as a colorless oil. (N.B. yield is based upon 100 mol% of 
alcohol as the limiting reagent and is calculated based upon product stoichiometry). 
 
Isotopic Labeling Experiments 
3-Deuterio-2,2-dimethyl-1-phenylbut-3-en-1-ol   
 
deuterio-3.16a 
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with Ir-complex II (23 mg, 0.025 mmol, 5 mol%) and toluene (1.0 M, 0.5 mL). 
Benzaldehyde 3.15a (53 mg, 0.5 mmol, 100 mol%), 1,1-dimethylallene (68 mg, 1.0 
mmol, 200 mol%) and d8-isopropanol (68 mg, 1.0 mmol, 200 mol%) were added and the 
reaction mixture was allowed to stir at 50 oC for 48 hr, at which point the reaction 
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mixture was concentrated in vacuo. Purification of the product by column 
chromatography (SiO2; ethyl acetate:hexanes, 1:50) provided deuterio-3.16a (65 mg, 
0.365 mmol) as a colorless oil in 73% yield. 
1H NMR (400 MHz, CDCl3): δ 7.29-7.23 (m, 5H), 5.90 (dd, J = 17.6, 10.8 Hz, 0.18H), 
5.18-5.09(m, 1.96H), 4.44 (s, 1H), 2.10 (s, 1H), 1.00 (s, 3H), 0.95 (s, 3H). 2H NMR (77 
MHz, CHCl3): δ 5.95 (s, 0.972H), 5.18-5.07 (m, 0.032H)*.  



















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with Ir-complex II (23 mg, 0.025 mmol, 5 mol%) and toluene (1.0 M, 0.5 mL). d2-
Benzyl alcohol (56 mg, 0.5 mmol, 100 mol%), 1,1-dimethylallene (68 mg, 1.0 mmol, 200 
mol%) and propionaldehyde (1.5 mg, 0.025 mmol, 5 mol%) were added and the reaction 
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mixture was allowed to stir at 50 oC for 48 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the product by column chromatography (SiO2: 
ethyl acetate:hexanes, 1:50) provided deuterio-3.16a’ (70 mg, 0.392 mmol) as a colorless 
oil in 78% yield. 
1H NMR (400 MHz, CDCl3): δ 7.29-7.23 (m, 5H), 5.90 (dd, J = 17.6, 10.8 Hz, 0.09H), 
5.12 (d, J = 10.8 Hz, 1H), 5.06 (d, J = 17.6 Hz, 1H), 4.39 (s, 1H), 2.10 (s, 1H), 1.00 (s, 



















5-Methyl isatin (1.50 g, 9.3 mmol, 100 mol%) was dissolved in N,N-
dimethylformamide (18 mL), and then the organic solution was cooled to 0 oC. Sodium 
hydride (448.3 mg, 11.2 mmol, 60% dispersion in oil, 120 mol%) was added in one 
portion, and the reaction mixture was stirred  at 0 oC for 20 min. Benzyl bromide (1.35 
mL, 11.4 mmol, 120 mol%) was added dropwise at 0 oC. The reaction mixture was 
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stirred at 0 oC for 30 min and allowed to stir overnight at the ambient temperature. Water 
was added to the reaction mixture, and a precipitate formed. The precipitate was filted 
and washed with water. This solid was recrystallized from ethanol, filtered and dried 
under reduced pressure to afford 1-benzyl-5-methylindoline-2,3-dione 3.18c (1.84 g, 7.33 
mmol, 77%). 
TLC (SiO2): Rf = 0.4 (ethyl acetate:hexanes, 1:3). 1H NMR (400 MHz, CDCl3): δ 7.41-
7.26 (m, 7H), 6.66 (d, J = 8.2 Hz, 1H), 4.91 (s, 2H), 2.29 (s, 3H). 13C NMR (100 MHz, 
CDCl3): δ 183.5, 158.3, 148.5, 138.7, 134.6, 133.6, 128.9, 128.0, 127.3, 125.6, 117.6, 
110.8, 43.9, 20.6. FTIR (neat): υ 1726, 1618, 1598, 1488, 1450, 1367, 1350, 1338, 1314, 
1227, 1203, 1173, 1126, 1081, 1024, 839, 819, 809, 775, 763, 719, 711, 967 cm-1. HRMS 
(CI) Calcd. for C16H14NO2 (M+H)+: 252.1025, Found: 252.1026. mp (Ethanol) 146-147 










6-Chloro isatin (1.51 g, 8.3 mmol, 100 mol%) was dissolved in N,N-
dimethylformamide (18 mL), and then the organic solution was cooled to 0 oC. Sodium 
hydride (406.1 mg, 10.2 mmol, 60% dispersion in oil, 120 mol%) was added in one 
portion, and the reaction mixture was stirred  at 0 oC for 20 min. Benzyl bromide (1.20 
mL, 10.1 mmol, 120 mol%) was added dropwise at 0 oC. The reaction mixture was 
stirred at 0 oC for 30 min and allowed to stir overnight at the ambient temperature. Water 
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was added to the reaction mixture, and a precipitate formed. The precipitate was filted 
and washed with water. This solid was recrystallized from ethanol, filtered and dried 
under reduced pressure to afford 1-benzyl-6-chloroindoline-2,3-dione 3.18e (1.68 g, 6.17 
mmol, 74%).  
TLC (SiO2): Rf = 0.4 (ethyl acetate:hexanes, 1:3). 1H NMR (400 MHz, CDCl3): δ 7.54 (d, 
J = 8.0 Hz, 1H), 7.40-7.30 (m, 5H), 7.07 (dd, J = 8.0, 1.7 Hz, 1H), 6.79 (d, J = 1.7 Hz, 
1H), 4.91 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 181.6, 158.2, 151.6, 144.7, 133.9, 
129.1, 128.3, 127.3, 126.4, 124.1, 115.9, 111.6, 44.1. FTIR (neat): υ 1732, 1609, 1584, 
1496, 1453, 1434, 1369, 1349, 1255, 1196, 1105, 1072, 1032, 878, 860, 837, 820, 753, 
726, 716, 711, 698 cm-1. HRMS (CI) Calcd. for C15H11ClNO2 (M+H)+: 272.0478, Found: 
272.0477. mp (Ethanol) 173-174 oC, Orange solid 
 
1H NMR  
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7-Fluoro isatin (1.51 g, 9.1 mmol, 100 mol%) was dissolved in N,N-
dimethylformamide (18 mL), and then the organic solution was cooled to 0 oC. Sodium 
hydride (439.0 mg, 11.0 mmol, 60% dispersion in oil, 120 mol%) was added in one 
portion, and the reaction mixture was stirred  at 0 oC for 20 min. Benzyl bromide (1.30 
mL, 11.0 mmol, 120 mol%) was added dropwise at 0 oC. The reaction mixture was 
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stirred at 0 oC for 30 min and allowed to stir overnight at the ambient temperature. Water 
was added to the reaction mixture, and a precipitate formed. The precipitate was filted 
and washed with water. This solid was recrystallized from ethanol, filtered and dried 
under reduced pressure to afford 1-benzyl-7-fluoroindoline-2,3-dione 3.18g (1.79 g, 7.03 
mmol, 77%). 
TLC (SiO2): Rf = 0.4 (ethyl acetate:hexanes, 1:3). 1H NMR (400 MHz, CDCl3): δ 7.44 
(dd, J = 7.3, 1.1 Hz, 1H), 7.39-7.26 (m, 6H), 7.09-7.04 (m, 1H), 5.06 (s, 2H). 13C NMR 
(100 MHz, CDCl3): δ 182.3 (d, JC-F= 3.8 Hz), 158.0, 147.9 (d, JC-F= 248.3 Hz), 136.7 (d, 
JC-F= 8.9 Hz), 135.6, 128.8, 128.1, 127.7 (d, JC-F= 1.4 Hz), 126.6 (d, JC-F= 19.5 Hz), 
124.8 (d, JC-F= 6.0 Hz), 121.5 (d, JC-F= 3.0 Hz), 120.3 (d, JC-F= 3.0 Hz), 45.9 (d, JC-F= 4.5 
Hz). FTIR (neat): υ 1748, 1731, 1623, 1487, 1455, 1369, 1339, 1320, 1244, 1205, 1171, 
1149, 1114, 1063, 1035, 968, 924, 822, 778, 755, 710, 700, 689 cm-1. HRMS (CI) Calcd. 


















1H NMR  
 
 
13C NMR  
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An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzylindoline-2,3-dione 3.18a (46.9 mg, 0.20 mmol, 100 mol%), [Ir(cod)Cl]2 
(3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 mol%), 4-
cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (13.0 mg, 0.040 
mmol, 20 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and allyl acetate (45 
μL, 0.414 mmol, 200 mol%) were added and the reaction mixture was allowed to stir at 
100 oC for 40 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the product by column chromatography (SiO2; ethyl acetate:toluene, 1:20 
to 1:10) provided 3.19a (40.1 mg, 0.144 mmol) as a white solid in 73% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 5:1). 1H NMR (400 MHz, CDCl3): δ 7.40 (d, 
J = 7.2 Hz, 1H), 7.32-7.18 (m, 6H), 7.08-7.04 (m, 1H), 6.70 (d, J = 7.8 Hz, 1H), 5.67-
5.57 (m, 1H), 5.16-5.08 (m, 2H), 5.02 (d, J = 15.7 Hz, 1H), 4.72 (d, J = 15.7 Hz, 1H), 
3.41 (brs, 1H), 2.85-2.80 (m, 1H), 2.74-2.68 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 
177.9, 142.4, 135.4, 130.5, 129.6, 129.6, 128.7, 127.6, 127.3, 124.1, 123.1, 120.6, 109.5, 
 315
75.9, 43.8, 43.0. HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 90:10, 0.8 mL/min, 
254 nm), tminor = 13.5 min, tmajor = 24.9 min; ee = 91%., [α]D26 –8.9 (c 1.01, CHCl3) FTIR 
(neat): υ 3281, 1691, 1615, 1495, 1469, 1437, 1389, 1375, 1358, 1289, 1180, 1137, 1113, 
1080, 990, 938, 919, 779, 757, 744, 697, 667 cm-1. HRMS (CI) Calcd. for C18H17NO2: 
279.1259, Found: 279.1261. mp (DCM/Hexane) 152-154 oC, White solid 
 




















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-5-bromoindoline-2,3-dione 3.18b (62.6 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (6.5 mg, 
0.02 mmol, 10 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
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temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and allyl acetate (45 
μL, 0.414 mmol, 200 mol%) were added and the reaction mixture was allowed to stir at 
100 oC for 72 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the product by column chromatography (SiO2; ethyl acetate:toluene, 1:20 
to 1:10) provided 3.19b (57.3 mg, 0.160 mmol) as a white solid in 80% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 10:1). 1H NMR (400 MHz, CDCl3): δ 7.51 
(d, J = 2.0 Hz, 1H), 7.33-7.23 (m, 6H), 6.55 (d, J = 8.4 Hz, 1H), 5.68-5.57 (m, 1H), 5.20-
5.13 (m, 2H), 4.98 (d, J = 15.8 Hz, 1H), 4.71 (d, J = 15.8 Hz, 1H), 3.18 (brs, 1H), 2.79 
(dd, J = 13.3, 6.3 Hz, 1H), 2.69 (dd, J = 13.3, 8.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): 
δ 177.4, 141.4, 134.8, 132.4, 131.6, 129.9, 128.8, 127.8, 127.4, 127.2, 121.1, 115.9, 
111.0, 75.9, 43.9, 42.9. HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 90:10, 0.8 
mL/min, 254 nm), tminor = 13.0 min, tmajor = 20.2 min; ee = 94%., [α]D25 –6.0 (c 1.01, 
CHCl3). FTIR (neat): υ 3349, 2917, 1693, 1606, 1496, 1479, 1456, 1428, 1362, 1343, 
1174, 1070, 1025, 922, 817, 742, 698, 675, 655 cm-1. HRMS (CI) Calcd. for 
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An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-5-methylindoline-2,3-dione 3.18c (50.2 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (13.0 mg, 
0.040 mmol, 20 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and allyl acetate (45 
μL, 0.414 mmol, 200 mol%) were added and the reaction mixture was allowed to stir at 
100 oC for 40 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the product by column chromatography (SiO2; ethyl acetate:toluene, 1:20 
to 1:10) provided 3.19c (52.3 mg, 0.178 mmol) as a white solid in 89% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 5:1). 1H NMR (400 MHz, CDCl3): δ 7.31-
7.22 (m, 6H), 6.99 (d, J = 7.8 Hz, 1H), 6.57 (d, J = 8.0 Hz, 1H), 5.67-5.57 (m, 1H), 5.17-
5.08 (m, 2H), 5.00 (d, J = 15.7 Hz, 1H), 4.70 (d, J = 15.7 Hz, 1H), 3.40 (brs, 1H), 2.81 
(dd, J = 13.2, 6.3 Hz, 1H), 2.71 (dd, J = 13.2, 8.6 Hz, 1H), 2.30 (s, 3H). 13C NMR (100 
MHz, CDCl3): δ 117.8, 140.0, 135.5, 132.7, 130.6, 129.8, 129.6, 128.7, 127.6, 127.2, 
124.8, 120.5, 109.2, 76.0, 43.8, 43.0, 21.0. HPLC: (Chiralpak AD-H column, hexanes:i-
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PrOH = 90:10, 0.8 mL/min, 254 nm), tminor = 13.8 min, tmajor = 15.7 min; ee = 92%., 
[α]D26 –6.0 (c 1.00, CHCl3). FTIR (neat): υ 3265, 2922, 1692, 1625, 1604, 1495, 1435, 
1399, 1374, 1349, 1282, 1243, 1193, 1155, 1130, 1093, 1079, 990, 928, 803, 781, 750, 
733, 700, 655 cm-1. HRMS (CI) Calcd. for C19H19NO2: 293.1416, Found: 293.1417. mp 
(DCM/Hexane) 156-157 oC, White solid. 
 



















An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-5-methoxyindoline-2,3-dione 3.18d (52.3 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (13.0 mg, 
0.040 mmol, 20 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
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temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and allyl acetate (45 
μL, 0.414 mmol, 200 mol%) were added and the reaction mixture was allowed to stir at 
100 oC for 40 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the product by column chromatography (SiO2; ethyl acetate:toluene, 1:20 
to 1:10) provided 3.19d (55.4 mg, 0.179 mmol) as a white solid in 92% yield. 
TLC (SiO2): Rf = 0.3 (hexane:ethyl acetate, 2:1). 1H NMR (400 MHz, CDCl3): δ 7.33-
7.23 (m, 5H), 7.02 (d, J = 2.7 Hz, 1H), 6.72 (dd, J = 8.3, 2.7 Hz, 1H), 6.58 (d, J = 8.3 Hz, 
1H), 5.69-5.58 (m, 1H), 5.19-5.09 (m, 2H), 5.00 (d, J = 15.7 Hz, 1H), 4.70 (d, J = 15.7 
Hz, 1H), 3.76 (s, 3H), 3.25 (brs, 1H), 2.80 (dd, J = 13.3, 6.3 Hz, 1H), 2.69 (dd, J = 13.3, 
8.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 177.9, 156.2, 135.6, 135.4, 131.0, 130.5, 
128.7, 127.6, 127.2, 120.4, 114.0, 111.1, 109.9, 76.4, 55.7, 43.8, 43.0. HPLC: (Chiralcel 
OJ-H column, hexanes:i-PrOH = 90:10, 0.8 mL/min, 254 nm), tminor = 16.4 min, tmajor = 
26.8 min; ee = 94%., [α]D25 –13.1 (c 0.99, CHCl3). FTIR (neat): υ 3265, 2926, 1689, 
1610, 1498, 1473, 1435, 1402, 1379, 1352, 1299, 1277, 1257, 1198, 1184, 1168, 1134, 
1119, 1089, 1080, 1043, 1020, 1003, 994, 971, 926, 889, 862, 810, 780, 763, 748, 731, 
701, 661 cm-1. HRMS (CI) Calcd. for C19H19NO2: 309.1365, Found: 309.1370. mp 
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An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-6-chloroindoline-2,3-dione 3.18e (53.5 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (13.0 mg, 
0.040 mmol, 20 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and allyl acetate (45 
μL, 0.414 mmol, 200 mol%) were added and the reaction mixture was allowed to stir at 
100 oC for 40 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the product by column chromatography (SiO2; ethyl acetate:toluene, 1:20) 
provided 3.19e (45.3 mg, 0.144 mmol) as a white solid in 73% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 5:1). 1H NMR (400 MHz, CDCl3): δ 7.35-
7.26 (m, 5H), 7.04 (dd, J = 7.9, 1.8 Hz, 1H), 6.69 (d, J = 1.8 Hz, 1H), 5.66-5.56 (m, 1H), 
5.17-5.10 (m, 2H), 4.99 (d, J = 15.8 Hz, 1H), 4.69 (d, J = 15.8 Hz, 1H), 3.08 (brs, 1H), 
2.79 (dd, J = 13.2, 6.2 Hz, 1H), 2.66 (dd, J = 13.2, 8.5 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ 177.9, 143.6, 135.3, 134.8, 130.1, 128.9, 128.0, 127.9, 127.2, 125.1, 123.0, 
120.9, 110.1, 75.6, 43.9, 42.9. HPLC: (Chiralpak AD-H column, hexanes:i-PrOH = 95:5, 
0.5 mL/min, 254 nm), tminor = 35.9 min, tmajor = 37.2 min; ee = 96%., [α]D26 –23.0 (c 1.00, 
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CHCl3). FTIR (neat): υ 3384, 3030, 1708, 1610, 1489, 1434, 1374, 1352, 1174, 1115, 
1071, 1029, 991, 924, 841, 817, 753, 698 cm-1. HRMS (CI) Calcd. for C18H17ClNO2 
(M+1): 314.0948, Found: 314.0945. mp (DCM/Hexane) 163-164 oC, White solid 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-6-bromoindoline-2,3-dione 3.18f (63.1 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (6.5 mg, 
0.02 mmol, 10 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and allyl acetate (45 
μL, 0.414 mmol, 200 mol%) were added and the reaction mixture was allowed to stir at 
100 oC for 72 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the product by column chromatography (SiO2; ethyl acetate:toluene, 1:20) 
provided 3.19f (57.3 mg, 0.160 mmol) as a white solid in 80% yield. 
TLC (SiO2): Rf = 0.2 (toluene:ethyl acetate, 10:1). 1H NMR (400 MHz, CDCl3): δ 7.36-
7.20 (m, 7H), 6.85 (d, J = 1.6 Hz, 1H), 5.66-5.56 (m, 1H), 5.17-5.10 (m, 2H), 5.00 (d, J = 
15.7 Hz, 1H), 4.69 (d, J = 15.7 Hz, 1H), 3.19 (brs, 1H), 2.79 (dd, J = 13.3, 6.3 Hz, 1H), 
2.67 (dd, J = 13.3, 8.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 117.8, 143.7, 134.8, 
130.1, 128.9, 128.6, 127.9, 127.2, 126.0, 125.5, 123.2, 120.9, 112.8, 75.7, 43.9, 42.8. 
HPLC: (Chiralpak AD-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 254 nm), tminor = 
35.0 min, tmajor = 39.4 min; ee = 94%., [α]D25 –6.9 (c 1.01, CHCl3). FTIR (neat): υ 3391, 
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3066, 2923, 1707, 1605, 1486, 1429, 1352, 1173, 1116, 1079, 1059, 990, 923, 835, 815, 
738, 697 cm-1. HRMS (CI) Calcd. for C18H17BrNO2 (M+1): 358.0443, Found: 358.0438. 
mp (DCM/Hexane) 163-164 oC, White solid 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-7-fluoroindoline-2,3-dione 3.18g (50.7 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (13.0 mg, 
0.040 mmol, 20 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and allyl acetate (86 
μL, 0.8 mmol, 400 mol%) were added and the reaction mixture was allowed to stir at 100 
oC for 40 hr, at which point the reaction mixture was concentrated in vacuo. Purification 
of the product by column chromatography (SiO2; ethyl acetate:toluene, 1:20) provided 
3.19g (38.5 mg, 0.130 mmol) as a white solid in 65% yield 
TLC (SiO2): Rf = 0.2 (toluene:ethyl acetate, 10:1). 1H NMR (400 MHz, CDCl3): δ 7.33-
7.16 (m, 6H), 7.04-6.96 (m, 2H), 5.63-5.53 (m, 1H), 5.14-5.05 (m, 3H), 4.95 (d, J = 15.5 
Hz, 1H), 3.38 (brs, 1H), 2.78 (dd, J = 13.3, 6.3 Hz, 1H), 2.68 (dd, J = 13.3, 8.4 Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ 177.7, 147.4 (d, JC-F= 245.3 Hz), 136.5, 132.6, 130.0, 
128.8 (d, JC-F= 8.2 Hz), 128.5, 127.6, 127.5, 123.9 (d, JC-F= 6.0 Hz), 120.8, 120.0 (d, JC-
F= 3.0 Hz), 117.7 (d, JC-F= 20.2 Hz), 76.0 (d, JC-F= 2.2 Hz), 45.3 (d, JC-F= 4.5 Hz), 43.1. 
HPLC: (Chiralpak AD-H column, hexanes:i-PrOH = 90:10, 0.8 mL/min, 254 nm), tminor = 
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12.5 min, tmajor = 15.6 min; ee = 93%., [α]D25 –21.0 (c 1.00, CHCl3). FTIR (neat): υ 3390, 
1705, 1632, 1488, 1473, 1348, 1247, 1189, 1159, 1079, 995, 923, 791, 751, 730, 698, 666 
cm-1. HRMS (CI) Calcd. for C18H17FNO2 (M+1): 298.1243, Found: 298.1241. mp 
(DCM/Hexane) 126-127 oC, White solid 
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An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzylindoline-2,3-dione 3.18a (46.9 mg, 0.20 mmol, 100 mol%), [Ir(cod)Cl]2 
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(3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 mol%), 4-
cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (6.5 mg, 0.02 mmol, 
10 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient temperature 
for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and acetic acid 3-buten-2-yl ester 
(51 μL, 0.40 mmol, 200 mol%) were added and the reaction mixture was allowed to stir 
at 100 oC for 72 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the product by column chromatography (SiO2; ethyl acetate:toluene, 1:20) 
provided 3.20a (48.7 mg, 0.166 mmol, anti:syn=13:1) as a white solid in 83% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 10:1). 1H NMR (400 MHz, CDCl3): δ 7.34-
7.19 (m, 6H), 7.03 (dt, J = 7.6, 1.0 Hz, 1H), 6.73 (d, J = 6.73 Hz, 1H), 6.12-6.03 (m, 1H), 
5.28-5.18 (m, 2H), 5.04 (d, J = 15.7 Hz, 1H), 4.75 (d, J = 15.7 Hz, 1H), 2.94-2.87 (m, 
1H), 2.71 (brs, 1H), 0.85 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 117.8, 
143.0, 136.7, 135.5, 129.5, 128.7, 128.3, 127.6, 127.3, 124.9, 122.8, 118.0, 109.3, 78.1, 
44.8, 43.9, 13.2. HPLC: (Chiralpak AD-H + OJ-H column, hexanes:i-PrOH =95:5, 0.8 
mL/min, 210 nm), tminor = 50.3 min, tmajor = 61.3 min; ee = 80%. FTIR (neat): υ 3361, 
2956, 1698, 1613, 1492, 1467, 1454, 1432, 1372, 1358, 1283, 1182, 1122, 1098, 1078, 
1045, 1005, 954, 924, 753, 722, 694, 660 cm-1. HRMS (CI) Calcd. for C19H20NO2 (M+1): 






1H NMR  
 
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-5-bromoindoline-2,3-dione 3.18b (62.6 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 5 mol%), CTH-(R)-P-PHOS (12.9 mg, 0.02 mmol, 10 
mol%), 4-cyano-3-nitrobenzoic acid (7.7 mg, 0.04 mmol, 20 mol%), Cs2CO3 (13.0 mg, 
0.04 mmol, 20 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and acetic acid 3-
buten-2-yl ester (51 μL, 0.40 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 100 oC for 72 hr, at which point the reaction mixture was concentrated 
in vacuo. Purification of the product by column chromatography (SiO2; ethyl 
acetate:toluene, 1:30 to 1:20) provided 3.20b (53.6 mg, 0.144 mmol, anti:syn=16:1) as a 
white solid in 72% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 10:1). 1H NMR (400 MHz, CDCl3): δ 7.44 
(d, J = 1.8 Hz, 1H), 7.34-7.25 (m, 6H), 6.59 (d, J = 8.4 Hz, 1H), 6.08-5.99 (m, 1H), 5.31-
5.28 (m, 2H), 5.00 (d, J = 15.7 Hz, 1H), 4.73 (d, J = 15.7 Hz, 1H), 2.93-2.86 (m, 1H), 
2.91 (brs, 1H), 0.86 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 117.3, 142.1, 
136.1, 135.0, 132.3, 130.4, 128.9, 128.1, 127.9, 127.3, 118.6, 115.6, 110.8, 78.1, 44.8, 
44.0, 13.2. HPLC: (Chiralpak OJ-H column, hexanes:i-PrOH = 93:7, 1.0 mL/min, 254 
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nm), tminor = 10.0 min, tmajor = 20.5 min; ee = 86%. FTIR (neat): υ 3300, 2972, 1693, 
1611, 1483, 1368, 1338, 1173, 1078, 908, 821, 742, 698, 655 cm-1. HRMS (CI) Calcd. 
for C19H20BrNO2 : 371.0521, Found: 371.0521. 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-5-methylindoline-2,3-dione 3.18c (50.2 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (13.0 mg, 
0.03 mmol, 20 mol%) and 2-methyl THF (2.0 mL, 0.1 M). The mixture was stirred at the 
ambient temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and acetic 
acid 3-buten-2-yl ester (51 μL, 0.40 mmol, 200 mol%) were added and the reaction 
mixture was allowed to stir at 100 oC for 40 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the product by column chromatography (SiO2; 
ethyl acetate:toluene, 1:20 to 1:10) provided 3.20c (49.8 mg, 0.162 mmol, anti:syn=18:1) 
as a white solid in 81% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 10:1). 1H NMR (400 MHz, CDCl3): δ 7.32-
7.21 (m, 5H), 7.15 (s, 1H), 7.01-6.98 (m, 1H), 6.60 (d, J = 8.0 Hz, 1H), 6.12-6.03 (m, 
1H), 5.27-5.18 (m, 2H), 5.00 (d, J = 15.7 Hz, 1H), 4.71 (d, J = 15.7 Hz, 1H), 3.08 (brs, 
1H), 2.94-2.87 (m, 1H), 2.29 (s, 3H), 0.84 (d, J = 6.7 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 177.8, 140.6, 136.8, 135.6, 132.3, 129.7, 128.7, 128.3, 127.6, 127.3, 125.7, 
117.9, 109.0, 78.2, 44.8, 43.9, 21.0, 13.3. HPLC: (Chiralpak AD-H + OD-H column, 
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hexanes:i-PrOH = 95:5, 0.4 mL/min, 254 nm), tminor = 100.5 min, tmajor = 104.8 min; ee = 
89%. FTIR (neat): υ 3341, 2924, 1693, 1624, 1603, 1495, 1454, 1414, 1374, 1352, 1195, 
1155, 1134, 810, 729, 696 cm-1.HRMS (CI) Calcd. for C20H21NO2 : 307.1572, Found: 
307.1577. 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-5-methoxyindoline-2,3-dione 3.18d (52.3 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (13.0 mg, 
0.03 mmol, 20 mol%) and 2-methyl THF (2.0 mL, 0.1 M). The mixture was stirred at the 
ambient temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and acetic 
acid 3-buten-2-yl ester (51 μL, 0.40 mmol, 200 mol%) were added and the reaction 
mixture was allowed to stir at 100 oC for 40 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the product by column chromatography (SiO2; 
ethyl acetate:toluene, 1:20 to 1:10) provided 3.20d (56.3 mg, 0.174 mmol, anti:syn=29:1) 
as a white solid in 87% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 8:1). 1H NMR (400 MHz, CDCl3): δ 7.35-
7.22 (m, 5H), 6.96 (d, J = 2.5 Hz, 1H), 6.70 (dd, J = 8.5, 2.5 Hz, 1H), 6.59 (d, J = 8.5 Hz, 
1H), 6.15-6.07 (m, 1H), 5.26-5.16 (m, 2H), 4.98 (d, J = 15.7 Hz, 1H), 4.68 (d, J = 15.7 
Hz, 1H), 3.72 (s, 3H), 3.59 (brs, 1H), 2.98-2.91 (m, 1H), 0.84 (d, J = 6.8 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): δ 177.7, 155.9, 136.7, 136.2, 135.5, 129.6, 128.7, 127.6, 127.3, 
117.8, 113.7, 112.1, 109.7, 78.5, 55.7, 44.6, 43.9, 13.1. HPLC: (Chiralcel OJ-H column, 
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hexanes:i-PrOH = 93:7, 1.0 mL/min, 254 nm), tminor = 15.1 min, tmajor = 30.5 min; ee = 
92%. FTIR (neat): υ 3383, 2969, 1695, 1603, 1488, 1455, 1435, 1371, 1346, 1269, 1199, 
1179, 1079, 1042, 1014, 955, 912, 878, 805, 782, 729, 697 cm-1. HRMS (CI) Calcd. for 
C20H21NO3: 323.3856, Found: 323.1521. 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-6-chloroindoline-2,3-dione 3.18e (53.5 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (6.5 mg, 
0.02 mmol, 10 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and acetic acid 3-
buten-2-yl ester (51 μL, 0.40 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 100 oC for 72 hr, at which point the reaction mixture was concentrated 
in vacuo. Purification of the product by column chromatography (SiO2; ethyl 
acetate:toluene, 1:20 to 1:10) provided 3.20e (45.9 mg, 0.140 mmol, anti:syn=19:1) as a 
colorless oil in 70% yield. 
TLC (SiO2): Rf = 0.24 (toluene:ethyl acetate, 10:1). 1H NMR (400 MHz, CDCl3): δ 7.36-
7.23 (m, 6H), 7.00 (dd, J = 7.9, 1.9 Hz, 1H), 6.71 (d, J = 1.9 Hz, 1H), 6.09-6.00 (m, 1H), 
5.28-5.16 (m, 2H), 5.00 (d, J = 15.7 Hz, 1H), 4.69 (d, J = 15.7 Hz, 1H), 3.07 (brs, 1H), 
2.93-2.86 (m, 1H), 0.83 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 177.8, 
144.3, 136.3, 135.4, 134.9, 128.9, 127.9, 127.3, 126.7, 125.8, 122.7, 118.3, 109.9, 77.8, 
44.7, 44.1, 13.1. HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 
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254 nm), tminor = 27.7 min, tmajor = 42.9 min; ee = 91%. FTIR (neat): υ 3393, 2973, 1708, 
1609, 1455, 1488, 1438, 1373, 1351, 1174, 1113, 1072, 954, 920, 875, 843, 813, 758, 
728, 699 cm-1. HRMS (CI) Calcd. for C19H18ClNO2: 328.1104, Found: 328.1107. 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-6-bromoindoline-2,3-dione 3.18f (63.1 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (6.7 mg, 0.01 mmol, 5 mol%), CTH-(R)-P-PHOS (12.9 mg, 0.02 mmol, 10 
mol%), 4-cyano-3-nitrobenzoic acid (7.7 mg, 0.04 mmol, 20 mol%), Cs2CO3 (13.0 mg, 
0.04 mmol, 20 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and acetic acid 3-
buten-2-yl ester (51 μL, 0.40 mmol, 200 mol%) were added and the reaction mixture was 
allowed to stir at 100 oC for 72 hr, at which point the reaction mixture was concentrated 
in vacuo. Purification of the product by column chromatography (SiO2; ethyl 
acetate:toluene, 1:30 to 1:20) provided 3.20f (60.3 mg, 0.162 mmol, anti:syn=15:1) as a 
colorless oil in 81% yield. 
TLC (SiO2): Rf = 0.25 (toluene:ethyl acetate, 20:1). 1H NMR (400 MHz, CDCl3): δ  
7.36-7.17 (m, 7H), 6.87-6.86 (m, 1H), 6.08-5.99 (m, 1H), 5.28-5.15 (m, 2H), 5.00 (d, J = 
15.7 Hz, 1H), 4.68 (d, J = 15.7 Hz, 1H), 3.05 (brs, 1H), 2.93-2.86 (m, 1H), 0.83 (d, J = 
6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 177.7, 144.4, 136.3, 134.9, 128.9, 127.9, 
127.3, 127.2, 126.2, 125.7, 123.2, 118.3, 112.6, 77.9, 44.6, 44.0, 13.1. HPLC: (Chiralpak 
AS-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 254 nm), tminor = 34.5 min, tmajor = 
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61.2 min; ee = 89%. FTIR (neat): υ 3392, 2971, 1707, 1604, 1485, 1455, 1429, 1373, 
1350, 1174, 1127, 1079, 1061, 1039, 997, 953, 909, 869, 727, 698 cm-1. HRMS (CI) 
Calcd. for C19H19BrNO2 (M+1): 372.0599, Found: 372.0599. 
1H NMR  
 






An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with 1-benzyl-7-fluoroindoline-2,3-dione 3.18g (50.7 mg, 0.20 mmol, 100 mol%), 
[Ir(cod)Cl]2 (3.4 mg, 0.005 mmol, 2.5 mol%), CTH-(R)-P-PHOS (6.5 mg, 0.010 mmol, 5 
mol%), 4-cyano-3-nitrobenzoic acid (3.9 mg, 0.020 mmol, 10 mol%), Cs2CO3 (6.5 mg, 
0.02 mmol, 10 mol%) and THF (2.0 mL, 0.1 M). The mixture was stirred at the ambient 
temperature for 0.5 hr. Isopropanol (62 μL, 0.805 mmol, 400 mol%) and acetic acid 3-
buten-2-yl ester (101 μL, 0.80 mmol, 400 mol%) were added and the reaction mixture 
was allowed to stir at 100 oC for 72 hr, at which point the reaction mixture was 
concentrated in vacuo. Purification of the product by column chromatography (SiO2; 
ethyl acetate:toluene, 1:20) provided 3.20g (39.9 mg, 0.128 mmol, anti:syn=19:1) as a 
white solid in 64% yield. 
TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 20:1). 1H NMR (400 MHz, CDCl3): δ 7.37-
7.24 (m, 5H), 7.13-7.11 (m, 1H), 7.04-6.96 (m, 2H), 6.05-5.96 (m, 1H), 5.25-5.14 (m, 
2H), 5.07 (d, J = 15.4 Hz, 1H), 4.99 (d, J = 15.4 Hz, 1H), 2.91-2.84 (m, 1H), 2.90 (brs, 
1H), 0.80 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 177.7, 147.4 (d, JC-F= 
244.6 Hz), 136.4 (d, JC-F= 26.9 Hz), 131.4 (d, JC-F= 3.0 Hz), 129.4 (d, JC-F= 8.2 Hz), 
128.5, 127.6, 123.6 (d, JC-F= 6.0 Hz), 120.8 (d, JC-F= 3.0 Hz), 118.1, 117.7 (d, JC-F= 19.4 
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Hz), 78.1 (d, JC-F= 1.5 Hz), 45.4 (d, JC-F= 5.2 Hz), 44.9, 13.0. HPLC: (Chiralpak OJ-H 
column, hexanes:i-PrOH = 97:3, 1.0 mL/min, 254 nm), tminor = 20.7 min, tmajor = 24.5 
min; ee = 85%. FTIR (neat): υ 3374, 2975, 1704, 1632, 1358, 1255, 1236, 1201, 1166, 















13C NMR  
 
 
General Pocedure for Enantioselective Reverse Prenylation of Isatins  
An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with [Ir(cod)Cl]2 (5.0 mg, 0.0075 mmol, 2.5 mol%), CTH-(R)-P-PHOS (9.7 mg, 0.015 
mmol, 5 mol%), 3-nitrobenzoic acid (3.8 mg, 0.0225 mmol, 7.5 mol%), Cs2CO3 (7.3 mg, 
0.0225 mmol, 7.5 mol%) and toluene (0.3 mL, 1.0 M). The mixture was stirred at 80 oC 
for 0.5 hr. Isatin (0.30 mmol, 100 mol%), 1,1-dimethylallene (59 μL, 0.6 mmol, 200 
mol%) and Isopropanol (46 μL, 0.6 mmol, 200 mol%) were added and the reaction 
mixture was allowed to stir at 60 oC for 40 hr, at which point the reaction mixture was 
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concentrated in vacuo. Purification of the product by column chromatography provided 





TLC (SiO2): Rf = 0.25 (toluene:ethyl acetate, 30:1). 1H NMR (400 MHz, CDCl3): δ 7.41 
(d, J = 7.5 Hz, 1H), 7.34-7.24 (m, 5H), 7.20 (dt, J = 7.7, 1.1 Hz, 1H), 7.02 (dt, J = 7.7, 
1.1 Hz, 1H), 6.70 (d, J = 7.9 Hz, 1H), 6.19 (dd, J = 17.5, 10.8 Hz, 1H), 5.22 (dd, J = 10.8, 
1.1 Hz, 1H), 5.15 (dd, J = 17.5, 1.1 Hz, 1H), 5.07 (d, J = 15.7 Hz, 1H), 4.64 (d, J = 15.7 
Hz, 1H), 2.89 (brs, 1H), 1.21 (s, 3H), 1.13 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 178.0, 
143.5, 141.9, 135.6, 129.4, 128.7, 128.4, 127.6, 127.4, 125.9, 122.2, 115.6, 109.0, 79.9, 
43.9, 43.7, 22.2, 20.0. HPLC: (Chiralcel OJ-H column, hexanes:i-PrOH = 90:10, 0.8 
mL/min, 254 nm), tmajor = 9.1 min, tminor = 12.7 min; ee = 96%., [α]D25 +139.6 (c 1.01, 
CHCl3). FTIR (neat): υ 3396, 3063, 2970, 2923, 1690, 1608, 1487, 1466, 1411, 1372, 
1341, 1260, 1188, 1156, 1122, 1096, 1079, 1050, 1027, 966, 950, 926, 907, 860, 847, 
800, 756, 746, 724, 694, 669 cm-1. HRMS (CI) Calcd. for C20H22NO2 (M+1): 308.1651, 
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TLC (SiO2): Rf = 0.3 (toluene:ethyl acetate, 30:1). 1H NMR (400 MHz, CDCl3): δ 7.51 
(d, J = 2.0 Hz, 1H), 7.34-7.25 (m, 6H), 6.56 (d, J = 8.4 Hz, 1H), 6.14 (dd, J = 17.5, 10.8 
Hz, 1H), 5.24 (dd, J = 10.8, 1.1 Hz, 1H), 5.16 (dd, J = 17.5, 1.1 Hz, 1H), 5.02 (d, J = 15.7 
Hz, 1H), 4.65 (d, J = 15.7 Hz, 1H), 2.88 (brs, 1H), 1.19 (s, 3H), 1.12 (s, 3H). 13C NMR 
(100 MHz, CDCl3): δ 177.4, 142.4, 141.4, 135.1, 132.1, 130.6, 129.1, 128.8, 127.7, 
127.3, 115.9, 115.0, 110.4, 79.8, 43.9, 43.7, 22.1, 19.9. HPLC: (Chiralpak AD-H column, 
hexanes:i-PrOH = 90:10, 1.0 mL/min, 254 nm), tmajor = 9.0 min, tminor = 15.2 min; ee = 
90%., [α]D26 +78.9 (c 1.00, CHCl3) FTIR (neat): υ 3377, 2969, 1689, 1601, 1495, 1479, 
1455, 1446, 1427, 1377, 1360, 1345, 1180, 1159, 1131, 1106, 1065, 1043, 1029, 1018, 
1006, 949, 918, 878, 854, 803, 748, 742, 728, 717, 697, 675 cm-1. HRMS (CI) Calcd. for 
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TLC (SiO2): Rf = 0.25 (toluene:ethyl acetate, 30:1). 1H NMR (400 MHz, CDCl3): δ 7.33-
7.22 (m, 6H), 7.04-6.98 (m, 1H), 6.58 (d, J = 8.0 Hz, 1H), 6.19 (dd, J = 17.5, 10.8 Hz, 
1H), 5.22 (dd, J = 10.8, 1.2 Hz, 1H), 5.15 (dd, J = 17.5, 1.2 Hz, 1H), 5.03 (d, J = 15.7 Hz, 
1H), 4.64 (d, J = 15.7 Hz, 1H), 2.82 (brs, 1H), 2.30 (s, 3H), 1.21 (s, 3H), 1.11 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ 177.9, 142.0, 141.1, 135.7, 131.7, 129.6, 128.6, 128.4, 127.5, 
127.3, 126.7, 115.4, 108.7, 80.0, 43.9, 43.6, 22.3, 21.1, 20.0. HPLC: (Chiralcel OJ-H 
column, hexanes:i-PrOH = 90:10, 0.8 mL/min, 254 nm), tmajor = 7.7 min, tminor = 9.7 min; 
ee = 93%., [α]D25 +83.9 (c 1.38, CHCl3). FTIR (neat): υ 3378, 2967, 2915, 1688, 1617, 
1602, 1496, 1469, 1455, 1412, 1379, 1363, 1347, 1198, 1178, 1103, 1053, 1031, 1018, 
1006, 975, 949, 924, 911, 884, 805, 776, 749, 743, 723, 696, 683, 664 cm-1. HRMS (CI) 
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TLC (SiO2): Rf = 0.30 (toluene:ethyl acetate, 30:1). 1H NMR (400 MHz, CDCl3): δ 7.33-
7.23 (m, 5H), 7.03 (d, J = 2.5 Hz, 1H), 6.72 (dd, J = 8.5, 2.6 Hz, 1H), 6.58 (d, J = 8.4 Hz, 
1H), 6.19 (dd, J = 17.5, 10.8 Hz, 1H), 5.22 (dd, J = 10.8, 1.2 Hz, 1H), 5.14 (dd, J = 17.5, 
1.2 Hz, 1H), 5.03 (d, J = 15.7 Hz, 1H), 4.62 (d, J = 15.7 Hz, 1H), 3.75 (s, 3H), 2.91 (brs, 
1H), 1.19 (s, 3H), 1.14 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 177.7, 155.5, 141.9, 
136.8, 135.7, 129.7, 128.7, 127.6, 127.3, 115.5, 113.7, 113.5, 109.3, 80.2, 55.8, 44.0, 
43.7, 22.2, 20.0. HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 90:10, 0.8 mL/min, 
254 nm), tmajor = 10.5 min, tminor = 12.2 min; ee = 96%. [α]D26 +97.2 (c 1.00, CHCl3). 
FTIR (neat): υ 3409, 2926, 1687, 1489, 1457, 1443, 1390, 1375, 1364, 1350, 1313, 1295, 
1203, 1181, 1150, 1101, 1082, 1050, 1035, 1019, 1003, 970, 949, 926, 917, 869, 802, 
772, 749, 741, 728, 696 cm-1. HRMS (CI) Calcd. for C21H23NO3 : 337.1678, Found: 







1H NMR  
 






TLC (SiO2): Rf = 0.30 (toluene:ethyl acetate, 30:1). 1H NMR (400 MHz, CDCl3): δ 7.34-
7.25 (m, 6H), 6.98 (dd, J = 8.0, 1.6 Hz, 1H), 6.68 (d, J = 1.2 Hz, 1H), 6.12 (dd, J = 17.6, 
10.4 Hz, 1H), 5.20 (d, J = 10.8 Hz, 1H), 5.12 (d, J = 17.6 Hz, 1H), 5.02 (d, J = 15.6 Hz, 
1H), 4.57 (d, J = 15.6 Hz, 1H), 3.00 (s, 1H), 1.16 (s, 3H), 1.12 (s, 3H). 13C NMR (100 
MHz, CDCl3): δ 177.8, 144.7, 141.5, 135.2, 135.1, 128.8, 127.8, 127.3, 126.9, 126.8, 
122.1, 115.8, 109.5, 79.5, 44.0, 43.7, 22.1, 19.9. HPLC: (Chiralcel AD-H column, 
hexanes:i-PrOH = 95:5, 1.0 mL/min, 254 nm), tmajor = 12.2 min, tminor = 15.8 min; ee = 
93%., [α]D26 +98.2 (c 1.43, CHCl3). FTIR (neat): υ 3434, 2969, 2360, 1710, 1606, 1488, 
1455, 1438, 1414, 1341, 1169, 1119, 1075, 959, 919, 868, 840, 817, 739, 722, 697 cm-1. 
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TLC (SiO2): Rf = 0.30 (toluene:ethyl acetate, 30:1). 1H NMR (400 MHz, CDCl3): δ 7.35-
7.13 (m, 7H), 6.83 (d, J = 8.0 Hz, 1H), 6.12 (dd, J = 17.6, 10.8 Hz, 1H), 5.20 (d, J = 10.8 
Hz, 1H), 5.12 (d, J = 17.6 Hz, 1H), 5.03 (d, J = 15.6 Hz, 1H), 4.57 (d, J = 15.6 Hz, 1H), 
2.97 (s, 1H), 1.16 (s, 3H), 1.11 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 177.7, 144.8, 
141.5, 135.0, 128.9, 127.8, 127.4, 127.3, 127.2, 125.1, 123.1, 115.9, 112.3, 79.6, 44.0, 
43.6, 22.1, 19.9. HPLC: (Chiralcel AS-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 
230 nm), tmajor = 12.8 min, tminor = 17.1 min; ee = 93%., [α]D26 +96.6 (c 1.24, CHCl3). 
FTIR (neat): υ 3431, 2923, 2359, 1709, 1601, 1485, 1455, 1429, 1340, 1169, 1120, 1063, 
1030, 959, 920, 859, 843, 816, 734, 712, 698 cm-1. HRMS (CI) Calcd. for 
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TLC (SiO2): Rf = 0.25 (toluene:ethyl acetate, 30:1). 1H NMR (400 MHz, CDCl3): δ 7.36-
7.18 (m, 6H), 7.02-6.92 (m, 2H), 6.11 (dd, J = 17.2, 10.4 Hz, 1H), 5.18 (d, J = 10.8 Hz, 
1H), 5.10 (d, J = 17.6 Hz, 1H), 5.03 (d, J = 15.2 Hz, 1H), 4.95 (d, J = 15.2 Hz, 1H), 3.00 
(s, 1H), 1.14 (s, 3H), 1.08 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 177.7, 147.2 (d, JC-F= 
243.8 Hz), 141.5, 136.7, 131.4, 129.0 (d, JC-F= 8.2 Hz), 128.5, 127.7, 127.5, 122.8 (d, JC-
F= 6.7 Hz), 121.9 (d, JC-F= 3.0 Hz), 117.7 (d, JC-F= 20.2 Hz), 115.7, 79.9 (d, JC-F= 1.5 
Hz), 45.4 (d, JC-F= 4.5 Hz), 43.8, 22.0, 19.9. HPLC: (Chiralcel AD-H column, hexanes:i-
PrOH = 95:5, 1.0 mL/min, 254 nm), tmajor = 11.3 min, tminor = 16.2 min; ee = 94%., [α]D26 
+99.6 (c 0.78, CHCl3). FTIR (neat): υ 3407, 2924, 1697, 1626, 1488, 1470, 1455, 1382, 
1361, 1247, 1197, 1162, 1133, 1028, 1005, 949, 924, 915, 867, 817, 779, 738, 710, 694 
cm-1. HRMS (CI) Calcd. for C20H21NO2F (M+H)+: 326.1556 Found: 326.1554. mp 
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Chapter 4: Total Synthesis of (+)-Roxaticin via C-C Bond Forming 
TransferHydrogenation 
4.1 INTRODUCTION 
Polyketide natural products represent a broad class of secondary metabolites that 
are used extensively in medicine.1,2 Many top selling small molecules are polyketides2,3 
and it is estimated that polyketides are five times more likely to possess drug activity than 
the other natural product families.3 As investigations in polyketide biosynthesis4 and 
chemical biology continue to uncover important biochemical pathways and novel 
therapeutic targets, the design of synthetic5 and bioengineered6 methods for polyketide 
construction remains at the forefront of current research. The complex issues of 
stereoselectivity posed by polyketides are most often addressed through the use of chiral 
auxiliaries, chiral reagents, and premetalated nucleophiles.5 Although these methods are 
highly effective, they often require multistage preactivation and excessive byproduct 
generation. By utilizing the recently developed asymmetric C-C bond forming transfer 
hydrogenation7, the total synthesis of (+)-roxaticin8,9,10 was achieved. 
4.2 SYNTHETIC PLAN 
This approach takes the advantage of carbonyl allylation7f,11a-d and crotylation7f,11e 
protocols recently developed in our laboratory, wherein primary alcohol dehydrogenation 
concurrently triggers aldehyde formation and reductive generation of allyliridium 
nucleophiles, enabling asymmetric carbonyl allylation and crotylation directly from the 
alcohol oxidation level. The synthetic plan is presented in Scheme 4.1. The macrocyclic 
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ring was formed according to the Yamaguchi method.12 Installation of the oxopentaene 
fragment exploited a sequence involving cross metathesis-Horner-Wadsworth-Emmons13 
olefination, which led to fragments 4.I and 4.II. Internal olefin of 4.II was prepared using 
cross metathesis reaction. Elaboration of the protected 1,3-polyol 4.V to (+)-roxaticin 
required differential elongation of the homotopic diol termini, which was achieved via 
sequential dehydration-cross-metathesis at C28 and direct carbonyl crotylation from the 
alcohol oxidation level at C14. Iterative two-directional carbonyl allylation of 1,3-
diols11c,d,14 was envisioned to deliver the requisite C2-symmetric 1,3-polyol substructure 
4.V. 


























































Scheme 4.1 Retrosynthetic analysis of (+)-roxaticin. 
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4.3 SYNTHESIS OF POLYOL FRAGMENT 4.IV 
Two directional bis C-allylation11c,d was conducted with 1,3-propanediol 4.1 
(Scheme 4.2). With the ortho-cyclometalated iridium C,O-benzoate (R)-I generated in 
situ from [Ir(cod)Cl]2, (R)-Cl,MeO-BIPHEP, 4-chloro-3- nitrobenzoic acid, and allyl 
acetate (Scheme 4.3), double allylation product 4.2 was isolated in 70% yield and >99% 
ee. The minor enantiomer of the monoadduct was converted to the meso-diastereomer of 
4.2.15,16 Interestingly, in the course of a synthetic approach to (+)-phorboxazole A,17 
 
 




Scheme 4.3 Ortho-cyclometalated iridium C,O-benzoate (R)-I generated in situ. 
 
the mono-TBS (tert-butyldimethylsilyl) derivative of C2-symmetric diol (S,S)-4.2 was 
prepared in seven steps from propylene glycol through successive use of Brown’s reagent 
for asymmetric carbonyl allylation, Ipc2(n-C3H5)B, and an improved procedure delivers 
(S,S)-4.2 in four steps from acetylacetone. On a larger scale (20 mmol), to mitigate cost, 
double allylation reactions were conducted using the corresponding (R)-BINAP complex, 
which provided 4.2 in 51% yield with equivalent levels of absolute stereocontrol. 
Conversion of 4.2 to acetonide 4.3 followed by ozonolysis of the olefinic termini 
provides the homologous diol 4.4, constituting “one iteration” of two-directional carbonyl 
allylation from the alcohol oxidation level. In principle, subsequent iterations of two-
directional carbonyl allylation could be performed from the diol or dialdehyde oxidation 
level. However, the β-alkoxy aldehydes were found to be quite unstable, whereas diol 
intermediates, such as 4.4, were highly tractable and could be stored for long periods of 
time under ambient conditions without decomposition. Therefore, in subsequent 
iterations of two-directional carbonyl allylation, ozonolysis reactions were quenched with 
NaBH4 to furnish the homologous diols. In large scale ozonolysis reactions, NaBH4 
reduction of the ozonide is preferred as this protocol circumvents generation of 
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stoichiometric organic byproducts; hence, facilitates product purification.18 Subsequent 
iteration of two-directional carbonyl allylation of 4.4 was conducted. Double allylation 
product 4.5 was produced in 71% yield and >20:1 dr, this reaction required shorter 
reaction time (48 hr) than the first double allylation. Protection with TBS group (4.6) 
followed by ozonolysis generated diol 4.7, which was ready for the third carbonyl bis-
allylation reaction. The final bis allylation produced bis-homoallylic alcohol 4.8 in 78% 
and >20:1 dr. Protecting group swap (4.9) followed by ozonolysis gave three acetonide 
protected diol 4.10. With three iterations of two-directional allylation, complete levels of 
catalyst-directed diastereoselectivity were observed, providing rapid access to the 
acetonide-protected C2-symmetric 1,3-polyol 4.10 as a single diastereomer. Thus, tris-
acetonide 4.10, which possesses six stereocenters, was prepared in only nine steps from 
1,3-propanediol (Scheme 4.2).  
Differentiation of diol temini of tris-acetonide 4.10 was required. As described in 




Scheme 4.4 Differential elongation of diol temini of 4.10. 
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Because the diol termini of 4.10 are homotopic, the selenylation product appeared as a 
component of a statistical mixture with 1.1 eq of o-(NO2)PhSeCN. Mono-selenide 4.11 
was obtained in 50% yield along with the formation of diselenide 4.11’ in 18% yield 
(Scheme 4.5). Recovered starting material 4.10 (21%) was submitted to the second round 




Scheme 4.5 Selenylation reaction of 4.10 with o-(NO2)PhSeCN. 
 
The second elimination step was very sensitive to base and the amount of H2O2. 
Among all the bases attempted, NaHCO3 appeared to be the best base additive (Table 4.1, 
entry 6). Reducing the amount of H2O2 from 1000 mol% to 500 mol% afforded the 
desired product 4.VI in 87% yield (Table 4.1, entry 7). 
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30% H2O2, (X mol%)
base (300 mol%)
THF (0.2 M), rt, 24 hr





































Tabel 4.1 Optimization of the elimination reaction of 4.11. 
 
4.4 SYNTHESIS OF FRAGMENT 4.II 
Cross metathesis was attempted with the previously prepared homoallylic ether 
  
 
Tabel 4.2 Optimization of cross metathesis of 4.VI. 
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4.1220 with various catalytic systems (Table 4.2). Hoveyda-Grubbs II catalyst was more 
reactive than Grubbs II catalyst in most cases. At high reaction temperature, 4.13 was 
produced in low yield because homo-dimerization dominated (Table 4.2, entry 1, 2, 4 and 
5). With 10 mol% of Hoveyda-Grubbs II catalyst, 53% of cross coupling product 4.13 
was obtained in DCM at 40 oC (Table 4.2, entry 7). 
Direct carbonyl crotylation from the alcohol oxidation level at C14 using the 
preformed iridium C,O-benzoate complex (S)-II (Scheme 4.6) delivered the desired 
adduct 4.II in 85% yield with 14:1 anti-diastereoselectivity (Scheme 4.7). Crotylation 
with Ir catalyst11e generated in situ showed lower selectivity (7:1) and required higher 
reaction temperature (90 oC). In most of the conventional carbonyl crotylation methods, 
the alcohol has to be oxidized to aldehyde for the reaction. However, the Ir catalytic 
system avoided the oxidation state manipulation and reduced the number of reaction 
steps.  
 
Scheme 4.6 Ortho-cyclometalated iridium C,O-benzoate (S)-II isolated by precipitation. 
 
 
Scheme 4.7 Direct carbonyl crotylation from the alcohol oxidation level. 
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4.5 ENDGAME OF (+)-ROXATICIN 
With homoallylic alcohol 4.II in hand, installation of the polyene substructure 
was undertaken. The unprotected homoallylic alcohol 4.II was subjected to cross-
metathesis with acrolein to deliver the corresponding enal 4.14 in 74% yield (BRSM) 
with complete (E)-selectivity as determined by 1H NMR (Scheme 4.8).21 TES protected 
ether 4.II’ did not participate in cross-metathesis, presumably due to the sterically 
demanding environment at the homoallylic olefin. 
 






















































DCE (0.1 M), 60 oC, 48 h
(two portions adding)
(1000 mol%)
Hoveyda-Grubbs II (15 mol%)
TESOTf (200 mol%)
lutidine (400 mol%)





Scheme 4.8 Cross-metathesis of 4.II with acrolein. 
 
Subsequent protection of the C14 alcohol provide the triethylsilyl (TES) ether 
4.15, which was followed by oxidative removal of the para-methoxybenzyl ether to 
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furnish hydroxy enal 4.16 (Scheme 4.9). Exposure of 4.16 to the previously reported 
Horner-Wadsworth-Emmons reagent, EtO2C(CH=CH)3CH2PO(OEt)222 delivered  
 
 
Scheme 4.9 Synthesis of polyunsaturated ester 4.16. 
 
polyunsaturated ester 4.17 in 61% yield. This transformation, which involved LHMDS 
mediated lithium enolate generation, represented the use of a premetalated C-nucleophile 
in the longest linear sequence.  
Ester hydrolysis followed by Yamaguchi lactonization2123 (4.18) and global 
deprotection, as practiced in prior syntheses by Mori9c-d and Evans,9e were attempted to 
deliver (+)-roxaticin (Table 4.3). Yamaguchi lactonization was very sensitive to the 
reaction temperature and time. High reaction temperature only gave a trace amount of 
product (Table 4.3, entry 1 and 2). Finally, 15% yield of roxaticin was obtained at 50 oC 
for 8 hr (Table 4.3, entry 3). Prolonging the reaction time improved product yield (Table 
4.3, entry 4). However, further increase of the reaction time decreased product yield, 
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presumably due to the instability of the product (Table 4.3, entry 5). This three-step 




Table 4.3 Optimization of macrolatonization. 
 
macrolactonization of 4.16’, which lacks a C14 hydroxyl protecting group, was 
unsuccessful under various reaction conditions (Scheme 4.10). 
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1. LiOH (5 eq)
THF:MeOH:H2O (4:1:1)
25 oC, 8 hr
4.18'  
 
Scheme 4.10 Attempted macrolactonization of 4.17’. 
 
4.6 SUMMARY 
In summary, in this novel application of “C-C bond forming hydrogenation” 
methodology, (+)-roxaticin was prepared from 1,3-propane diol over 20 steps (longest 
linear sequence), with a total number of 29 manipulations. Notably, 9 of 10 C-C bonds 
formed in the longest linear sequence were made via metal catalysis (7 hydrogen-
mediated C-C couplings, 2 cross-metatheses) in processes that exploit “native 
functionality” (alcohols, olefins). This approach circumvents additional manipulations 
associated with the use of non-native functional groups or substructures to mediate bond 
construction, as evident in the use of chiral auxiliaries; it also minimized 
(re)functionalizations, especially redox manipulations. Indeed, as demonstrated in 
carbonyl additions from the alcohol oxidation level, as in the conversion of 4.13 to 4.II, 
the union of oxidation-construction events allows one to bypass discrete alcohol 
oxidation while gaining access to more tractable synthetic intermediates in the form of 
alcohols. These features are aligned with longstanding ideals of synthetic efficiency.24,25 
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4.7 EXPERIMENTAL SECTION 
 
General 
All reactions were run under an atmosphere of nitrogen. Tetrahydrofuran, toluene, 
dichloromethane were obtained from Pure-Solv MD-5 Solvent Purification System 
(Innovative Technology). Commercially available allyl acetate (Acros) and α-methyl 
allyl acetate (acetic acid 3-buten-2-yl ester, TCI) were purified by distillation prior to use. 
[Ir(cod)2Cl] was used as received from Strem Chemicals. Cesium carbonate were 
purchased from Alfa Aesar and used directly without further purification. Analytical thin-
layer chromatography (TLC) was carried out using 0.2-mm commercial silica gel plates 
(DC-Fertigplatten Kieselgel 60 F254). Infrared spectra were recorded on a Perkin-Elmer 
1600 spectrometer. High-resolution mass spectra (HRMS) were obtained on a Karatos 
MS9 and are reported as m/z (relative intensity). Accurate masses are reported for the 
molecular ion (M+1, M or M-1) or a suitable fragment ion. Nuclear magnetic resonance 
spectra (1H NMR and 13C NMR) spectra were recorded with a Varian Gemini (400 MHz) 
spectrometer for CDCl3 solutions and chemical shifts are reported as parts per million 
(ppm) relative to residual CHCl3 δH (7.26 ppm) and CDCl3 δC (77.0 ppm), respectively, 













To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (1.35 g, 2.012 mmol, 5 mol%), (R)-Cl,MeO-BIPHEP (2.61 g, 4.008 mmol, 
10 mol%), Cs2CO3 (5.22 g, 16.03 mmol, 40 mol%) and 4-chloro-3-nitrobenzoic acid 
(1.62 g, 8.016 mmol, 20 mol%) was added 1,4-dioxane (100 mL) followed by allyl 
acetate (43 mL, 0.401 mol, 1000 mol%). The reaction mixture was allowed to stir at 90 
oC for 0.5 hr and cooled to ambient temperature. 1,3-Propanediol (3.05 g, 40.08 mmol, 
100 mol%) in 1,4-dioxane (100 mL, 0.4 M) was added to the reaction mixture and the 
reaction mixture was allowed to stir at 90 oC for 72 hr. The reaction mixture was filtered 
through the pad of celite and evaporated in vacuo. Purification of the product by column 
chromatography (SiO2: ethyl acetate:hexanes 1:3 to 1:1 with 0.1% TEA) provided 4.2 
(4.36 g, 27.93 mmol, dr > 30:1) as pale yellow oil in 70% yield. 
TLC (SiO2): Rf = 0.25 (ethyl acetate:hexanes, 1:2). [α]24D = –23.5 (c = 1.0, CHCl3). 1H 
NMR (400 MHz, CDCl3): δ 5.86-5.75 (m, 2H), 5.15-5.09 (m, 4H), 4.01-3.94 (m, 2H), 
2.69 (br s, 2H), 2.28-2.23 (m, 4H), 1.62 (t, J = 6.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): 
δ 134.9, 118.3, 68.3, 42.2, 41.7. FTIR (neat): υ 3346, 3076, 3005, 2978, 2936, 1827, 
1641, 1433, 1335, 1230, 1131, 1071, 1046, 994, 871, 830 cm-1. HRMS (CI) Calcd. for 
C9H17O2 (M+H)+: 157.1229, Found: 157.1225. HPLC: Enantiomeric excess was 
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determined by HPLC analysis of bis-4-nitro-benzoate derivative of the product. 
(Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 254 nm), tminor = 17.2 
min, tmajor = 40.8 min; ee > 99%. 
1H NMR  
 
 








To a stirred solution of the diol 4.2 (3.5 g, 22.42 mmol, 100 mol%) in DCM (224 
mL, 0.1 M) were added 2,2-dimethoxypropane (41 mL, 0.336 mol, 1500 mol%) and 
pyridinium p-toluenesulfonate (0.56 g, 2.242 mmol, 10 mol%) at ambient temperature. 
The reaction mixture was stirred for 1 hr and quenched with saturated aq. NaHCO3 (100 
mL). The aqueous layer was extracted with DCM (100 mL × 2). The combined organic 
extracts were washed with brine (20 mL), dried over MgSO4, filtered and concentrated in 
vacuo. The residue was purified by column chromatography (SiO2: ethyl acetate:hexanes, 
1:50 to 1:15 with 0.1% TEA) to give the acetonide 4.3 (3.99 g, 20.33 mmol) as a 
colorless oil in 91% yield. 
TLC (SiO2): Rf = 0.40 (ethyl acetate:hexanes, 1:20). [α]24D = –56.0 (c = 1.0, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ 5.84-5.73 (m, 2H), 5.10-5.01 (m, 4H), 3.88-3.80 (m, 2H), 
2.33-2.25 (m, 2H), 2.21-2.13 (m, 2H), 1.59 (t, J = 7.6 Hz, 2H), 1.34 (s, 6H). 13C NMR 
(100 MHz, CDCl3): δ 134.7, 117.1, 100.5, 66.4, 40.4, 37.7, 25.1. FTIR (neat): υ 3077, 
2986, 2937, 1831, 1642, 1431, 1377, 1361, 1172, 1121, 1015, 993, 911, 833, 814 cm-1. 



















To a stirred solution of the acetonide 4.3 (3.8 g, 19.36 mmol, 100 mol%) in 
DCM/MeOH (1:1, 130 mL, 0.15 M) was bubbled ozone at −78 oC until a blue color 
persisted. The excess ozone was then purged with argon for 5 min. Sodium borohydride 
(7.3 g, 0.194 mol, 1000 mol%) was added in one portion at – 78 oC and the resulting 
solution was slowly warmed to ambient temperature. The mixture was stirred for 24 hr at 
ambient temperature, and then quenched with H2O (40 mL). The resulting mixture was 
concentrated and extracted with DCM (200 mL × 2). The combined organic extracts were 
dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by 
column chromatography (SiO2: ethyl acetate:hexanes, 1:1 to ethyl acetate:methanol, 20:1 
with 0.1% TEA) to give the diol 4.4 (3.42 g, 16.74 mmol) as a colorless oil in 86% yield. 
TLC (SiO2): Rf = 0.28 (ethyl acetate). [α]25D = –29.0 (c = 1.0, CH2Cl2). 1H NMR (400 
MHz, CDCl3): δ 4.08-4.00 (m, 2H), 3.71 (m, 4H), 2.62 (s, 2H), 1.75-1.69 (m, 4H), 1.66 
(t, J = 7.6 Hz, 2H), 1.34 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 100.8, 66.8, 61.1, 38.3, 
37.9, 25.1. FTIR (neat): υ 3357, 2986, 2939, 2879, 2359, 1654, 1441, 1416, 1381, 1223, 
1164, 1123, 1014, 974, 937, 902, 877 cm-1. HRMS (CI) Calcd. for C10H21O4 [M+H]+: 
















To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (0.58 g, 0.857 mmol, 5 mol%), (S)-Cl,MeO-BIPHEP (1.12 g, 1.714 mmol, 
10 mol%), Cs2CO3 (2.23 g, 6.856 mmol, 40 mol%) and 4-chloro-3-nitrobenzoic acid 
(0.69 g, 3.428 mmol, 20 mol%) was added THF (43 mL) followed by allyl acetate (1.85 
mL, 0.171 mol, 1000 mol%). The reaction mixture was allowed to stir at 90 oC for 0.5 hr 
and cooled to ambient temperature. The diol 4.4 (3.5 g, 17.14 mmol, 100 mol%) in THF 
(43 mL) was added to the reaction mixture and the reaction mixture was allowed to stir at 
110 oC for 48 hr. The reaction mixture was filtered through the pad of celite and 
evaporated in vacuo. Purification of the product by column chromatography (SiO2: ethyl 
acetate:hexanes 1:3 to 1:1 with 0.1% TEA) provided 4.5 (3.46 g, 12.17 mmol, dr > 20:1) 
as pale yellow oil in 71% yield. 
TLC (SiO2): Rf = 0.30 (ethyl acetate:hexanes, 1:3). [α]24D = –18.0 (c = 1.0, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ 5.85-5.74 (m, 2H), 5.11-5.06 (m, 4H), 4.17-4.09 (m, 2H), 
3.86 (br m, 2H), 2.61 (br s, 2H), 2.25-2.15 (m, 4H), 1.66-1.55 (m, 6H), 1.33 (s, 6H). 13C 
NMR (100 MHz, CDCl3): δ 135.1, 118.0, 100.9, 67.9, 64.6, 42.3, 41.5, 38.0, 25.0. FTIR 
(neat): υ 3415, 3075, 2985, 2938, 2917, 2850, 1837, 1717, 1640, 1433, 1380, 1222, 1163, 
1129, 1081, 1035, 994, 869, 810 cm-1. HRMS (CI) Calcd. for C16H29O4 (M+H)+: 
285.2066, Found: 285.2066. 
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To a stirred solution of the diol 4.5 (0.49 g, 1.723 mmol, 100 mol%) in DMF (3.4 
mL, 0.5 M) were added imidazole (0.47 g, 6.892 mmol, 400 mol%) and TBSCl (0.78 g, 
5.169 mmol, 300 mol%) at ambient temperature. The reaction mixture was allowed to stir 
for 48 hr at 45 oC, and then quenched with H2O (5 mL). The reaction mixture was 
extracted with EtOAc (15 mL × 2). The combined organic extracts were washed with 
H2O (3 mL × 2), dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:50 to 1:30 with 0.1% 
TEA) to give 4.6 (0.75 g, 1.464 mmol) as a colorless oil in 85% yield. 
TLC (SiO2): Rf = 0.33 (ethyl acetate:hexanes, 1:30). [α]26D = +24.0 (c = 0.5, CHCl3). 1H 
NMR (400 MHz, CDCl3): δ 5.88-5.77 (m, 2H), 5.11-5.01 (m, 4H), 3.95-3.82 (m, 4H), 
2.30-2.16 (m, 4H), 1.67-1.41 (m, 6H), 1.33 (s, 6H), 0.89 (s, 18H), 0.68 (s, 12H). 13C 
NMR (100 MHz, CDCl3): δ 135.0, 127.2, 99.9, 68.8, 63.8, 44.1, 42.8, 39.3, 26.2, 25.9, 
18.3, -3.7, -4.2. FTIR (neat): υ 3078, 2989, 2945, 2929, 2882, 2856, 1641, 1472, 1462, 
1434, 1377, 1253, 1223, 1168, 1112, 1061, 1003, 948, 912, 833 cm-1. HRMS (CI) Calcd. 




1H NMR  
 








To a stirred solution of 4.6 (0.58 g, 1.132 mmol, 100 mol%) in DCM/MeOH (1:1, 
57 mL, 0.02 M) was bubbled ozone at −78 oC until a blue color persisted. The excess 
ozone was then purged with argon for 5 min. Sodium borohydride (0.43 g, 11.32 mmol, 
1000 mol%) was added in one portion at –78 oC and the resulting solution was slowly 
warmed to ambient temperature. The mixture was stirred for 12 hr at ambient 
temperature, and then quenched with H2O (5 mL). The resulting solution was then 
concentrated and extracted with DCM (20 mL × 2). The combined organic extracts was 
dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by 
column chromatography (SiO2: ethyl acetate:hexanes, 1:3 to 1:1 with 0.1% TEA) to give 
the diol 4.7 (0.50 g, 0.962 mmol) as a colorless oil in 85% yield. 
TLC (SiO2): Rf = 0.24 (ethyl acetate:hexanes, 1:2). [α]26D = +28.0 (c = 1.0, CHCl3). 1H 
NMR (400 MHz, CDCl3): δ 4.01-3.93 (m, 2H), 3.90-3.71 (m, 4H), 3.70-3.65 (m, 2H), 
2.40 (br s, 2H), 1.86-1.53 (m, 10H), 1.31 (s, 6H), 0.85 (s, 18H), 0.67 (s, 6H), 0.53 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 100.3, 69.1, 64.1, 59.7, 43.7, 39.4, 39.2, 26.1, 26.0, 25.7, 
18.2, -4.1, -4.3. FTIR (neat): υ 3398, 2986, 2951, 2992, 2882, 2856, 2242, 1472, 1462, 
1429, 1379, 1252, 1223, 1165, 1055, 1005, 938, 909 cm-1. HRMS (CI) Calcd. for 
C26H57O6Si2 [M+H]+: 521.3694, Found: 521.3691. 
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1H NMR  
 
 









To an oven-dried sealed tube under one atmosphere of nitrogen gas charged with 
[Ir(cod)Cl]2 (32.2 mg, 0.048 mmol, 5 mol%), (S)-Cl,MeO-BIPHEP (62.5 mg, 0.096 
mmol, 10 mol%), Cs2CO3 (0.125 g, 0.384 mmol, 40 mol%) and 4-chloro-3-nitrobenzoic 
acid (39 mg, 0.192 mmol, 20 mol%) was added THF (2.4 mL) followed by allyl acetate 
(1.04 mL, 9.599 mol, 1000 mol%). The reaction mixture was allowed to stir at 90 oC for 
0.5 hr and cooled to ambient temperature. The diol 4.7 (0.5 g, 0.960 mmol, 100 mol%) in 
THF (2.4 mL) was added to the reaction mixture and the reaction mixture was allowed to 
stir at 110 oC for 48 hr, at which point the reaction mixture was evaporated onto silica 
gel. Purification of the product by column chromatography (SiO2: ethyl acetate:hexanes 
1:5 to 1:3 with 0.1% TEA) provided 4.8 (0.45 g, 0.749 mmol, dr > 20:1) as pale yellow 
oil in 78% yield. 
TLC (SiO2): Rf = 0.28 (ethyl acetate:hexanes, 1:3). [α]26D = +15.0 (c = 0.3, CHCl3). 1H 
NMR (400 MHz, CDCl3): δ 5.87-5.76 (m, 2H), 5.12-5.07 (m, 4H), 3.94-3.81 (m, 6H), 
2.99 (s, 2H), 2.21 (t, J = 6.4 Hz, 4H), 1.85-1.76 (m, 2H), 1.74-1.68 (m, 2H), 1.62-1.53 
(m, 6H), 1.32 (s, 6H), 0.88 (s, 18H), 0.79 (s, 12H). 13C NMR (100 MHz, CDCl3): δ 135.2, 
117.7, 100.5, 70.3, 69.0, 64.4, 44.4, 43.9, 42.6, 39.8, 26.1, 25.3, 18.1, -4.0, -4.1. FTIR 
(neat): υ 3432, 3075, 2948, 2928, 2856, 2030, 1720, 1641, 1472, 1462, 1429, 1379, 1359, 
 386
1251, 1223, 1165, 1115, 1063, 1003, 938, 912 cm-1. HRMS (CI) Calcd. for C32H65O6Si2 
(M+H)+: 601.4320, Found: 601.4318. 
1H NMR  
 








To a stirred solution of 4.8 (0.4 g, 0.666 mmol, 100 mol%) in methanol (6.7 mL, 
0.1 M) was added p-toluenesulfonic acid monohydrate (12.7 mg, 0.067 mmol, 10 mol%). 
The reaction mixture was stirred for 1 hr at ambient temperature. TLC analysis showed 
complete consumption of the starting material. The reaction mixture was diluted with 2,2-
dimethoxypropane (8.2 mL, 66.55 mmol, 10000 mol%) and stirred for 1 hr at ambient 
temperature. After concentrated in vacuo, the residue was diluted with 2,2-
dimethoxypropane (4.1 mL, 33.28 mmol, 5000 mol%) and stirred for 1 hr at ambient 
temperature. The reaction mixture was again concentrated in vacuo. 2,2-
Dimethoxypropane (4.1 mL, 33.28 mmol, 5000 mol%) was added and the reaction 
mixture was stirred for 1 hr at ambient temperature. The reaction mixture was diluted 
with EtOAc (30 mL) and washed with saturated aq. NaHCO3 (15 mL) and brine (15 mL). 
The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The residue 
was purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:20 to 1:15 with 
0.1% TEA) to give 4.9 (0.28 g, 0.619 mmol) as a colorless oil in 93% yield. 
TLC (SiO2): Rf = 0.38 (ethyl acetate:hexanes, 1:10). [α]26D = +18.5 (c = 0.6, CHCl3). 1H 
NMR (400 MHz, CDCl3): δ 5.82-5.72 (m, 2H), 5.08-5.01 (m, 4H), 4.06-3.98 (m, 4H), 
3.89-3.83 (m, 2H), 2.31-2.25 (m, 2H), 2.16-2.09 (m, 2H), 1.55-1.46 (m, 8H), 1.40 (s, 
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6H), 1.36 (s, 6H), 1.30 (s, 6H), 1.16-1.07 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 134.1, 
117.0, 100.4, 98.5, 68.7, 64.9, 62.4, 42.2, 40.8, 39.0, 36.8, 30.2, 24.4, 19.8. FTIR (neat): 
υ 2989, 2941, 2907, 2860, 2239, 2106, 1736, 1642, 1460, 1431, 1373, 1350, 1223, 1199, 
1143, 1111, 1024, 981, 939, 911, 881, 812 cm-1. HRMS (CI) Calcd. for C26H45O6 
[M+H]+: 453.3216, Found: 453.3216. 
 
 




















To a stirred solution of 4.9 (0.15 g, 0.331 mmol, 100 mol%) in in DCM/MeOH 
(1:1, 17 mL, 0.02 M) was bubbled ozone at −78 oC until a blue color persisted. The 
excess ozone was then purged with argon for 5 min. Sodium borohydride (0.0.125 g, 3.31 
mmol, 1000 mol%) was added in one portion at –78 oC and the resulting solution was 
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warmed to ambient temperature slowly. The mixture was stirred for 12 hr at ambient 
temperature, and then quenched with H2O (5 mL). The resulting mixture was 
concentrated and extracted with DCM (20 mL × 2). The combined organic extracts was 
dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by 
column chromatography (SiO2: ethyl acetate:hexanes, 1:1 to ethyl acetate:methanol 1:20 
with 0.1% TEA) to give the diol 4.10 (0.119 g, 0.258 mmol) as a colorless syrup in 78% 
yield. 
TLC (SiO2): Rf = 0.20 (ethyl acetate:hexanes, 1:1). [α]26D = +72.5 (c = 0.8, CHCl3). 1H 
NMR (400 MHz, CDCl3): δ 4.13-4.02 (m, 6H), 3.81-3.74 (m, 4H), 2.55-2.52 (m, 2H), 
1.74-1.70 (m, 4H), 1.58-1.50 (m, 6H), 1.44 (s, 6H), 1.43-1.38 (m, 2H), 1.37 (s, 6H), 1.30 
(s, 6H), 1.32-1.24 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 100.7, 98.9, 77.5, 69.6, 65.2, 
62.6, 60.9, 42.3, 39.1, 38.3, 37.3, 30.5, 24.6, 20.1. FTIR (neat): υ 3400, 2990, 2942, 
2917, 2882, 1467, 1422, 1380, 1346, 1242, 1222, 1198, 1167, 1137, 1095, 1049, 1010, 










1H NMR  
 
 











To a stirred solution of the alcohol 4.10 (288 mg, 0.626 mmol, 100 mol%) in THF 
(3.1 mL, 0.2 M) were added 2-nitrophenyl selenocyanate (156 mg, 0.689 mmol, 110 
mol%) and freshly distilled n-tributylphosphine (0.17 mL, 0.689 mmol, 110 mol%). The 
reaction mixture was stirred for 4 hr at ambient temperature and concentrated in vacuo. 
The residue was purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:15 
to 1:10 with 0.1% TEA) to give the selenide 4.11 (202 mg, 0.313 mmol) as a brownish 
oil in 50% yield and the starting diol 4.10 (61 mg, 0.131 mmol, 21% recovered yield). 
The recovered diol 4.10 was subjected to second round of mono-selenylation to 4.11 (29 
mg, 0.066 mmol, 10% yield). 
TLC (SiO2): Rf = 0.20 (ethyl acetate:hexanes, 1:1). [α]26D = +2.47 (c = 1.0, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ 8.28 (d, J = 8.0 Hz, 1H), 7.58 (d, J = 8.0 Hz, 1H), 7.51 (t, J = 
7.6 Hz, 1H), 7.30 (t, J = 7.6 Hz, 1H), 4.16-3.88 (m, 6H), 3.82-3.68 (m, 2H), 3.10-3.03 
(m, 1H), 2.97-2.90 (m, 1H), 2.56 (br s, 1H), 1.95-1.84 (m, 2H), 1.74-1.69 (m, 2H), 1.56-
1.46 (m, 6H), 1.43 (s, 3H), 1.42 (s, 3H), 1.40 (s, 3H), 1.37 (s, 3H), 1.31 (s, 6H), 1.29-1.15 
(m, 4H). 13C NMR (100 MHz, CDCl3): δ 146.8, 133.6, 133.5, 129.0, 126.5, 125.3, 100.5, 
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98.7, 98.6, 77.2, 69.7, 68.4, 64.9, 62.4, 62.3, 61.0, 42.2, 42.1, 38.9, 38.0, 37.0, 35.1, 30.3, 
30.2, 24.4, 21.5, 19.9, 19.8. FTIR (neat): υ 2945, 1591, 1514, 1381, 1333, 1304, 1248, 


























To a stirred solution of the selenide 4.11 (420 mg, 0.651 mmol, 100 mol%) in 
THF (13 mL, 0.05 M) were added NaHCO3 (164 mg, 1.953 mmol, 300 mol%) and H2O2 
(0.71 mL, 500 mol%, 30% w/w in H2O). The reaction mixture was stirred for 24 hr at 
ambient temperature and extracted with EtOAc. The combined organic extracts was 
washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The residue 
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was purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:3 with 0.1% 
TEA) to give the allylic ether 4.IV (251 mg, 0.566 mmol) as a colorless oil in 87% yield.  
TLC (SiO2): Rf = 0.45 (ethyl acetate:hexanes, 1:1). [α]26D = +11.3 (c = 0.8, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ 5.85-5.77 (m, 1H), 5.24 (d, J = 17.6 Hz, 1H), 5.11 (d, J = 
10.4 Hz, 1H), 4.37-4.33 (m, 1H), 4.14-4.01 (m, 5H), 3.78-3.75 (m, 2H), 2.55 (br s, 1H), 
1.74-1.70 (m, 2H), 1.61-1.46 (m, 8H), 1.45 (s, 3H), 1.44 (s, 3H), 1.41 (s, 3H), 1.37 (s, 
3H), 1.32 (s, 6H), 1.30-1.23 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 138.7, 115.3, 
100.4, 98.6, 70.3, 69.5, 64.9, 64.7, 62.3, 60.8, 42.1, 42.1, 38.9, 38.0, 37.1, 37.0, 30.3, 
30.2, 24.4, 19.8, 19.7. FTIR (neat): υ 3491, 2989, 2942, 2915, 1380, 1250, 1224, 1200, 
1169, 1142, 1040, 1013, 992, 938, 916, 874, 827, 792 cm-1. HRMS (CI) Calcd. for 
C24H43O7 [M+H]+: 443.3009, Found: 443.3011. 
1H NMR  
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To a stirred solution of 4.IV (245 mg, 0.554 mmol, 100 mol%) and 4.12(413 mg, 
1.662 mmol, 300 mol%) in DCM (5.5 mL, 0.1 M) was added Hoveyda-Grubbs catalyst 
2nd generation (35 mg, 0.055 mmol, 10 mol%). The reaction mixture was stirred for 24 hr 
at 40 oC and concentrated in vacuo. Purification of the product by column 
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chromatography (SiO2: ethyl acetate:hexanes 1:3 with 0.1% TEA) provided 4.13 (195 
mg, 0.29 mmol) as pale yellow oil in 53% yield. 
TLC (SiO2): Rf = 0.50 (ethyl acetate:hexanes, 1:1). [α]26D = +11.0 (c = 1.0, CHCl3). 1H 
NMR (400 MHz, CDCl3): δ 7.27 (m, 2H), 6.86 (dd, J = 6.8, 2.0 Hz, 2H), 5.65 (dd, J = 
15.6, 7.6 Hz, 1H), 5.46 (dd, J = 15.6, 6.4 Hz, 1H), 4.47 (s, 2H), 4.36-4.27 (m, 1H), 4.14-
4.02 (m, 5H), 3.80 (s, 3H), 3.80-3.74 (m, 2H), 2.96 (m, 1H), 2.54 (br s, 1H), 2.48-2.38 
(m, 1H), 1.83-1.78 (m, 1H), 1.74-1.70 (m, 2H), 1.60-1.52 (m, 6H), 1.44 (s, 6H), 1.40 (s, 
3H), 1.37 (s, 3H), 1.32 (s, 6H), 1.30-1.21 (m, 4H), 1.06 (d, J = 6.4 Hz, 3H), 0.93 (d, J = 
6.4 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 158.9, 135.7, 131.1, 129.8, 129.2, 113.6, 
100.4, 98.5, 98.4, 88.4, 74.7, 70.3, 69.3, 64.9, 64.7, 62.3, 60.6, 55.1, 42.1, 39.4, 38.9, 
38.2, 38.0, 37.5, 37.0, 30.9, 30.2, 24.3, 20.2, 19.7, 17.7, 15.2. FTIR (neat): υ 2997, 1979, 
1674, 1514, 1382, 1215, 1037, 935, 746, 696, 667 cm-1. HRMS (CI) Calcd. for C38H61O9  
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An oven-dried sealed tube under one atmosphere of nitrogen gas was charged 
with alcohol 4.13 (133 mg, 0.2 mmol, 100 mol%), (S)-II11k (20.7 mg, 0.02 mmol, 10 
mol%), K3PO4 (43 mg, 0.20 mmol, 100 mol%). THF (0.2 mL, 1.0 M), H2O (18 μL, 1.0 
mmol, 500 mol%) and crotyl acetate (68 mg, 0.60 mmol, 300 mol%) were added and the 
mixture was stirred at ambient temperature for 0.5 hr. The reaction mixture was allowed 
to stir at 70 oC for 48 hr, at which point the reaction mixture was concentrated in vacuo. 
Purification of the residue by column chromatography (SiO2; ethyl acetate: hexanes, 1:7 
with 0.1% TEA) provided 4.II (121.9 mg, 0.17 mmol) as a yellow oil in 85% yield (14:1 
dr). 
TLC (SiO2): Rf = 0.65 (ethyl acetate:hexanes, 1:3). [α]26D = +98.0 (c = 1.0, CH2Cl2). 1H 
NMR (300 MHz, CDCl3): δ 7.27 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 5.86-5.77 
(m, 1H), 5.65 (dd, J = 15.2, 7.6 Hz, 1H), 5.46 (dd, J = 15.2, 6.4 Hz, 1H), 5.07 (s, 1H), 
5.03 (d, J = 6.0 Hz, 1H), 4.47 (s, 2H), 4.34-4.26 (m, 1H), 4.14-3.98 (m, 5H), 3.79 (s, 3H), 
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3.72-3.66 (m, 1H), 3.45 (s, 1H), 2.97-2.94 (m, 1H), 2.44-2.39 (m, 1H), 2.24-2.20 (m, 
1H), 1.83-1.78 (m, 1H), 1.56-1.46 (m, 8H), 1.45 (s, 3H), 1.44 (s, 3H), 1.40 (s, 3H), 1.36 
(s, 3H), 1.32 (s, 6H), 1.30-1.20 (m, 4H), 1.05 (d, J = 7.2 Hz, 3H), 1.04 (d, J = 7.2 Hz, 
3H), 0.93 (d, J = 6.8 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ 158.9, 140.4, 135.7, 131.1, 
129.8, 129.2, 115.0, 113.6, 100.3, 98.6, 98.5, 88.4, 74.7, 74.6, 70.4, 70.2, 64.9, 64.7, 62.3, 
62.2, 55.1, 43.8, 42.1, 42.0, 39.7, 39.4, 38.9, 37.5, 37.4, 30.9, 30.2, 30.1, 24.3, 20.2, 19.8, 
19.8, 17.7, 15.4, 15.2. FTIR (neat): υ 3502, 2987, 2943, 1940, 1737, 1613, 1514, 1461, 
1431, 1380, 1301, 1247, 1224, 1200, 1168, 1127, 1087, 1037, 980, 936, 913, 874, 823, 
702 cm-1. HRMS (CI) Calcd. for C42H67O9  [M-H]+: 715.4786, Found: 715.4786 















To a stirred solution of 4.II (122 mg, 0.170 mmol, 100 mol%) and acrolein (48 
mg, 0.85 mmol, 500 mol%) in DCE (1.7 mL, 0.1 M) was added Hoveyda-Grubbs catalyst 
2nd generation (8.0 mg, 0.013 mmol, 7.5 mol%). The reaction mixture was stirred for 24 
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hr at 60 oC. Acrolein (48 mg, 0.85 mmol, 500 mol%) and Hoveyda-Grubbs catalyst 2nd 
generation (8.0 mg, 0.013 mmol, 7.5 mol%) were added and the reaction mixture was 
stirred for 24 hr at 60 oC. The reaction mixture was concentrated in vacuo. Purification of 
the product by column chromatography (SiO2: ethyl acetate:hexanes 1:3 with 0.1% TEA) 
provided the starting material 4.II (37 mg, 0.051mmol, 30% recovered yield) and the 
product 4.14 (66 mg, 0.09 mmol, 52% yield, 74% BRSM) as a pale yellow oil. 
TLC (SiO2): Rf = 0.25 (ethyl acetate:hexanes, 1:3). [α]26D = +70.0 (c = 1.0, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ 9.53 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 8.4 Hz, 2H), 6.94 (dd, J 
= 15.6, 8.0 Hz, 1H), 6.85 (d, J = 8.4 Hz, 2H), 6.12 (dd, J = 15.6, 8.0 Hz, 1H), 5.65 (dd, J 
= 15.2, 7.6 Hz, 1H), 5.45 (dd, J = 15.2, 6.0 Hz, 1H), 4.47 (s, 2H), 4.32-4.27 (m, 1H), 
4.12-3.98 (m, 5H), 3.86-3.80 (m, 2H), 3.79 (s, 3H), 2.97-2.93 (m, 1H), 2.49-2.40 (m, 
2H), 1.83-1.77 (m, 1H), 1.56-1.46 (m, 8H), 1.46 (s, 3H), 1.44 (s, 3H), 1.40 (s, 3H), 1.37 
(s, 3H), 1.31 (s, 3H), 1.30 (s, 3H), 1.28-1.19 (m, 4H), 1.15 (d, J = 6.8 Hz, 3H), 1.05 (d, J 
= 6.8 Hz, 3H), 0.93 (d, J = 6.4 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 194.0, 160.0, 
158.9, 135.7, 132.9, 131.1, 129.8, 129.2, 113.6, 100.4, 98.8, 98.5, 88.4, 74.8, 74.7, 70.8, 
70.3, 64.8, 64.7, 62.3, 62.2, 55.2, 43.2, 42.1, 41.9, 40.4, 39.4, 38.8, 37.5, 37.4, 30.9, 30.2, 
30.1, 24.3, 20.2, 19.8, 19.7, 17.7, 15.6, 15.2. FTIR (neat): υ 3508, 2987, 2940, 
1690,1613, 1514, 1459, 1380, 1301, 1247, 1224, 1200, 1168, 1127, 1085, 1036, 977, 936, 
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To a stirred solution of 4.14 (37 mg, 0.05 mmol, 100 mol%) in DCM (0.5 mL, 0.1 
M) were added 2,6-lutidine (23 µL, 0.2 mmol, 400 mol%) and TESOTf (23 µL, 0.1 
mmol, 200 mol%)  at -78 oC. The reaction mixture was stirred for 2 hr at -78 oC, and 
then quenched with saturated aq. NaHCO3 (2 mL). The reaction mixture was extracted 
with DCM. The combined organic extracts wase washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo. The residue was purified by column chromatography 
(SiO2: ethyl acetate:hexanes, 1:20 to 1:10 with 0.1% TEA) to give 4.15 (38 mg, 0.044 
mmol) as a yellow oil in 87% yield. 
TLC (SiO2): Rf = 0.60 (ethyl acetate:hexanes, 1:3). [α]26D = +29.0 (c = 1.0, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ 9.51 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 8.0 Hz, 2H), 6.90-6.85 
(m, 1H), 6.86 (d, J = 8.0 Hz, 2H), 6.09 (dd, J = 15.6, 8.0 Hz, 1H), 5.65 (dd, J = 15.6, 8.0 
Hz, 1H), 5.45 (dd, J = 15.2, 5.6 Hz, 1H), 4.47 (s, 2H), 4.34-4.26 (m, 1H), 4.10-3.96 (m, 
4H), 3.95-3.88 (m, 1H), 3.88-3.82 (m, 1H), 3.79 (s, 3H), 2.97-2.94 (m, 1H), 2.66-2.58 
(m, 1H), 2.46-2.38 (m, 1H), 1.84-1.76 (m, 1H), 1.56-1.46 (m, 8H), 1.44 (s, 3H), 1.39 (s, 
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6H), 1.34 (s, 3H), 1.32 (s, 6H), 1.28-1.21 (m, 4H), 1.12 (d, J = 6.4 Hz, 3H), 1.05 (d, J = 
6.0 Hz, 3H), 0.98-0.92 (m, 15H), 0.63 (q, J = 7.6 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ 
193.9, 160.4, 158.9, 135.6, 132.9, 131.1, 129.8, 129.1, 113.5, 100.3, 98.4, 98.2, 88.4, 
74.7, 71.5, 70.2, 65.6, 64.9, 64.7, 62.3, 55.1, 42.1, 42.0, 41.9, 41.8, 39.4, 38.9, 37.6, 
37.5,30.8, 30.2, 30.1, 24.3, 20.2, 19.7, 19.6, 17.7, 15.9, 15.1, 6.8, 5.0. FTIR (neat): υ 
2987, 2950, 2912, 2876, 1693, 1613, 1514, 1460, 1379, 1301, 1246, 1224, 1199, 1169, 
1128, 1083, 1034, 981, 938, 873, 854, 821, 781, 740, 726 cm-1. HRMS (CI) Calcd. for 
C49H81O10Si1 [M-H]+: 857.5599, Found: 857.5602. 
 
















To a stirred solution of 4.15 (38 mg, 0.044 mmol, 100 mol%) in DCM/H2O (1.4 
mL/0.07 mL, 0.03M) was added DDQ (13 mg, 0.057 mmol, 130 mol%) at 0 oC. The 
reaction mixture was stirred for 2 hr at 0 oC, and then quenched with saturated aq. 
NaHCO3 (0.5 mL). The reaction mixture was extracted with DCM. The combined organic 
extracts were washed with H2O, dried over MgSO4, filtered and concentrated in vacuo. 
The residue was purified by column chromatography (SiO2: ethyl acetate:hexanes, 1:7 to 
1:5 with 0.1% TEA) to give 4.16 (28 mg, 0.037 mmol) as a colorless oil in 85% yield. 
TLC (SiO2): Rf = 0.40 (ethyl acetate:hexanes, 1:3). [α]26D = +78.0 (c = 1.0, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ 9.50 (d, J = 7.6 Hz, 1H), 6.87 (dd, J = 15.6, 8.0 Hz, 1H), 
6.09 (dd, J = 15.6, 8.0 Hz, 1H), 5.62 (dd, J = 15.6, 6.8 Hz, 1H), 5.48 (dd, J = 15.6, 6.0 
Hz, 1H), 4.34-4.31 (m, 1H), 4.10-3.96 (m, 4H), 3.95-3.87 (m, 1H), 3.87-3.81 (m, 1H), 
3.16-3.13 (m, 1H), 2.66-2.57 (m, 1H), 2.36-2.31 (m, 1H), 1.74-1.67 (m, 1H), 1.59-1.45 
(m, 8H), 1.44 (s, 3H), 1.39 (s, 6H), 1.34 (s, 3H), 1.32 (s, 6H), 1.28-1.21 (m, 4H), 1.12 (d, 
J = 6.8 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.98-0.89 (m, 15H), 0.60 (q, J = 8.0 Hz, 6H). 
13C NMR (75 MHz, CDCl3): δ 194.0, 160.6, 134.8, 132.9, 130.9, 100.4, 98.5, 98.3, 79.5, 
71.6, 70.2, 65.7, 64.9, 64.7, 62.3, 42.2, 42.1, 41.8, 39.2, 38.9, 37.6, 30.4, 30.2, 30.1, 24.3, 
19.7, 19.6, 17.0, 15.9, 13.8, 6.8, 5.0. FTIR (neat): υ 3515, 2987, 2950, 2876, 1692, 1634, 
1459, 1379, 1224, 1199, 1168, 1142, 1084, 1021, 1006, 981, 938, 913, 874, 855, 816, 
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This entire experimental procedure was performed in the dark. To a stirred 
solution of EtO2C(CH=CH)3CH2PO(OEt)2 (34 mg, 0.111 mmol, 300 mol%) in THF 
(1.11 mL. 0.1 M) was added LHMDS (0.11 mL, 1.0 M in THF, 0.111 mmol, 300 mol%) 
at -78 oC. The reaction mixture was stirred for 30 min at -78 oC, and a solution of 4.16 
(28 mg, 0.037 mmol, 100 mol%) in THF (0.37 mL. 0.1 M) was added slowly -78 oC. The 
resulting solution was stirred for 30 min at -78 oC and gradually warmed to ambient 
temperature. The reaction mixture was stirred for an additional 8 hr, and then quenched 
with saturated aq. NH4Cl. The resulting solution was extracted with Et2O. The combined 
organic extracts were washed with brine, dried over MgSO4, filtered and concentrated in 
vacuo. The residue was purified by column chromatography (SiO2: ethyl acetate:hexanes, 
1:7 to 1:5 with 0.1% TEA) to give 4.17 (59 mg, 0.067 mmol) as a yellow oil in 61% 
yield. 
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TLC (SiO2): Rf = 0.55 (ethyl acetate:hexanes, 1:3). [α]26D = -11.0 (c = 1.0, CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ 7.31 (dd, J = 14.8, 11.2 Hz, 1H), 6.59 (dd, J = 14.4, 11.2 Hz, 
1H), 6.42 (dd, J = 14.0, 10.4 Hz, 1H), 6.34-6.25 (m, 3H), 6.20 (dd, J = 14.8, 10.4 Hz, 
1H), 6.07 (dd, J = 15.2, 10.0 Hz, 1H), 5.85 (d, J = 14.8 Hz, 1H), 5.74 (dd, J = 15.2, 8.0 
Hz, 1H), 5.62 (dd, J = 15.6, 6.8 Hz, 1H), 5.49 (dd, J = 14.8, 5.2 Hz, 1H), 4.28-4.36 (m, 
1H), 4.20 (q, J =7.2 Hz, 2H), 4.10-3.96 (m, 4H), 3.96-3.86 (m, 1H), 3.76-3.68 (m, 1H), 
3.20-3.12 (m, 1H), 2.37-2.33 (m, 2H), 1.74-1.67 (m, 1H), 1.56-1.44 (m, 8H), 1.43 (s, 
3H), 1.38 (s, 6H), 1.33 (s, 3H), 1.31 (s, 6H), 1.28-1.21 (m, 4H), 1.03-0.87 (m, 24H), 0.59 
(q, J = 8.0 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ 167.1, 144.4, 140.8, 139.0, 137.4, 
135.9, 134.8, 131.2, 131.0, 130.6, 130.5, 129.5, 120.3, 100.4, 98.6, 98.3, 79.6, 71.9, 70.2, 
66.2, 64.9, 64.7, 62.4, 62.3, 60.2, 42.6, 42.3, 42.1, 41.1, 39.2, 38.9, 37.6, 30.5, 30.2, 30.1, 
24.4, 19.8, 19.7,19.6, 17.1, 15.7, 14.3, 13.7, 6.9, 5.1. FTIR (neat): υ 3510, 2952, 2875, 
1708, 1622, 1578, 1459, 1379, 1300, 1248, 1224, 1199, 1168, 1128, 1007, 937, 912, 874, 
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This entire experimental procedure was performed in the dark. To a stirred 
solution of 4.17 (59 mg, 0.067 mmol, 100 mol%) in 4:1:1 THF/MeOH/H2O (3.35 mL, 
0.02 M) was added LiOH (0.34 mL, 1.0 M in H2O, 0.335 mmol, 500 mol%) at ambient 
temperature. The reaction mixture was stirred for 6 hr at ambient temperature, and diluted 
with saturated aq. NH4Cl. The resulting solution was extracted with EtOAc. The 
combined organic extracts were dried over MgSO4, filtered and concentrated in vacuo.  
 
The resulting seco-acid was employed directly in the next reaction. To a stirred 
solution of the seco-acid in THF (3.35 mL, 0.02 M) were added Et3N (19 µL, 0.134 
mmol, 200 mol%) and 2,4,6-trichlrobenzoyl chloride (16 µL, 0.101 mmol, 150 mol%). 
The reaction mixture was stirred for 3 hr at ambient temperature, filtered through the pad 
of celite and diluted with toluene (10 mL). This solution was added over a period of 8 hr 
using a syringe pump to a solution of 4-dimethylaminopyridine (327 mg, 2.68 mmol, 
4000 mol%) in toluene (133 mL, 0.02 M) at 50 oC. The reaction mixture was stirred for 
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an additional 4 hr, and toluene was removed under reduced pressure. The cloudy oil was 
diluted in 1:1 hexanes/ethyl acetate, filtered through a silica plug over a pad of celite and 
washed with 1:1 hexanes/ethyl acetate, then concentrated under reduced pressure to 
afford a bright yellow oil. The resulting oil was used directly in the next reaction. 
A solution of protected crude roxaticin in MeOH (5 mL) was treated with Dowex 
50Wx8 acidic resin (100 mg). After being stirred for 4 hr, the mixture was filtered and 
concentrated in vacuo. Purification by preparative reverse-phase thin-layer 
chromatography (RP-18, 100x100x0.25 mm, two plate, 10% H2O/MeOH) gave (+)-
roxaticin (12.6 mg, 0.0208 mmol, 31% yield) as a yellow solid.  
[α]26D = +11.3 (c = 0.17, dioxane).26 1H NMR (400 MHz, DMSO- d6): δ 7.11 (dd, J = 
15.6, 11.6 Hz, 1H), 6.69 (dd, J = 15.2, 10.8 Hz, 1H), 6.47 (dd, J = 14.4, 11.2 Hz, 1H), 
6.42-6.26 (m, 4H), 6.10 (dd, J = 15.2, 10.0 Hz, 1H), 5.88 (dd, J = 15.6, 7.2 Hz, 1H), 5.82 
(d, J = 15.2 Hz, 1H), 5.54 (dd, J = 15.6, 5.1 Hz, 1H), 5.34 (dd, J = 16.0, 3.6 Hz, 1H), 5.01 
(s, 1H), 4.65 (dd, J = 7.2, 2.5 Hz, 1H), 4.59 (d, J = 3.6 Hz, 1H), 4.36 (d, J = 4.0 Hz, 1H), 
4.20 (d, J = 5.4 Hz, 1H), 4.15 (m, 1H), 4.12 (d, J = 5.0 Hz, 1H), 3.93 (d, J = 5.8 Hz, 1H), 
3.84 (m, 1H), 3.98-3.72 (m, 5H), 3.42 (m, 1H), 2.55 (m, 2H), 1.86 (m 1H), 1.48 (m, 2H), 
1.40-0.99 (m, 10H), 1.00 (d, J = 6.9 Hz, 3H), 0.98 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6 
Hz, 3H), 0.84 (d, J = 6.6 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.1, 144.6, 
141.1,139.2, 137.6, 135.7, 133.1, 131.0, 130.4, 129.4, 129.1, 128.7, 120.2, 79.3, 71.0, 
69.8, 67.7, 64.9, 64.3, 62.9, 62.4, 47.3, 46.7, 46.6, 44.4, 44.3, 42.6, 40.9, 35.7, 28.8, 19.7, 
18.7, 13.7, 10.8. FTIR (neat): υ 3410, 1708, 1612, 1588, 1379, 1304, 1268, 1138, 1007, 
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933, 910, 872, 737 cm-1. HRMS (ESI) Calcd. for C41H73O9Si1 [M+Na]+: 629.3600, 
Found: 629.3663. 
1H NMR  
 
13C NMR  
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